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1.1  The health care problem addressed in this thesis
Of the older patients who visit their general practitioner 5-10% has a depres-
sive disorder (Lyness et al., 1999; Schulberg et al., 1998). Depression causes 
suffering and is associated with serious disability, reduced quality of life and 
general functioning. The prognosis of depression in elderly community and 
primary care populations is poor. It was found that only 12% of older primary 
care patients had recovered after six months (Schulberg et al., 1998), and in a 
meta-analysis it was estimated that 33% had recovered after two years (Cole 
et al., 1999). In a prospective study in the community, 23% of the patients had 
recovered after six years. (Beekman et al., 2002). If depression in the elderly 
remains untreated, it increases mortality from co-morbid medical conditions or 
suicide, and increases service utilisation and demands on caregivers (Charney 
et al., 2003; Penninx et al., 2000). Therefore, delivering efficacious treatments is 
of major importance for this group of patients.
Although more than 80% of older depressed persons regularly contact their 
general practitioner (Beekman et al., 1997), many of them do not receive specific 
depression care, despite the existence of efficacious treatment options such as 
treatment with antidepressants or psychotherapy (Baldwin et al., 2003). 
An important barrier to adequate care is that depression is often not diag-
nosed. Especially in elderly patients, neither the patient and his family, nor the 
general practitioner may recognise or acknowledge the symptoms of depres-
sion. In older patients, depressed mood is often less prominent than other 
depressive symptoms such as loss of appetite, sleeplessness, anergia, and loss 
of interest and enjoyment of the normal pursuits of life. Additionally, older 
patients frequently have physical illnesses and/or social and economic prob-
lems. The depressive symptoms may be interpreted as a “normal” consequence 
of these problems (Lebowitz et al., 1997). 
Case vignette
Mr. Jansen (66) and his wife visit the general practioner (GP). During the last 
year Mr. J. has not been feeling well: he is tired, has sleeping problems, has been 
losing weight, and has stopped most of his social activities. His wife advised 
him many times to go to see the doctor, but he did not want to. Now, she has 
forced him to come with her. Mrs. J.  thinks that maybe he has a physical dis-
ease that explains his lack of energy and weight loss, and she asks for further 
examination. The general practitioner explores the symptoms, does orienting 
physical examination, and decides to do several blood tests to check for pos-
sible abnormalities. They make a new appointment for the following week to 
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discuss the findings. During this second appointment the GP states that no 
signs of a physical disease were detected. Mrs.J. proposes further examination 
in a specialist health centre. However, the general practitioner considers the 
probability that Mr. J. suffers from depression. He explores depressive symp-
toms, alcohol use, and psychosocial circumstances. He concludes that the com-
plaints might very well be explained by a depressive disorder. The depression 
may be related to Mr. J.’s recent retirement. Possibly, alcohol abuse also plays a 
role, as alcohol induces depression. 
The GP discusses the depression and its possible association with recent life 
changes and alcohol use. This interpretation of the symptoms makes Mr. J. and 
his wife uncomfortable. As they have already spent far more than 10 minutes 
at this session, they are advised to think about what has been discussed, and 
are given written information about depression. A new appointment is made. 
A week later, Mrs. J. comes alone. Again, it is suggested that depression is the 
most probable explanation for the symptoms. Mrs. J. now agrees. She tells the 
GP that there were indeed some problems after her husband retired. She got 
nervous of him being around all the time, commenting on her housework. Her 
husband has had difficulty finding new activities, and she thinks he misses 
his work. He has started drinking more alcohol. Yet, they do not talk about this, 
they were never good at discussing “emotional things”. The possible treatment 
options are discussed: antidepressant medication as well as psychotherapy 
may be effective. Mrs. J. will talk to her husband about this and try to motivate 
him for one of these options. 
In this case vignette several aspects of diagnosing depression are illustrated: 
First, physical symptoms were presented as the main problem. These had to be 
explored and a physical disease ruled out. Second, the “shift” from a physical 
complaint to a psychological/psychiatric interpretation had to be made. It took 
several sessions before at least the patient’s wife accepted the labelling of de-
pression. Third, the patient will have to be motivated and well informed, before 
he will accept and comply with depression treatment. 
Even when depression is diagnosed and a treatment plan is proposed,  
there are still barriers that may cause insufficient depression treatment: physi-
cian related barriers (e.g. inadequate dosing of antidepressants and insuffi-
cient monitoring of symptoms and side-effects), patient-related barriers (e.g. 
non-adherence to treatment, refusing referral because of fear of stigma), and 
system-related barriers (e.g. psychotherapy not available within primary care) 
(Wetherell & Unutzer, 2003; Alexopoulos, 2001).
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1.2  Depression treatment guidelines for general practice
For classification of mental diseases the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV, American Psychiatric Association, 2000) is most  
frequently used. The DSM-IV criteria for major depressive disorder are pre-
sented in Table 1.1. The mood module of the PRIMary care Evaluation of Mental 
Disorders (PRIME-MD; Spitzer et al., 1994), which is based on DSM-IV, is often 
used in primary care research (Table 1.2).
Table 1.1  Diagnosis of major depressive disorder (DSM-IV-criteria) 
Major Depressive Episode 
A)  Five (or more) of the following symptoms have been present during the 
same 2-week period and represent a change from previous functioning; 
at least one of the symptoms is either (1) depressed mood or (2) loss of 
interest or pleasure.
 1)  Depressed mood most of the day, nearly every day, as indicated by 
either subjective report (e.g., feels sad or empty) or observation made by 
others (e.g., appears tearful).
 2)  Markedly diminished interest or pleasure in all, or almost all, activities 
most of the day, nearly every day (as indicated by either subjective ac-
count or observation made by others)
 3)  Significant weight loss when not dieting or weight gain (e.g., a change 
of more than 5% of body weight in a month), or decrease or increase in 
appetite nearly every day.
 4) Insomnia or hypersomnia nearly every day.
 5)  Psychomotor agitation or retardation nearly every day (observable by 
others, not merely subjective feelings of restlessness or being slowed 
down).
 6) Fatigue or loss of energy nearly every day.
 7)  Feelings of worthlessness or excessive or inappropriate guilt (which 
may be delusional) nearly every day (not merely self-reproach or guilt 
about being sick).
 8)  Diminished ability to think or concentrate, or indecisiveness, nearly 
every day (either by subjective account or as observed by others).
 9)  Recurrent thoughts of death (not just fear of dying), recurrent suicidal 
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ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide 
B) The symptoms do not meet criteria for a Mixed Episode.
C)  The symptoms cause clinically significant distress or impairment in 
social, occupational, or other important areas of functioning.
D)  The symptoms are not due to the direct physiological effects of a sub-
stance (e.g., a drug of abuse, a medication) or a general medical condi-
tion (e.g., hypothyroidism).
E)  The symptoms are not better accounted for by Bereavement, i.e., after 
the loss of a loved one, the symptoms persist for longer than 2 months 
or are characterised by marked functional impairment, morbid preoc-
cupation with worthlessness, suicidal ideation, psychotic symptoms,  
or psychomotor retardation. 
Diagnostic Criteria for Major Depressive Disorder 
A. Presence of Major Depressive Episode.
B. The Major Depressive Disorder is not better accounted for by Schizo-
affective Disorder and is not superimposed on Schizophrenia, Schizo-
phreniform Disorder, Delusional Disorder, or Psychotic Disorder Not 
Otherwise Specified. 
C. There has never been a Manic Episode, a Mixed Episode, or a Hypo-
manic Episode. 
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Table 1.2  PRIME-MD mood module 
Major Depression
For the last 2 weeks, have you had any of the following problems  
nearly every day?
1. Trouble falling or staying asleep, or sleeping too much? Yes No
 
2. Feeling tired or having little energy? Yes No
 
3. Poor appetite or overeating? Yes No
 
4. Little interest or pleasure in doing things? Yes No
 
5. Feeling down, depressed, or hopeless? Yes No
 
6.  Feeling bad about yourself – or that you are a failure Yes No 
or have let yourself or your family down?
 
7.  Trouble concentrating on things, such as reading the Yes No 
newspaper or watching television?
 
8.  Being so fidgety or restless that you were moving around 
a lot more than usual? 
If No: What about the opposite – moving or speaking so 
slowly that other people could have noticed?  
Count as Yes if Yes to either question, or if psycho-    Yes    No
 motor agitation or retardation observed during interview. 
 
9.  In the last 2 weeks, have you had thoughts that you would Yes No 
be better off dead or of hurting yourself in some way? 
If Yes: Tell me about it. 
 
10.  Are answers to five or more of #1 to #9  Yes  Yes No 





In the Netherlands, the majority of depressed patients are treated in general 
practice (Verhaak, 1993). The Dutch College of General Practitioners (NHG) has 
developed a depression treatment guideline (Van Marwijk et al, 1994), which 
has recently been revised (Van Marwijk et al., 2003). After depression is diag-
nosed, the first steps in a depression treatment plan consist of exploring the 
existence of potential co-morbid disorders (and treating them), giving psycho-
education about depression and giving lifestyle advices. If the depression has 
lasted for less than three months, no other specific interventions are advised 
(“watchful waiting”), because in the general population 50% of younger adults 
recover spontaneously within three months (Spijker et al., 2002). When patients 
still have symptoms after three months, antidepressant drug treatment and/or 
short-term psychotherapy are indicated. Usually, depression treatment consists 
of antidepressant drug treatment, because drug treatment fits well into the 
usual practice of the GP and referral is not necessary. 
The question is whether these guidelines, which are mainly based on 
research in younger adults, should be applied to older patients. For example, 
relatively little is known about the effectiveness of the main treatment options 
(antidepressants and some forms of psychotherapy) for older depressed pa-
tients in general practice. In a review on treatments for late life depression in 
primary care, Freudenstein (2001) found no studies of psychological treatment, 
nor any high quality studies of drug treatment. Furthermore, it may be doubted 
whether the watchful waiting time period of three months is adequate for 
older patients, given the poor prognosis of untreated depression in the elderly. 
Moreover, the need for easily accessible psychotherapy for older depressed pa-
tients should probably be more emphasized, as these patients are at risk from 
side effects of antidepressants and from drug interactions. They are also more 
reluctant to be referred (Bartels et al., 2004). 
1.3 Intervention to improve depression care for elderly patients in  
general practice
The starting point of our research project was to contribute to improved 
depression care for older patients in general practice. We knew that depres-
sion in older primary care patients is a serious health care problem and that 
the efficacy of antidepressant drugs and some forms of psychotherapy (e.g., 
Interpersonal Psychotherapy, IPT) for elderly secondary care patients has been 
proven (Reynolds,  et al., 1999; Wilson et al., 2001). However, these studies were 
conducted under strictly controlled conditions: only motivated patients with 
no (somatic) co-morbidity were included, the selected therapists and doctors 
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were highly skilled, and the treatment effect was based on a comparison with 
placebo. No studies were available on the effectiveness of these interventions 
for older patients in “normal life” general practice. We also knew that several 
barriers obstructed the application of these evidence-based treatments to gen-
eral practice. 
Representatives of both the Departments of General Practice and Psychia-
try at our research institute (Institute for Research in Extramural Medicine 
(EMGO), VU University Medical Centre, Amsterdam) joined the project group. 
We chose to focus on two barriers to optimal depression treatment: the insuf-
ficient detection and acknowledgment of major depression, and the absence of 
evidence based psychotherapy in most general practices. By removing these 
barriers we would be able to study the effectiveness of the psychotherapy inter-
vention compared with usual GP care for older depressed patients in general 
practice. 
For detecting depression we used a screening procedure that identified 
patients with major depressive disorder according to DSM-IV. This strategy, 
screening for depression, is somewhat contradictory to the usual approach of 
GPs: the problem as presented by the patient is usually the basis for further 
action. In addition, GPs are less focused at classification of depression or other 
mental disorders than psychiatrists, because psychic problems in primary care 
patients are often diffuse and less pronounced than in secondary care. Yet, be-
cause we wanted to target underdiagnosis of depression and we assumed that 
evidence based psychotherapy would be helpful for all detected patients with 
major depressive disorder, we considered screening a suitable approach. 
As evidence based psychotherapy we chose interpersonal psychotherapy 
(IPT) to be delivered by specialist mental health workers within general prac-
tice. We had several reasons for choosing this method:
•   At the time we started our project, IPT and Cognitive Behavioural Therapy 
(CBT), were mentioned in most depression treatment guidelines as evidence 
based psychotherapies. We chose IPT, because it had not only proven to be 
effective in older patients (Reynolds et al., 1999) and in adult primary care 
patients (Schulberg et al., 1996), but it can also be learnt relatively easily by 
therapists with different therapeutic backgrounds. It is time-limited, and the 
treatment protocol is available in a manual (Weissman et al., 2000). At the 
beginning of the therapy the therapist discusses and labels the depressive 
symptoms as a disorder that can be treated. He/she emphasizes the interac-
tion between depressive symptoms and social relationships. Together, the 
therapist and patient choose a specific psychosocial problem to work through 
– 15 –
and solve. The therapist has an active role in educating the patient about 
depression and in supporting the improvement of relationships and social 
functioning. The IPT format fits well to the problems of older patients (Miller 
et al., 1997).
•   Therapists instead of GPs themselves delivered the psychotherapy, because 
providing IPT is very time-consuming and not part of GPs vocational back-
ground. Therefore, training of GPs to carry out psychotherapy was not con-
sidered to be feasible. 
•   The IPT was to be delivered within the general practice, because in the Neth-
erlands, GPs are the gatekeepers of the health system. The high numbers of 
elderly depressed people that visit their GP (>80% yearly) in combination with 
the high costs and the negative stigma attached to formal psychiatric treat-
ment, supported the idea that treatment for late life depression should be 
centred within primary care. 
•   In recent years, the transfer of expertise from specialised care settings to the 
primary care setting has had priority in Dutch health policy. The develop-
ment and implementation of a transmural psychotherapeutic intervention, 
aimed to serve large numbers of older depressed patients in primary care, 
was therefore highly relevant for public health. If it could be demonstrated 
that it is feasible and effective to deliver evidence based psychotherapy 
transmurally, this would prove that ‘expertise transfer’ and collaboration 
between primary and secondary care settings is an effective approach in 
daily practice, and that organisational changes, necessary to implement this 
intervention, should be supported. 
1.4  Preparation of the randomised controlled trial
We sent a letter, describing the project and asking for participation, to key 
representatives of specialist mental health centres and general practices in 
and around Amsterdam. About one week later we contacted them by telephone. 
Four Specialist Mental Health Centres and 12 (mostly group) general practices 
agreed to participate. 
Our research assistants carried out the patient screening procedure. They 
visited the practices every month to collect the names and addresses of the pa-
tients aged 55 years or older who had recently visited the GP. To these patients 
we sent a letter on behalf of their GP, in which they were asked to complete and 
return the screening questionnaire to our Research Institute. By performing the 
screening procedure in this way, we avoided probable bias from patient selec-
tion by the GP. 
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Although many therapists were interested in IPT, none of them were trained 
in this method. Therefore, we had one of the project members (AvS) trained as 
an IPT supervisor and trainer by Marc Blom and Kosse Jonker (Dutch Centre 
for IPT, The Hague). Then, we had to develop training materials and a training 
course to prepare therapists for participation in the project. We wrote an IPT 
manual in Dutch, integrating the possible adaptations for elderly patients de-
scribed in the IPT manual (Weissman et al., 2000). For use in primary care, we 
reduced the usual number of 14 IPT sessions to 10. In the mental health teams 
for older patients, relatively few psychotherapists were available. Therefore, we 
also recruited experienced psychiatric nurses, as it was demonstrated in other 
projects that psychiatric nurses can carry out manual based psychotherapies 
(Mossey et al., 1996; Mynors-Wallis, et al., 1997). This approach has several ad-
vantages with regard to the implementation potential of the intervention. Not 
only is the intervention probably more cost-effective when delivered by nurses, 
there is also a tendency in the Netherlands that GPs will be more and more 
supported by psychiatric nurses in the treatment of mental health problems. In 
this way, IPT may be easily integrated in the primary care tasks of these nurses. 
1.5  Aims and structure of the thesis
The primary aim of this thesis was to study the feasibility and effectiveness of 
transmural Interpersonal Psychotherapy (IPT) for late life depression in general 
practice. We conducted a randomised clinical trial and recorded, analysed and 
described feasibility and effectiveness data. Afterwards, we studied predic-
tors of outcome in our research population and in patients of a parallel study 
on the effectiveness of guideline driven drug treatment for late life depression 
in general practice (West Friesland Study, Bijl et al., 2003). Furthermore, we 
reviewed the international literature to place our findings in a broader perspec-
tive. Theoretically, literature reviews should be completed before the beginning 
of a research project. However had we limited ourselves to the literature that 
appeared before the start of this project, the results would have been meagre 
and outdated. Therefore we also added more recent publications. We explored 
the effectiveness and cost-effectiveness of psychotherapy interventions for de-
pressive disorder in primary care, and we summarized findings about patients’ 
preferences regarding depression treatment in primary care. The thesis is 
structured as follows:
In Chapter 2 the systematic review of the effectiveness of psychotherapy 
and counselling for depressive disorder in primary care is described. Because 
we knew that very little was known about the effectiveness of these interven-
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tions in older primary care patients, we explored the results in younger adults 
to get an indication about the effectiveness we could expect in our trial. 
In Chapter 3 the systematic review of the cost-effectiveness of psychothera-
py interventions for depression in general practice is presented. With regard to 
the feasibility of implementing psychotherapy in general practice, we thought 
it important to know how the costs relate to usual GP care or to antidepressant 
drug treatment. 
In Chapter 4 patients’ preferences in the treatment of depressive disorder 
in general practice are outlined. In the light of our project, we were especially 
interested in what patients think about psychotherapy compared with antide-
pressant drug treatment.
Chapter 5 concerns the feasibility of introducing IPT in general practice. In 
this study we used a descriptive approach, recording feasibility from the per-
spective of the patients, the GPs and the therapists.
Chapter 6 presents the results of the effectiveness trial comparing IPT with 
usual GP care. 
Chapter 7 reports on a predictor study of (treatment) outcome in the  
patients of the IPT study and those of the parallel West Friesland Study. 
In Chapter 8 the results are summarized and in the general discussion com-
ments are given and limitations discussed. 
Chapter 9 describes the summary in Dutch. 











The effectiveness of psychotherapy for  
depressive disorder in primary care:  
a systematic review
Van Schaik DJF, Van Marwijk HWJ, van der Windt DAWM,  
Beekman ATF, De Haan M, and Van Dyck R. (2002).  




Background   Psychotherapy may be an alternative to drug treatment for de-
pressive disorder in primary care.
Aim   To explore what is known about the effectiveness of psychotherapy for 
depressive disorder in primary care.
Method   Systematic review. Randomised controlled trials were selected in 
which the effectiveness of psychotherapy was studied in primary care patients 
with depressive disorder.
Results   Ten studies met the selection criteria. Overall (based upon five stud-
ies), psychotherapy applied in a primary care setting was slightly more effec-
tive than usual care by a primary care physician for patients with depressive 
disorder. In seven studies, psychotherapy was as effective as antidepressant 
treatment. In one study, psychotherapy was more effective than placebo medi-
cation for patients with major depression. In patients with minor depression or 
dysthymia there was no difference compared to placebo (two studies). 
Conclusion   Psychotherapy is a good alternative to drug treatment in adult 




According to the World Health Report 2001 (WHO, 2001), depression is the first 
leading cause of disability worldwide. Depression is consistently associated 
with increased utilisation of health services and with a substantial burden 
of disability (Simon 2002a). In the Netherlands, it has been found that the 
one-year prevalence of depression among adult patients visiting their general 
practitioner is 14.3% (Ormel & Tiemens, 1997). Although in the general popula-
tion 50% of the patients with depression recovered within three months, 20% 
still had depression after two years. This underlines the necessity of diagnos-
ing and treating those at risk (Spijker et al., 2002). The majority of the depressed 
patients are being treated in primary care settings (Verhaak, 1993). In second-
ary care, specific depression treatments have been developed and studied. Some 
forms of psychotherapy and antidepressant drug treatment have proven to be 
efficacious in secondary care populations. However, relatively little is known 
about the effectiveness of these interventions in primary care populations. 
In 1994 The Dutch College of General Practitioners (NHG) developed a de-
pression treatment guideline (Van Marwijk et al, 1994). This guideline focussed 
on how to deliver antidepressant drug treatment optimally, but relatively little 
attention was paid to psychotherapy. This seems to be an omission as there are 
patients who are not motivated for drug treatment or who do not tolerate it. 
Furthermore, patients may be reluctant to be referred to mental health care. For 
these patients, delivering psychotherapy within general practice may lower the 
barrier to adequate care. 
The aim of this paper was to explore the effectiveness of psychotherapy and 
counselling for depressive disorder in primary care. We performed a systematic 
review of the literature. Our research question was: how effective are psycho-
therapy interventions in the treatment of depressive disorder in general prac-
tice compared with a) usual general practitioners care b) antidepressant drug 
treatment, and c) placebo medication? 
2.2  Methods
2.2.1 Search strategy and study selection 
A computer-assisted search of Medline, Psychinfo, the Cochrane Library and  
EMBASE was carried out. Search terms and keywords used were: “depressive 
disorder”, “depression “, “dysthymic disorder”, “primary health care”, “general 
practice”, “family practice”, “psychotherapy”, “counselling”, “problem solving”, 
“interpersonal psychotherapy”, “outcome,” “effectiveness”, “randomised control-
led trial”, “clinical trial”. References given in relevant identified publications 
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and reviews were also screened. 
Studies to be included were selected by screening titles and abstracts of 
all publications downloaded from the electronic databases. Inclusion criteria 
were: (a) the subjects of study were adults or elderly patients with depressive 
disorder or dysthymia,  (b) the study design was a randomised clinical trial, (c) 
the setting of the study was primary care, (d) the intervention under study was 
psychotherapy or counselling delivered as a mono therapy, (e) data were pre-
sented in a way that quantitative comparison with other studies was possible.  
2.2.2  Methodological quality assessment and data abstraction
The methodological quality of the studies was assessed independently by  
two reviewers (AvS and HvM) using the validity items of the Amsterdam-
 Maastricht-consensus questionnaire (Van Tulder et al., 1997). This question-
naire aims to assess the internal validity of randomised controlled trials. 
Disagreements between the reviewers were solved by consensus. 
Relevant data were extracted and summarised. In our analysis, we used the 
results of the assessments directly post-treatment. When several depression 
measures were used in one study, we extracted the results of the measure that 
was most frequently used in the other studies of the review. Other relevant 
differences in design or study population of the studies are mentioned in the 
discussion of the study results.  
2.2.3 Analysis
To evaluate the effectiveness of the psychotherapy interventions three compari-
sons were made: 
a)  Psychotherapy versus care as usual by the GP or primary care physician 
(CAU)
b) Psychotherapy versus antidepressant drug treatment
c) Psychotherapy versus pill placebo. 
Primary outcomes were mean end scores on continuous depression measures 
and remission percentages. To compare mean end scores of different depression 
measures, effect sizes (Cohen’s d) were calculated by dividing the difference 
between the end scores of the intervention and control groups by the pooled 
standard deviation of the end scores. An effect size of less than 0.5 is consid-
ered to represent a small effect, an effect size of 0.5 – 0.8 represents a moder-
ate effect and 0.8 or higher a strong effect of the intervention over the control 
condition (Cohen, 1988). A negative value of the effect size means that patients 
in the control condition improved more than those in the intervention group. 
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Effect sizes were calculated using Revman (version 4.1, The Cochrane Col-
laboration). Homogeneity of the different studies was explored by using the 
Cochran Q-test, a chi-square test (Cochran, 1954). If the p value of the Cochran 
Q-test was ≥ 0,1, studies were considered to be homogeneous, and a pooled  
effect size was calculated using a random-effects model (DerSimonian & Laird 
N, 1986). 
2.3  Results
Eleven original studies were available for analysis. Two of them described the 
results of the same study at different time-points (Bedi et al., 2000; Chilvers  
et al., 2001). The relevant characteristics of the studies are summarised in  
Table 2.1.  
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HSCLD     1.4
HRSD     13.4
> 60 6 and 
11 
weeks
Note: CAU= Usual Care by the GP; PST = Problem Solving Therapy; CBT = Cognitive Behavioural  
Therapy; SW =Social Worker; * RDC=Research Diagnostic Criteria (Spitzer et al., 1978)
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2.3.1 Characteristics of the selected studies
Interventions. Cognitive Behavioural Therapy (CBT, Beck, 1979), Interpersonal 
Psychotherapy (IPT, Klerman et al, 1984), and Problem Solving Therapy (Haw-
ton & Kirk, 1989; Nezu & Nezu, 1989) are the psychotherapies that were used in 
the included studies. Additionally, the effectiveness of counselling was studied 
(Rowland et al., 2001). Counselling is not described in a manual and therefore 
more heterogeneous in its process. It is carried out by professionals with differ-
ent therapeutic backgrounds. If available, the therapist’s profession is present-
ed in Table 2.1. In two studies (Friedli et al., 1997; Simpson et al., 2000) a small 
percentage (<30%) of the patients received a combination treatment of counsel-
ling and antidepressants. Despite this, we included these studies, because we 
did not want to further reduce the limited number of available studies.
Control conditions. The CAU as a control condition does not follow a protocol 
of course, and may therefore differ considerably between general practices. The 
drug and placebo treatments were carried out according to a protocol. 
Inclusion criteria. In three studies, a score of 14 or more on the Beck Depres-
sion Inventory (BDI) was the inclusion criterion (Lasa et al., 2000). In the other 
studies, a cut-off score on a depression severity scale in combination with a 
diagnosis of depression were used as inclusion criteria. 
Outcome measures. The outcome measures are presented in Table 2.1. They con-
sist of self-report instruments (BDI; Hopkins Symptom Check List- Depression 
-20 ) and observer rating scales (Hamilton Rating Scale for Depression -17). 
2.3.2  Methodological quality of the selected studies
Internal validity was assessed using the “Amsterdam-Maastricht-Consensuslijst”. 
We found that one study had a very pragmatic design (Bedi, 2000) and therefore 
the internal validity may have been insufficient. In the other studies the internal 
validity was satisfactory. As there were hardly any differences in validity scores 
between these studies, we did not use these scores in the meta- analysis. 
2.3.3  Psychotherapy compared with usual GP care (CAU)
The different outcome measures, remission percentages and standardised mean 
differences (SMDs), revelealed comparable results. We only present the results 
of the continuous outcome measures. Table 2.2 summarizes the mean end 
scores on the depression severity measures in the different studies. These end 
scores were used to calculate the SMD’s. In Figure 2.1, the SMDs are presented. 
The pooled SMD is 0.31 (95% BI:  0.12 - 0.50), meaning that, overall, psycho-
therapy had slightly more effect than CAU. It is remarkable that Simpson (2000) 
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and Scott (1992) did not find a significant difference between psychotherapy 
and CAU. These studies are distinct from the others in that the mean baseline 
scores were relatively low (See Table 2.1). In the study of Simpson an additional 
inclusion criterion was that patients had to have depressive symptoms for more 
than six months. In some of the studies of this comparison a follow-up assess-
ment was carried out at one year (Table 2.1). The effects of the intervention were 
smaller after one year.
Table 2.2.  Psychotherapy compared with usual GP care 
Study   (Measure) Psychotherapy Usual GP care
n Mean end score (SD) n Mean end score (SD)
Friedli




  9.30 (8.68) 92 13.10  (8.63)
Ward




  6.70 (6.10) 29
 
  8.40 (7.50)
Simpson
(BDI) 82 16.00 (9.30) 79 16.00 (8.10)
Note: SD= standard deviation 
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Figure 2.1.  Psychotherapy compared with usual GP care.
 
=  Effect size of psychotherapy intervention compared with usual GP care 
=  95%-Confidence Interval
2.3.4  Psychotherapy compared with antidepressant drug treatment by the GP. 
Seven studies were available for this comparison (Table 2.3). Figure 2.2 shows 
that on the continuous measures none of the studies demonstrated a significant 
difference between psychotherapy and medication. The pooled effect size was  
–0.08 (95% BI: -0.21 - 0.05). In the comparison using remission percentages as 
an outcome measure (not presented), it was found in one study that drug treat-
ment was more effective than psychotherapy in patients with dysthymia, the 
difference in remission percentage was 23% (95% BI: 2-44%;Barrett et al., 2001). 
This finding was not replicated in a parallel study with the same design but 
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n Mean end score (SD) n Mean end score (SD)
Scott 
(HRSD) 29 6.70 (6.10) 26 8.00 (8.50)
Mynors-Wallis ’95 
(HRSD) 29 7.10 (6.70) 27 8.10 (7.10)
Bedi
(BDI) 39 15.10 (9.69) 43 15.00 (9.67)
Schulberg 
(HRSD) 93 9.30 (8.68) 91 9.00 (9.54)
Barrett
(HSCLD) 80 0.79 (0.80) 80 0.88 (0.72)
Williams
(HSCLD) 138 0.52 (0.59) 137 0.61 (0.59)
Mynors-Wallis ’00 
(HRSD) 36 8.70 (8.52) 34 6.20 (7.35)
Figure 2.2.   Psychotherapy compared with antidepressant drug treatment.
=  Effect size of psychotherapy intervention compared with antidepressant drug treatment 
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2.3.5  Psychotherapy compared with placebo medication.
Because problem-solving treatment (PST) was developed for use in primary 
care, its efficacy first had to be demonstrated. Therefore, the design of the 
PST studies was less pragmatic than that of the other studies in this review. 
Placebo medication was used as the control condition. The three PST stud-
ies differed with regard to inclusion criteria: Mynors-Wallis (1995) focused on 
patients with major depression, Barrett (2001) and Williams (2000) on patients 
with minor depression and dysthymia. The study sample of Williams consists 
of elderly patients (>60 yrs.). We present the dichotomous outcome measures 
here, because Barrett and Williams made an interesting distinction between 
dysthymic disorder and minor depression regarding the remission percentages 
(Table 2.4). Figure 2.3 presents the differences in remission percentage. This 
difference is 33 % (95% BI: 10-57 %) in favour of the psychotherapy intervention 
in the study of Mynors-Wallis on adult patients with major depressive disorder. 
In patients with dysthymia and minor depression this difference was smaller 
and not significant. Pooling of the data is not useful because of the differences 
in patient populations. 





n remission / 
n total
Barrett 21/37 16/36
Barrett a 19/29 21/32
Williams 32/63 25/62
Williams a 22/50 28/57
Mynors-W ’95 18/30 8/30
Note: 
Barrett and Williams: patients with dysthymia
Barrett a and Williams a: patients with minor depression
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Figure 2.3.   Psychotherapy (PST) versus placebo.
=  Difference in remission percentage between psychotherapy intervention and placebo   
=  95%-Confidence Interval 
2.3.6  Conclusion
Psychotherapy for patients with major depressive disorder was slightly more 
effective than usual GP care. No significant differences in effectiveness were 
found between psychotherapy and antidepressant drug treatment by the GP 
(seven studies). In one study, drug treatment was more effective than psycho-
therapy in the treatment of dysthymia in adult patients. Problem solving treat-
ment was significantly more effective than placebo medication in adult patients 
with major depressive disorder. PST was not effective in patients with dys-
thymia and minor depression. No studies were found that specifically studied 
the effectiveness of psychotherapy in elderly primary care patients with major 
depressive disorder. 
2.4  Discussion
A limitation of this review is that only ten randomised controlled trials were 
available. These ten trials could not be used in all the three comparisons we 
wanted to make. In addition, the studies differed considerably for example 
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ments. Therefore, the results should be interpreted with some caution. However, 
despite these shortcomings and differences, the results were quite unambiguous. 
We conclude that psychotherapy is a good alternative to antidepressants 
in general practice. Yet, there still remain many questions. For example, we 
do not know which of the treatment conditions works for whom, or whether 
there are differences in effectiveness between the psychotherapy interven-
tions. The finding that PST was more effective for major depression than for 
dysthymia and minor depression is interesting and should be further studied, 
not only regarding PST but also in relation to the other psychotherapies. In a 
post-hoc analysis Friedli (1997) found a significant difference between counsel-
ling and CAU in patients with major depressive disorder (BDI≥14), but not in 
the whole study sample (inclusion criterion “emotional problems”). Elkin (1995) 
also found that there was a significant difference in efficacy of specific depres-
sion treatments (IPT, antidepressants) compared with placebo medication in 
the subgroup of patients with more severe depression (HRSD ≥20), while in the 
whole study sample, including patients with mild depression, this difference 
was not significant. Thus, future research should focus on the (differential) ef-
fect of baseline depression severity on treatment outcome. Schulberg (1998a) 
explored in a post-hoc analysis whether IPT was also as effective as medication 
in patients with more severe (non-psychotic) depression (HRSD ≥ 20). Indeed, he 
did not find a difference in effectiveness of these interventions in patients with 
more severe depression, although patients treated with IPT improved a few 
weeks later. 
Another interesting question is what the optimal “dose” of psychotherapy 
sessions is. It is remarkable that PST, with a total intervention time of less than 
half that of IPT or CBT, was also effective for major depressive disorder. Fur-
thermore, it was demonstrated that nurses or GPs could deliver this therapy. 
This raises the question of whether mental health workers, other than psycho-
therapists can be trained in IPT and CBT too. 
What are the consequences of our findings for the treatment of depression 
in general practice? As the effectiveness of psychotherapy and antidepressant 
drug treatment does not seem to differ, patients can be offered the choice. How-
ever, antidepressant drug treatment can be given by the GP him/herself, which 
makes it more easily accessible than psychotherapy, and therefore preferable 
for many patients. The direct costs of psychotherapy are most probably higher 
than that of drug treatment by the GP, and it is not yet known whether this is 
compensated by, for example, a decrease in medical consumption. It should be 
noted that there are patients who prefer psychotherapy, who are explicitly not 
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motivated for drug treatment, who do not tolerate it, and who do not want to be 
referred for psychotherapy. Future study should explore whether it is feasi-
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ABSTRACT
Objective  To systematically review the cost-effectiveness of psychological 
treatments, psychotherapy and counselling, in adult primary care patients with 
depression. 
Method   A computer-assisted search of MEDLINE, EMBASE, CINAHL, Psyc-
INFO, and the Cochrane Library was carried out. Two independent reviewers 
selected studies for the review, extracted data and assessed the methodological 
quality of the included studies.
Results  In comparison with usual care, cognitive behavioural therapy was 
associated with insignificant differences in both costs and effects. Interper-
sonal therapy (IPT) was significantly more effective and expensive than usual 
care. It remains uncertain whether couple therapy and IPT are cost-effective in 
comparison with antidepressant therapy. There was no evidence for the cost-
effectiveness of counselling in comparison with usual care or antidepressant 
treatment.
Conclusions  Based on this review, no firm conclusions can be drawn on the 
cost-effectiveness of psychotherapy and counselling in primary care. Given 
the large economic impact of depression, there is a need for well designed and 
well powered economic evaluations of those psychological treatments that have 




Depression is an important health problem. The 6-month prevalence of major 
depression was 6.9% in a pan-European community survey (Lepine et al., 1997). 
Because depression is associated with increased work absenteeism (Broadhead 
et al., 1990) and increased health care costs (Manning & Wells, 1992; Simon et 
al., 1995), the societal costs of depression are high. Most patients with de-
pression are treated in primary care (Lepine et al., 1997). There are two main 
treatment options: antidepressant drug treatment and psychological treatment. 
Antidepressants are effective in treating depression in primary care (Simon, 
2002). However, antidepressants may have intolerable side effects. Moreover, a 
substantial group of patients is reluctant to use antidepressants and prefers 
psychological treatments (van Schaik et al., 2004). 
The objective of this study was to systematically review the literature on the 
cost-effectiveness of psychotherapy and counselling in comparison with usual 
care by primary care physicians or with antidepressant drug treatment in de-
pressed primary care patients.
3.2  Method
3.2.1  Search strategy
A computer-assisted search of MEDLINE (up to June 2004), EMBASE (up to June 
2004), CINAHL (up to 21st May 2004), PsycINFO (up to 26th April 2004) and the 
Cochrane Library including the NHS Economic Evaluation Database (Issue 2, 
2004) was carried out. Search terms and keywords used were “depression”, “de-
pressive disorder”, “Economics”, “Economics, Hospital”, “Economics, Medical”, 
“Economics, Nursing”, “Costs and Cost Analysis”, “Value of Life”, “economic*”, 
“cost”, “costs”, “expenditure*”, “Primary Health Care”, “family practice”, “Physi-
cians, Family”, “primary AND care”, “general pract*”, “family pract*”, “family 
physician*” and “general physician*”. The full search strategy was developed 
with the help of an experienced librarian and is available on request. Addi-
tionally, references given in relevant identified publications and reviews were 
screened.
3.2.2  Study selection
Two reviewers (JB and AS) independently selected studies to be included in the 
systematic review by screening titles and abstracts of all publications down-
loaded from the electronic databases. Economic evaluations were included in 
the review if (a) the subjects of study were depressed adults who were consid-
ered to be eligible for depression treatment with exclusion of patients with 
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dysthymic or bipolar disorders, (b) the study contained a full economic evalua-
tion (i.e. both costs and effects were presented), (c) the setting of the study was 
primary care, (d) the intervention tested in the study was aimed at the acute 
treatment of depressive symptoms, and (e) at least one of the treatment arms 
consisted of psychotherapy or counselling. Disagreements between reviewers 
about the eligibility of a study were resolved by consensus. A copy of the full 
article was retrieved for all eligible studies and for all studies in which there 
was any doubt about their eligibility. The final decision on the inclusion of a 
study was based on the full article.
3.2.3  Methodological quality assessment 
The methodological quality of the economic evaluations was assessed inde-
pendently by two reviewers (JB and AS/HH/HM) using a recently developed 
checklist (Evers et al., 2005). All items were scored as positive (+) or negative (-). 
Two reviewers (JB and AS/HH/HM) independently extracted data using a stand-
ardised form. Data were extracted on the study design, setting, study popu-
lation, interventions, clinical outcomes, costs and cost-effectiveness. Again, 
disagreements were solved by consensus. 
After exploring the cost and cost-effectiveness data it became clear that 
there were many differences between the included studies. Included cost cat-
egories varied widely and most studies did not present resource use separately 
from costs. Also, many different outcome measures were used. Therefore, it was 
not possible to pool the results in one meta-analysis. Rather than performing 
many small meta-analyses with few studies, we chose to undertake a narrative 
synthesis while focusing on the methodological quality of the studies.
3.3  Results
3.3.1  Literature search and study selection
The abstracts of 1580 potentially relevant articles identified by the search were 
screened, and the full publications of 28 articles were retrieved for further 
examination. Of these, 20 articles were excluded for the following reasons: 
subjects included in the study were not primarily depressed patients (Richards 
et al., 2003; Robson et al., 1984; Mynors-Wallis et al., 1997), the intervention 
tested in the study was a so called collaborative care model (Jarjoura et al., 
2004; Katon et al., 2002; Liu et al., 2003; Pyne et al., 2003a; Pyne et al., 2003b; 
Schoenbaum et al., 2001; Simon et al., 2000; Simon et al., 2001a; Simon et al., 
2001b; von Korff et al.,  1998), cost and effect data were not reported (Finley et 
al., 2003), intervention tested in the study was not primarily aimed at the acute 
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treatment of depressive symptoms (Simon et al., 2002b; Sturm & Wells, 1995), 
the study did not present original data (Chisholm et al., 2004), and the study 
was an observational study (Katzelnick et al., 1997; Chisholm et al., 2003; Simon 
et al., 2002a). Six original studies (reported in eight articles) were available for 
analysis (Bower et al., 2000; King et al., 2000; Lave et al., 1998; Leff et al., 2000; 
Miller et al., 2003; Scott & Freeman, 1992; Simpson et al., 2000 and 2003).  
No other studies were identified through reference checking.
3.3.2.  Study characteristics
Data on sample size, age, baseline depression score, and type of intervention 
are listed in Table 3.1. Five studies were conducted in the United Kingdom 
(Bower et al., 2000; Scott & Freeman, 1992; Leff et al., 2000; Miller et al., 2003; 
Simpson et al., 2003) and one was conducted in the United States of America 
(Lave et al., 1998). Follow up assessments ranged from 16 weeks to 24 months. 
The IPT and couple therapy “dose” (12-20 sessions) was relatively high com-
pared with 5-12 sessions  of counselling or Cognitive Behavioural Therapy 
(CBT) in the other studies. Finally, studies differed in the sources they used to 
collect resource use data. 
3.3.3.  Methodological quality of economic evaluations
The methodological quality assessment of the economic evaluations is present-
ed in Table 3.2. All studies scored positively on at least 13 of the 19 methodo-
logical criteria, which can be considered to be a remarkably good score.  
The majority of the included studies gave a clear description of the study 
population and the competing alternatives, measured and valued costs and 
outcomes appropriately, and reported conclusions that followed from the re-
ported data. In the following section, the most important aspects regarding the 
methodology of the included studies will be discussed in more detail.
Perspective. Economic evaluations can be performed from different perspec-
tives. The perspective determines which cost categories have to be taken into 
account. The societal perspective, the broadest perspective, is usually recom-
mended by health economists (Drummond & Jefferson, 1996), and indicates that 
all relevant outcomes and costs, regardless of who pays, are taken into account 
(Drummond et al., 2005). Sometimes a narrower perspective can be chosen, such 
as the perspective of insurance companies, health care providers or patients. 
One study used a societal perspective (Bower et al., 2000). One study that did 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































but excluded them from the analysis because there were no between-group dif-
ferences at any of the time points (Simpson et al., 2003). 
Costs. Cost categories that are usually distinguished in economic evalua-
tions are direct health care costs (for example primary care and medication 
costs), direct non-health care costs (for example patient time and transporta-
tion costs), and indirect costs (for example productivity costs due to work 
absenteeism). As stated earlier, the cost categories included in the studies of 
this review varied considerably. Also, few studies gave a clear description of 
included cost categories (Table 3.1). Different sources were used to collect 
resource use data: administrative databases (Lave et al., 1998), medical records 
(Bower et al., 2000; Scott & Freeman, 1992; Miller et al., 2003; Simpson et al., 
2003), trial records (Lave et al., 1998), patient interviews (Bower et al., 2000; 
Scott & Freeman, 1992), and self-report questionnaires (Lave et al., 1998; Leff et 
al., 2000; Simpson et al., 2003).
Outcomes. All studies included some measure of depression severity, includ-
ing the Beck Depression Inventory (BDI), and the Hamilton Depression Rating 
Scale (HDRS) (Table 3.3). One study calculated Depression Free Days (DFDs) and 
Quality Adjusted Life-Years (QALYs) (Lave et al., 1998). To calculate DFDs, each 
day in an interval between 2 assessments is assigned a value between 1 (“de-
pression free”) and 0 (“fully symptomatic”) based on cut-off values on a clinical 
depression scale using a linear interpolation of clinical ratings at the beginning 
and end of the interval. The obtained DFDs were transformed into quality-ad-
justed life years by weighting them using utilities assigned to depression from 
literature (Lave et al., 1998).
– 42 –
Table 3.3   Outcomes of economic evaluations of psychotherapy or  









† including cost of amitriptyline 
mean cost was £120
‡ including drug costs mean cost 
was £34. including costs of other 
NHS staff and resources mean cost 
was £55
HDRS*
CBT vs UC –1.7 (-5.3; 1.9)
Co vs UC –3.5 (-7.0; 0.0)
AD vs UC –0.4 (-4.8; 3.9)
Recovery rate
CBT vs UC -0.07, p=NS
Co vs UC 0.24, p=0.05
AD vs UC 0.10, p=NS
UC 0.48
NA















Mean DFD’s based on BDI
IPT 187, AD 220, UC 148, 
F=8.96, p=0.01
Mean DFD’s based on HDRS
IPT 234, AD 243, UC 185, 
F=10.11, p<0.01
Cost per DFD 
based on HDRS
AD vs UC 14.79, 
p<0.01
IPT vs UC 29.36, 
p=0.04
Cost per DFD 
based on BDI
AD vs UC 11.44, 
p<0.01





UC vs CBT 24.0 (-201.3; 249.3)
UC vs Co –28.5 (-268.4; 211.3)
Indirect costs (£)*
UC vs CBT 133.1 (-424.0; 690.2)
UC vs Co -152.5 (-864.7; 559.6)
Total costs (£)*
UC vs CBT 157 (-458.0; 772.2)










Leff 2000 Direct costs (£ per 
month) during treat-
ment period*
CT vs AD 5 (-76; 71)
Direct costs (£ per 
month) during follow-
up period*
CT vs AD -24 (-83; 25)
BDI*
CT vs AD 6.4  
(1.62; 11.54)
HDRS*
CT vs AD NS
NA
Miller 2003 All depression-related 
health services costs 
(£)***
Co 301.63  
(225.91; 377.35)
AD 343.64  
(219.45; 467.82)
p=0.56
Global outcome using 
the RDC, BDI and GP 
notes
Good or moderate
Co 29/52, AD 33/51, 
p=0.85 
Good
Co 13/52, AD 21/51, 
p=0.20
Cost-effectiveness 








Simpson 2003 Direct costs (£)*












Note: UC = primary care physician usual care; CBT = cognitive behavioural therapy; Co = counselling; 
AD = antidepressant treatment; IPT = interpersonal psychotherapy; CT = couple therapy; BDI = Beck 
Depression Inventory; HDRS = Hamilton Depression Rating Scale; QALYs = Quality Adjusted Life-
Years; NS = not significant; NA = Not Applicable
* Mean (95% CI) difference
**  Mean (SD)
*** Mean (95% CI)
Incremental costs and cost-effectiveness analysis. In a full economic evaluation 
costs and effects of two or more interventions are compared. The first step is to 
analyse costs and effects separately. Costs typically have a heavily skewed distri-
bution, which is usually due to a few patients who incur high costs. Nevertheless, 
the arithmetic mean is the most informative measure for policy makers, because 
the estimated mean costs can be easily converted into the required informa-
tion on the total costs needed to treat all patients. T-tests and other parametric 
methods are only appropriate to compare mean costs, if the costs are reasonably 
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normally distributed. Parametric analysis of log-transformed costs, leads to a 
comparison of geometric means instead of arithmetic means. Non-parametric 
methods are not appropriate to compare costs, because those methods provide 
no statistical test of the mean costs, but of the cost distributions. Therefore, 
nowadays the preferred method to analyse cost data is bootstrapping. With 
bootstrapping statistical analysis is based on repeated sampling with replace-
ment from the observed data. Subsequently, 95% confidence intervals around the 
observed mean difference in total costs between the compared treatment groups 
are calculated based on the distribution of the resamples (Barber &Thompson, 
2000; Thompson & Barber, 2000). Before the widespread use of bootstrapping, it 
was standard practice to use parametric tests of log-transformed costs or to use 
non-parametric tests. Of the included studies, four studies used bootstrapping 
to analyse differences in mean costs between the treatment groups (Bower et 
al., 2000; Leff et al., 2000; Miller et al., 2003; Simpson et al., 2003). The two other 
included studies used analysis of variance to compare costs between the groups 
(Scott & Freeman, 1992; Lave et al., 1998). 
The second step in a full economic evaluation is to directly evaluate costs 
and effects in an incremental cost-effectiveness ratio (ICER). The ICER is cal-
culated by dividing the difference in mean total costs between the treatment 
groups by the difference in mean effects. In a cost-effectiveness analysis the ef-
fects are expressed in any clinical outcome measure such as the BDI or recovery 
rate. In a cost-utility analysis the effects are expressed in QALYs. Bootstrap-
ping can be used to calculate 95% confidence intervals around the ICERs. How-
ever, the interpretation of the confidence interval around an ICER is ambiguous. 
Nowadays, bootstrap estimates are preferred for calculating cost-effectiveness 
planes and acceptability curves, which are more useful in the interpretation of 
the uncertainty around an ICER. Cost-effectiveness planes give an indication of 
the variation in the ICER (Black, 1990) and acceptability curves show the prob-
ability that a treatment is cost effective at a specific ceiling ratio (Van Hout et 
al., 1994). 
Although all included studies were considered a cost-effectiveness analy-
sis or a cost-utility analysis (Lave et al., 1998), four studies did not perform an 
incremental cost-effectiveness analysis (Bower et al., 2000; Scott & Freeman, 
1992; Leff et al., 2000; Simpson et al., 2003). One study presented a point esti-
mate of the ICER and an accompanying significance test for the ICER based on 
bootstrapping (Lave et al., 1998). A cost-effectiveness plane and a cost-effective-
ness acceptability curve using bootstrap estimates were presented by one other 
study (Miller et al., 2003). 
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Sensitivity analysis. In a sensitivity analysis the robustness of the results is 
assessed by varying the values of the key parameters in the study. Since there is 
much uncertainty associated with cost measurement and valuation, sensitivity 
analysis is particularly important in economic evaluations. Two studies in-
cluded a sensitivity analysis (Bower et al., 2000; Miller et al., 2003) of which one 
was considered appropriate (Bower et al., 2000) and the other one was consid-
ered incomplete by the authors (Miller et al., 2003).  
3.3.4.  Cost-effectiveness
Psychotherapy in comparison with usual care. CBT was compared with usual 
care (UC) in two studies (Scott & Freeman, 1992; Bower et al., 2000). In an early 
cost-effectiveness study, Scott and Freeman found remarkable improvement in 
both the CBT and UC group, but no significant differences in HDRS scores at 16 
weeks between CBT and UC. Only intervention costs were included in this study, 
which made it impossible to investigate a possible cost-offset effect in other 
health care costs, and cost differences were not statistically tested. The interven-
tion costs in the CBT group were approximately 4.5 times higher than in the UC 
group. No incremental cost-effectiveness analysis was performed. In the well-de-
signed study by Bower et al. CBT was more effective than UC in the short-term (4 
months). However, there were no significant differences in effects at 12 months, 
and no significant differences in direct, indirect or total societal costs were 
found. No incremental cost-effectiveness analysis was performed in this study. 
Lave et al. (1998) compared IPT with UC. Patients in the IPT group experi-
enced significantly more DFDs than patients in the UC group. Direct and total 
costs were significantly higher in the IPT group, which could be attributed to 
the IPT costs. The extra cost per DFD gained in the IPT group in comparison 
with the UC group was $29.36.
Psychotherapy in comparison with antidepressant drug treatment. Cou-
ple therapy (CT) was compared with antidepressant treatment (AD) by Leff 
et al.(2000). They found that CT had significantly greater effects on the BDI 
than AD, but not on the HDRS. The costs per month did not differ significantly 
between the two treatment groups. An incremental cost-effectiveness analysis 
was not performed. However, it should be noted that more than half of the pa-
tients in the AD group did not receive antidepressants as allocated. 
In the study by Lave et al. (1998), patients in the AD group experienced 
somewhat more DFDs than patients in the IPT group. The direct and total costs 
in the IPT group were higher than in the AD group. However, these differences 
were not statistically significant. 
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Counselling in comparison with usual care. Counselling was compared 
with usual care in three studies. In the study by Scott & Freeman (1992) a 
borderline statistical difference in clinical effects in favour of the counsel-
ling group was found. Only intervention costs were included in this study and 
incremental costs and cost-effectiveness analyses were not performed. Bower 
et al. (2000) found no significant differences in effects and costs in their study. 
No incremental cost-effectiveness analysis was performed. In the most recent 
study by Simpson et al. (2003) no significant difference in depression severity 
between the treatment groups was found at the end of the follow-up. However, 
they found a significant difference in the number of depression cases in favour 
of the counselling group at the end of the follow-up period. Primary care costs 
were increased in the short term, which was linked to the use of counselling 
services. There were no significant differences in costs at 12 months. An incre-
mental cost-effectiveness analysis was not performed.
Counselling in comparison with antidepressant drug treatment. Miller et 
al. (2003) compared counselling with antidepressant treatment. They found no 
significant differences in effects and costs. Cost-effectiveness planes and ac-
ceptability curves indicated that there was no significant difference in cost-ef-
fectiveness between the two treatment groups. 
3.4   Discussion
This article systematically reviewed economic evaluations of psychological 
treatments in depressed primary care patients. Six studies were included in the 
review that all scored at least 13 out of 19 in the methodological assessment of 
the studies. Based on this review, no firm conclusions on the cost-effectiveness 
of CBT in comparison with usual care can be drawn. IPT was significantly more 
effective than usual care, but was associated with significantly higher costs. 
In this case it is up to decision makers in the health care sector whether the 
additional costs associated with the additional benefits are worth it. IPT was 
also compared with antidepressant treatment; in this comparison there were 
no significant differences in costs and effects. The last form of psychotherapy 
that was evaluated in the studies included in this review, was couple therapy, 
for which it remains uncertain whether it is cost-effective in comparison with 
antidepressant treatment. The evidence for the cost-effectiveness of counselling 
in comparison with usual care is limited. 
Most studies had methodological shortcomings, of which the most impor-
tant are mentioned below. These shortcomings are partly caused by the in-
troduction of new methods in the field of health technology assessment after 
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publication of some of the included studies. Only two studies were performed 
from a societal perspective and included lost productivity costs. The other four 
studies did not include lost productivity costs. Given the high costs of produc-
tivity losses associated with depression, this is a limitation of these studies. 
Although all studies employed an appropriate design and could be consid-
ered a cost-effectiveness or cost-utility study, four studies did not present an 
incremental cost-effectiveness analysis. One could argue that non-significant 
effects justify the omission of an incremental cost-effectiveness analysis in an 
economic evaluation, resulting in a cost minimisation analysis. However, since 
‘absence of evidence is not evidence of absence’, Briggs & O’Brien (2001) argue 
that a cost minimisation analysis is only appropriate when a study has been 
specifically designed to show the equivalence of treatments. In all other cases, 
the focus should be on estimation of cost-effectiveness, for example by present-
ing the results in a cost-effectiveness plane.
An important problem in economic evaluations is the power. Because costs 
typically have a heavily skewed distribution, large sample sizes are needed to 
detect differences in costs (Briggs, 2000). Most studies recognised this problem 
with the power and made a remark on it. Bower et al. (2000) pooled individual 
patient data to overcome sample size limitations in economic analyses. They 
showed that the included studies may have been underpowered to detect dif-
ferences in costs between the treatment groups and that this problem can be 
overcome by a meta-analysis. 
There are several possible ways to improve the cost-effectiveness of psycho-
therapy in primary care. One is to provide psychotherapy as part of a collabo-
rative care model as was done in two studies by Von Korff et al. (1998) and Sch-
oenbaum et al. (2001). In these studies, substantial clinical effects were found. 
Thus, the cost-effectiveness of depression treatment on the whole may be 
improved by incorporating psychotherapy into enhanced care models, tailored 
to the needs of individual patients. Also, the cost-effectiveness of psychological 
treatments may be improved when treatment is given by trained nurses instead 
of by psychotherapists, as has been demonstrated for problem-solving therapy 
by Mynors-Wallis et al.(1997). 
In conclusion, as psychotherapy is a good alternative to antidepressant drug 
treatment for patients who do not benefit (enough) from antidepressant drug 
treatment or who are reluctant to use these medicines, and because depression 
has a large economic impact, there is a need for better designed, and better 
conducted economic evaluations of psychological treatments for depression 
in primary care. Since psychotherapy seems to have more substantial clini-
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cal effects than counselling, the emphasis should be on economic evaluations 
of those forms of psychotherapy that have proved to be effective. In addition, 
research is needed to identify ways to improve the cost-effectiveness of psycho-
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Abstract
Background   Patients’ preferences in the treatment of depression are impor-
tant in clinical practice and in research. Antidepressant medication is often 
prescribed, but adherence is low. This may be caused by patients preferring 
psychotherapy, which is often not available in primary care. In randomised 
clinical trials, patients’ preferences may affect the external validity.
Aim   To study patients’ preferences regarding psychotherapy and antidepres-
sant medication and the impact of these preferences on treatment outcome. 
Method   A systematic review of the literature was performed. 
Results   The majority of patients preferred psychotherapy in all available 
studies. Antidepressants were often regarded as addictive and psychotherapy 
was assumed to solve the cause of depression. Discussing and supporting 
preferences as part of a quality improvement programme of depression care, 
resulted in more patients receiving the treatment that was most suitable to 
them. In two patient preference trials preferences did not influence treatment 
outcome.  
Conclusion   A substantial percentage of well-informed patients prefer psycho-
therapy. Patients with strong preferences, mostly for psychotherapy, are likely 
not to enter antidepressant treatment or randomised clinical trials if their 




In recent years patients’ treatment preferences and their impact on depres-
sion care have received growing interest, not only because “patient-centered” 
medicine has influenced health care in general (Laine & Davidoff, 1996) but also 
because it is thought that taking account of patients’ preferences may improve 
compliance (Dwight-Johnson et al., 2000 ). From a research perspective, it has 
been argued that patients’ treatment preferences influence patient selection, 
treatment compliance and attrition in randomised clinical trials. Therefore, the 
external validity of clinical trials is affected by these preferences and alterna-
tive study designs have been used that incorporated patients’ preferences into 
the study design (Ten Have et al., 2003). 
Antidepressant medication and short-term psychotherapies, such as In-
terpersonal Psychotherapy (IPT), Cognitive Behavioural Therapy (CBT) and 
Problem Solving Therapy (PST) are equally effective. In addition, counselling is 
often provided. However, counselling is not a manual based psychotherapy and 
therefore heterogeneous in its process. Its effectiveness has not been sufficient-
ly demonstrated (Schulberg et al., 2002).
Patients with major depressive disorder in primary care are generally 
offered treatment with antidepressant medication, because psychotherapy 
is mostly not available. Prescribing medication fits more easily into the rou-
tine practice of the physician. It has been found that general practitioners 
prescribed antidepressant medication during the first visit in which depres-
sion was diagnosed in 73 % of cases (Van Marwijk et al., 2001). Yet, in another 
study it was observed that 50% of patients ceased taking the antidepressants 
within six weeks (Lawrenson et al., 2000). Although several factors contribute 
to compliance problems, divergent views between patient and physician with 
regard to type of treatment may be a crucial component. The beliefs held by 
the general public about mental disorders differ substantially from those of 
health practitioners (Jorm et al., 1997), and patients often prefer psychotherapy 
to antidepressants(Dwight-Johnson et al., 2000; Simpson et al., 2000). Patient 
choice and autonomy should be valued, but more knowledge about patients’ 
preferences and their influence on the treatment process is necessary to learn 
to what extent the preferences should be supported by changes in the organisa-
tion of primary care practice.  
As patients’ preferences are affected by attitudes and beliefs of the general 
public, it is not only findings from surveys carried out in depressed primary 
care populations that are of interest but also surveys conducted in non-de-
pressed populations. Furthermore, findings from clinical trials in which atten-
– 52 –
tion has been paid to patients’ preferences are relevant to understand more 
about preferences and their influence on treatment outcome. 
The research questions of this review are: 
1.  Which treatment do people with and without depression prefer for depres-
sive disorder in primary care? 
2.  What are the underlying assumptions and associated factors of patients’ 
preferences?
3.  Do patients’ preferences affect treatment compliance and outcome in clini-
cal trials? 
4.2.  Method
4.2.1  Identification of relevant publications
Two systematic searches of Medline, PsychInfo and the Cochrane Library were 
performed separately for depressed primary care populations and for prima-
rily non-depressed general populations over the period 1990 - January 2003. To 
retrieve studies in depressed primary care populations we used the following 
medical subject headings and key words: depressive disorder/therapy, depres-
sion/therapy, depression, psychotherapy, counselling, antidepressants, patient 
satisfaction, preference, family practice, general practice, and primary care. 
To find surveys carried out in the general population we used the subsequent 
headings and keywords: depressive disorder/therapy, depression/therapy, 
public attitude, belief, general public, and lay public. All studies that presented 
data about attitudes or preferences towards psychotherapy and antidepressant 
medication were included. References from relevant articles were explored. 
4.2.2.  Data extraction and analysis 
From all surveys, percentages of respondents with a positive attitude towards 
psychotherapy and antidepressants were extracted. Differences between these 
percentages were calculated. In addition, arguments underlying these prefer-
ences and factors associated with them were summarized. Data about the influ-
ence of depressed patients’ preferences on entry into treatment, compliance, 
treatment outcome and satisfaction were summarized.  
4.3.  Results
4.3.1 Preferences among depressed primary care patients and among non-de-
pressed primary care or general populations
Nine articles, concerning six studies, were identified as presenting preference 








































































































































































































































































































































































































































Cooper-Patrick et al., 1997; Dwight-Johnson et al., 2000; Dwight-Johnson et al., 
2001; King et al., 2000; Simpson et al., 2000; Unützer et al., 2002; Ward et al., 
2000). Relevant characteristics of the studies are presented in Table 4.1. Articles 
presenting data of the same studies are presented in one row. From Table 4.1 
it can be seen that in studies comparing counselling with antidepressants 23% 
- 38% more patients preferred counselling. In the two studies comparing psy-
chotherapy with antidepressants the differences were 6% and 13 % favouring 
psychotherapy. In the study of King et al. (2000) both counselling and psycho-
therapy were rated; it turned out that counselling was preferred more often. 
One study only presented qualitative data (Cooper-Patrick et al., 1997). 
We selected nine articles, about seven studies, presenting percentages of 
positive attitudes towards antidepressant medication and psychotherapy or 
counselling in general (nondepressed) populations (Althaus et al., 2002; Anger-
meyer & Matschinger, 1999; Angermeyer et al., 1993, 1996; Benkert et al., 1997; 
Jorm et al., 1997; Lauber, et al., 2001; McKeon et al., 1991; Paykel et al., 1998). 
Three additional surveys were included that had been carried out in primarily 
nondepressed primary care populations (Brody et al., 1997; Churchill et al., 
2000; Zeitlin et al., 1997). Table 4.2 shows the relevant characteristics of the 
selected surveys. Articles presenting data of the same studies are presented in 
one row. Paykel et al. (1998) reported the results of three surveys of public at-
titudes at the start, during and at the end of the Defeat Depression Campaign in 
Great Britain. We present the results of the last survey. 
Table 4.2 indicates that in all studies respondents had a more positive at-
titude towards psychotherapy or counselling than towards medication. 5% to 
66% more respondents preferred psychotherapy or counselling compared with 
antidepressant medication. 
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843 GP Germany ≥ 18 44 PT 17 27
Benkert
1997
1088 GP Germany ≥ 16 64 PT 26  38
Brody
1997
130 PCP USA 15-75 62 C 23 39
Churchill 
2000
895 PCP UK  ≥ 18 51 C 15 36
Jorm
1997
1010 GP Australia 18-74 34 PT 29 5
Lauber
2001
873 GP Switzerland 16-76 36 PT 25 11
McKeon
1991
1403 GP Ireland ≥ 16 32 C 23 9
Paykel 
1999
1946 GP UK ≥ 15 90 C 24  66
Zeitlin
1997
180 PCP UK 18-86 98 C 35 63
Note: GP= general population; PCP= primary care population PT= psychotherapy; C=counselling; 
AD=antidepressants
4.3.2  Underlying assumptions and associated factors 
It has been found that the most important argument against psychotropic drugs, 
mentioned by 33-80% of the respondents, was the risk of undesirable side effects 
and addiction (Althaus et al., 2002; Angermeyer & Matschinger, 1996; Church-
ill et al., 2000; Cooper-Patrick et al., 1997; Paykel et al., 1998). At the end of the 
Defeat Depression Campaign 60% still believed antidepressants to be addictive. 
This proportion had fallen by only 4% over the period of the campaign (Paykel 
et al., 1998). Benkert et al. (1997) compared the attitudes towards psychotropic 
drugs with attitudes towards drugs for “physical” diseases such as cardiac 
drugs. It seemed clear that psychotropic drugs were believed to cause signifi-
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cantly more side effects and to provoke more fear of losing control. A positive 
argument mentioned in the study of Angermeyer & Matschinger (1996) was that 
some respondents regarded the sedative side effect as supportive.
In a German general population survey, preference for psychotherapy seemed 
primarily based on the ideas that this treatment modality provides an oppor-
tunity for personal exchange and that the cause of the problem can be solved 
(Angermeyer et al., 1993). Respondents who were negative about psychotherapy 
tended to prefer alternative treatment options (e.g. lifestyle changes and talking 
to friends), 13% thought that psychotherapy was not effective and 8% thought 
that problems would increase by talking about them. These concerns were also 
raised in focus groups among recently depressed primary care patients (Coop-
er-Patrick et al., 1997) 
Three studies described factors associated with preferences among de-
pressed primary care patients. In the study of Dwight-Johnson et al. (2000) 
female gender, ethnicity (African American people compared with white people), 
greater knowledge about counselling, paid sick leave and no recent antidepres-
sant treatment were associated with a preference for counselling. Bedi et al. 
(2000) described those preferring counselling as tending to have a more mid-
dle-class profile. In addition, they found that those who preferred antidepres-
sants were more likely to have a more severe depressive illness. Simpson et al. 
(2000) observed that patients with any kind of preference were less likely to be 
married, had more minor psychiatric disorders and reported more problems, 
compared with patients who accepted randomisation. 
In the general population surveys, respondents’ characteristics positively 
associated with preference for psychotherapy or counselling were: female 
gender or female gender and being single (McKeon & Carrick., 1991; Churchill 
et al., 2000); being highly educated (Angermeyer & Matschinger, 1999); being of 
upper and middle social class, living in a city (McKeon & Carrick., 1991); having 
personal experience with psychotherapy or counselling (Angermeyer & Mat-
schinger, 1999; Churchill et al., 2000); believing that depression can be a serious 
illness and that 20% of people suffer from depression some time in their life 
(Churchill et al., 2000). Respondents’ characteristics positively associated with 
preference for antidepressants or psychotropic drugs were: having personal 
experience with psychotropic drugs (Benkert et al., 1997) living outside the city,  
being female and married (McKeon & Carrick., 1991), and being older (McKeon 
& Carrick., 1991; Zeitlin et al., 1997). 
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4.3.3 Clinical trials incorporating patients’ preferences
Dwight-Johnson et al. (2001) explored whether quality improvement programs 
for depression addressed patients’ preferences for treatment. Patients’ prefer-
ences were measured at baseline and were discussed and supported by health 
care personnel as part of the quality improvement intervention. It was found 
that more patients entered treatment and more patients received the preferred 
treatment in the quality improvement intervention compared with usual care 
patients. Furthermore, in the usual care group it was found that patients who 
preferred counselling but did not receive it were likely to go without treatment 
altogether.
Two trials in this review used a partially randomised patient-preference 
design (Bedi et al., 2000; King et al., 2000): patients who did not accept ran-
domisation were given the treatment of their preference. Neither of the studies 
found significant differences in outcome scores between participants who were 
randomised to psychotherapy and those who chose it, nor was the preference 
option associated with higher rates of follow up. Both studies also measured 
satisfaction with treatment and did not observe significant differences in sat-
isfaction with treatment between the preference groups and the randomised 
groups. 
4.4  Conclusions
1.  Which treatment do depressed and non-depressed people prefer? In all 
studies psychotherapy and counselling were preferred to antidepressants. 
2.  What are the underlying assumptions and the associated factors? Psycho 
therapy was preferred because it was assumed to provide an opportunity 
for personal exchange and to solve the problem underlying the depression. 
Antidepressants were often seen as addictive. Using psychotropic drugs was 
accompanied by more fear of losing control than using drugs for physi-
cal diseases. Female gender, former experience with psychotherapy, and a 
middle class profile were in several studies associated with a preference 
for psychotherapy; experience with psychotropic drugs, and old age were 
predictors of preference for antidepressants. 
3.  Do patients’ preferences affect treatment compliance and outcome in clini-
cal trials?  When health care personnel supported patients’ preferences as 
part of a quality improvement intervention programme, patients could be 
encouraged to use the treatment that was most suitable for them. In addi-
tion, it was found that patients who strongly preferred counselling, but did 
not receive it were likely to go without treatment altogether. In two partially 
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randomised patient-preference trials, preference did not predict outcome. 
Yet, in these studies all patients were offered a choice; many of them (mostly 
those preferring psychotherapy) would not have entered the study if they 
were to accept randomisation i.e. antidepressant medication. 
4.5.  Discussion
The finding that psychotherapy and counselling were preferred to antidepres-
sant medication was strikingly unequivocal. However, considerable differences 
were found in the degree to which the preferences for psychotherapy over 
antidepressants were expressed. Interpretation of this variation is difficult, 
because of methodological variation among studies. For example, the amount 
of information provided about the  treatment options, the way questions were 
formulated and the timing of the questions differed substantially. Literature 
on decision-making processes has demonstrated  that methods of assessment 
and framing of the questions highly affect preferences (Mayhorn et al., 2002; 
Stiggelbout et al., 2001).  
Few studies paid attention to assumptions underlying preferences . Prefer-
ences were quite often affected by a lack of information and the arguments 
used can be contradicted: psychotherapy cannot resolve the cause of depres-
sion, antidepressants are not addictive and the effectiveness of counselling has 
not been sufficiently proven. Yet, the existence of these incorrect assumptions 
in depressed patients and in the general public underlines the need for the pro-
vision of adequate information not only by physicians to individual patients, 
but also by professional organisations to the general public.
It is important to notice that preferences of patients who are not properly 
informed about the treatment options cannot be used for studying  medical 
decision- making. When specific preference assessment techniques are used, 
for example in oncology, clear descriptions are given of the different treatment 
options, their side effects and possible outcomes. Although some studies in this 
review presented  a complete description of the treatment options (e.g. Dwight-
Johnson et al., 2000) no preference assessment techniques such as utility as-
sessment or probability trade-off methods were used (Stiggelbout et al., 2001; 
Froberg & Kane, 1989).   
In the studies exploring patient characteristics associated with preferences, 
it was found that patients who already received psychotherapy or medication 
tended to prefer this same treatment. This phenomenon has been observed in 
other fields of medical decision-making and is explained by cognitive disso-
nance reduction: subjects make their preferences agree with the decision that 
– 59 –
was made (Stiggelbout et al., 2001). Therefore, when studying preferences, it is 
important to distinguish between patients who have already experienced one of 
the treatment options and those who have not.
Several trials of this review integrated patients’ preferences into a clinical 
trial. The data of Dwight-Johnson et al. (2000) were obtained from the Partners 
in Care study (Wells, 1999). This study resembles the traditional RCT, but after 
randomisation, different intervention protocols are allowed depending on pa-
tient preferences, implicitly assuming that preferences are important. The aim 
of this design is to enhance generalizibility of findings to usual care practice 
and not to study the role of preference as such. Two studies used a partially 
randomised preference design. The main reason for using this design was to be 
able to recruit more representative patients, especially because strong prefer-
ences among some patients existed. In the preference arms of the studies, many 
more patients chose psychotherapy or counselling. This design can be criti-
cised because of several methodological difficulties, the most important being 
that unobserved confounders may have occurred (TenHave et al., 2003). Results 
should therefore be interpreted with caution.  
Some findings of this review can be applied to clinical practice. There is no 
doubt that providing information and discussing the assumptions underlying 
the preferences is a necessary approach before starting therapy. Sometimes 
it is necessary to involve family or friends, as they may strongly influence a 
patients’ opinion. As a substantial percentage of depressed patients prefer psy-
chotherapy after being informed, short-term psychotherapy should be made ac-
cessible in primary care, particularly as previous studies have shown that most 
patients do not wish a specialty mental health referral (McKeon &Carrick, 1991) 
In future research, attention should be paid to the validation of prefer-
ence measures so that comparability between studies is enhanced (Wensing & 
Elwyn, 2003; Thornett, 2001; Cooper et al., 2000). Utility assessment techniques 
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Abstract
Objective  To explore the feasibility and barriers to introducing Interpersonal 
Psychotherapy (IPT) for the treatment of depressed elderly patients in general 
practice. 
Method  Feasibility data were recorded in a randomised clinical trial compar-
ing IPT with usual general practitioner (GP) care. Depressed patients were 
identified by means of a two-stage screening procedure among elderly patients 
visiting their general practitioner. Included were all patients (≥55 years) who 
met the DSM-IV criteria for major depressive disorder. Feasibility was assessed 
by recording motivation and evaluation of patients, GPs and therapists. Organi-
sational barriers were assessed.
Results  Of the 205 eligible patients, 143 (70%) entered the study, and of the 69 
patients who were offered IPT, 77% complied with the treatment. All four spe-
cialist mental health organisations that were contacted supported this inter-
vention. The majority of the participants evaluated the intervention positively. 
Organisational barriers were lack of room in some general practices and time 
and financial restraints for psychotherapists working in private practices. 
Conclusions  Providing IPT by mental health workers in general practice is 
feasible, as long as the practices have room for the therapists and financial bar-
riers can be overcome. Consolidation may be achieved by making this interven-
tion available through practice nurses or community psychiatric nurses who 




Depression among elderly primary care patients is common. Of the older pa-
tients who visit a primary care clinic 5-10% has a depressive disorder (Lyness 
et al., 1999; Schulberg et al., 1998). Depression causes suffering and is associ-
ated with serious disability, reduced quality of life and general functioning. The 
course of depression is often chronic or recurrent (Cole et al., 1999; Beekman 
et al., 2002). Delivering efficacious treatments is of major importance for this 
group of patients. 
Although research on depression treatment in older primary care patients 
is limited (Freudenstein et al., 2001), antidepressant drugs and some forms 
of psychotherapy are both considered to be evidence based therapies, as they 
were effective in older secondary care patients (Baldwin et al., 2003). Yet, it 
has consistently been found that the majority of depressed elderly patients in 
primary care do not receive adequate depression treatment (Young et al., 2001). 
When depression treatment is started, usually antidepressants are offered. 
Because older patients are more sensitive to side-effects and interactions with 
other medication, psychotherapy may be given as an alternative to drug treat-
ment. However, evidence based psychotherapy is not available in most general 
practices, while referrals to secondary care are frequently not completed by 
older patients (Schulberg et al., 2001). Therefore, few older patients receive psy-
chotherapy. Introducing an easily accessible psychotherapy in general practice 
may contribute to the improvement of depression care for older patients.
Interpersonal psychotherapy (IPT) seems to be a suitable form of psycho-
therapy to be delivered to older primary care patients. Its efficacy has been 
proved (Thase et al., 1997), and it has been studied both in older patients (Rey-
nolds et al., 1999) and in adult primary care patients (Schulberg et al., 1996 ). 
Furthermore, therapists with different therapeutic backgrounds can learn this 
therapy relatively easily (Weissman et al., 2000). Despite the favourable results 
of IPT in research populations, the dissemination to general practice is surpris-
ingly limited. To explore the implementation potential of IPT, it is important 
to study the feasibility and barriers to introducing this therapy in normal life 
(general) practice. 
This paper focuses on the feasibility of providing IPT for depressed elderly 
patients in general practice. Data on feasibility were recorded in a randomised 
clinical trial comparing IPT with care as usual provided by the general practi-
tioner (GP). Because there are no strict quantitative criteria to define a positive 
or negative result of a feasibility study, the study consists of a description of 
the feasibility and barriers to the introduction of IPT in general practice. 
– 64 –
5.2  Methods
The study was conducted in 12 general practices in Amsterdam and surround-
ings, based on a protocol approved by the Medical Ethics Review Committee of 
the VU University Medical Centre in Amsterdam. 
Patients. The patients were recruited by means of a two-stage screening 
procedure in the general practices. All patients of 55 years or older who visited 
their general practitioner (GP) were sent a depression screening questionnaire: 
the 15-item Geriatric Depression Scale, GDS-15 (Sheikh & Yesavage, 1986). Pa-
tients who scored 5 or more on the GDS-15, were contacted by telephone by one 
of the research assistants and were invited to participate in the diagnostic pro-
cedure. The diagnostic instrument used to assess depressive disorder was the 
mood module of the PRIMary care Evaluation of Mental Disorders, PRIME-MD 
(Spitzer et al., 1994). Exclusion criteria were: receiving treatment for depression 
at the time of screening, insufficient command of the Dutch language or severe 
cognitive impairment. 
Therapists and general practitioners. Specialist mental health centres and 
private psychotherapists’ practices were approached for participation. Training 
in standardized IPT was given in a 2-day course, followed by group supervision 
sessions every two weeks during participation in the trial. General practices 
which could be reached within half an hour from the workplace of the mental 
health workers were contacted by telephone and invited to participate. 
Intervention. IPT is a structured, time-limited therapy (Weissman et al., 
2000). In the initial phase of the treatment the depressive symptoms are 
explored and psycho-education about depression is given. The interpersonal 
context of the patient is explored and the depressive symptoms are linked to 
recent interpersonal events. There are four possible treatment focuses to be 
distinguished: complicated grief, interpersonal conflict, role-transition and 
interpersonal deficit. One of these focuses is chosen. The nature of this spe-
cific interpersonal event is explored and accompanying emotions are elicited. 
The patient is supported in considering and working out possible solutions. 
During the last sessions, the therapy is evaluated, and attention is paid to the 
prevention of relapses. For use in general practice the number of IPT sessions 
was reduced from the usual 14 to 10. We assumed that with this number of 
sessions drop-out would be less likely. We also assumed that a less intensive 
type of treatment would be sufficient, because of the less severe nature of major 
depressive disorders in general practice (Schwenk et al.,1998). The aim was to 
complete the therapy within five months. 
Feasibility. To asses the motivation of the participants, data concerning the 
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recruitment of patients, therapists and GPs were collected. The number of IPT 
sessions completed, drop-out rates and drop-out reasons were recorded by the 
therapists. Additionally, the intervention was evaluated by all participants. 
Interviews with the patients were carried out by independent and specifically 
trained interviewers. At six months follow-up, patients were asked to evaluate 
the intervention by means of the 8-item Client Satisfaction Questionnaire (De 
Brey, 1983). At the end of the project, the therapists and the participating GPs 
were sent a questionnaire containing specific and open-ended questions about 
the intervention. Furthermore, organisational barriers and facilitating factors 
were recorded during the project. 
5.3 Results
5.3.1  Motivation of the participants
Patients. The GDS-15 was presented to 6.719 patients. Of them, 4.143 patients 
(62%) could be fully screened (GDS-15 and PRIME-MD if the GDS-15 score was 
≥5). Of the 205 eligible patients with current major depression, 143 (70%) gave 
informed consent and therefore had a positive or at least neutral attitude to-
wards IPT. The research population of this feasibility study consisted of the 69 
patients who were allocated to the IPT condition. Table 5.1 presents the char-
acteristics of these patients. The mean number of treatment sessions was eight. 
Of the 69 patients who started the therapy 47 (68%) completed 10 sessions. 6 
patients (9%) terminated the therapy earlier while the therapist agreed that they 
did not need to continue any longer. Thus, 77% of the patients were compliant 
with the therapy. 
General practices. Of the 18 general (mostly group) practices that were ap-
proached, 6 refused. Lack of available room for the therapists was mentioned 
as the main barrier by representatives of four practices. One objected to the 
screening procedure and one saw no need for this intervention. 
Private psychotherapy practices, specialist mental health centres and 
mental health workers. The two psychologists’ private practices that were 
approached, were interested in IPT, but could not join the project, because of 
financial and organisational reasons. Specialist mental health centres were 
motivated, as long as the extra workload of the therapists was limited. Four 
centres provided therapists. The geriatric teams of these organisations received 
training in IPT, and it turned out that the majority of therapists were interested 
in joining the research project. Nine psychiatric nurses and six psychologists 
participated in the study. Supervision was provided at the workplace of the 
therapists and was well attended.
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Table 5. 1 Baseline characteristics of patients allocated to the IPT intervention 
Characteristics IPT (n=69)
Sociodemographic
  Mean (SD) age, years 68.4 (8.1)
  Female (%) 48 (70)
  Married or living together (%) 33 (48)
  Level of Education (%)      
        Low 
        Intermediate





MADRS, mean (SD) 19.4 (7.9)
CGI-s , median (SD)   3.3 (1.3)
Note: MADRS=Montgomery Asberg Rating Scale; CGI-s=Clinical Global Impression severity scale.
5.3.2  Evaluation of the intervention
Patients. Patient satisfaction was measured by means of the CSQ-8, which was 
completed by 54/69 patients. The mean item score on this scale (ranging from  
1 to 4) was 3.0 (SD 0.6). which represents a very positive evaluation.
General practitioners. Patients of 22 GPs received IPT, and all of these 22 
GPs returned the evaluation questionnaire. Their evaluation of IPT was posi-
tive, mainly because of its time-limited, practical and structured nature. All but 
one of the GPs thought that this intervention lowered the barrier to providing 
adequate care for a group of elderly patients, who do not want to be referred to 
specialist mental health facilities. These same GPs stated that they would use 
this intervention if it were available after the end of the research project. 
Therapists. The participating therapists were positive about working within 
the general practice. Most of them were used to doing outreaching work, and 
the visits to the GP could be integrated well into their schedule. Of the 15 thera-
pists, 11 reported that they occasionally needed extra time and flexibility to 
find office space, and one found this a very unpleasant complication. Therapists 
were positive about the structure and strategies provided by the IPT protocol. 
5.4  Discussion
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In this study we explored the feasibility and barriers to the introduction of IPT 
for depressed elderly patients in general practice. Of the 205 eligible patients, 
the majority (70%) was motivated to participate, and 53 patients (77%) who were 
offered IPT, complied with the therapy. All four specialist mental health organi-
sations that were contacted joined the project, and the majority of the mental 
health workers and general practitioners were welll-motivated and evaluated 
the intervention positively afterwards. 
The percentage of compliant patients (77%) is high compared to the compli-
ance found in treatment with antidepressants in general practice. It has been 
found that more than 50% of the patients stop their medication within three 
months (Lawrenson et al., 2000) Schulberg et al. (1996), who also used a screen-
ing procedure to recruit patients, and who compared IPT with antidepressant 
drug treatment for adult patients in primary care, found higher drop-out rates 
in their IPT group: 14% failed to appear at the start, and 50% did not complete 
all 16 weekly sessions. The number of treatment sessions in our project was 
lower and in general, elderly patients tend to have relatively low drop-out rates 
in treatment for depression (Bech et al., 2003; Salzman, 1995).
The percentage of eligible patients who were motivated for the interven-
tion (70%) cannot be generalised as such to all older primary care patients, 
because we were not able to screen the whole target population. Probably, the 
percentage of refusals would be higher among the depressed non-completers 
of the screening procedure. Additionally, our population was primarily from 
(sub)urban regions. In the survey of McKeon, living in a city was positively as-
sociated with a preference for psychotherapy (McKeon & Carrick, 1991). Thus, 
the estimate of 70% is probably optimistic, but notwithstanding that we can 
conclude that from the perspective of many older patients in general practice, 
IPT is a feasible and welcome treatment option. 
GPs and therapists were not randomly selected and those who participated 
probably represent the more motivated professionals. However, our findings 
give an indication that at least a substantial percentage of therapists and GPs 
is interested in this intervention and that, once on board, they evaluate it posi-
tively. 
Some findings may not be generalisable to other countries. Patients did not 
have to pay for their therapy. Therefore, we do not know to what extent financial 
barriers may influence uptake in real life practice in countries with a different 
financial organisation of the health service. Training and supervision in IPT 
may also be more difficult to organise in other places, but there is an Interna-
tional Society for IPT, and in Europe there is an active group of initiators who 
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share knowledge and experiences in IPT research, training and supervision 
(www.interpersonalpsychotherapy.org ).
Organisational changes to implement an intervention can only be made if 
the intervention is feasible ànd effective in the population under study. IPT 
was more effective than usual GP care in reducing the number of patients 
with major depressive disorder (Van Schaik et al., 2006). This finding was more 
pronounced in patients with moderate to severe depression at baseline, than in 
patients with mild depression. Determinants of treatment outcome, other than 
initial depression severity, will be explored. The effectiveness of depression 
teatment as a whole can probably be improved when patients can choose or 
switch between interventions, and combination therapies can be given. In two 
recent studies, IPT and Problem Solving Therapy (PST) were delivered as part of 
depression management programmes for older primary care patients (Bruce et 
al., 2004; Unützer et al., 2002). In these programmes, treatment was tailored to 
the needs of individual patients, and switching and combining of therapies was 
possible. The results of these studies were positive. 
The present study shows that it is feasible to make IPT available in real life 
general practice for older patients with major depression as long as the prac-
tices have room for the therapists and financial barriers can be overcome. This 
implies that an important gap in the depression care for older patients can be 
filled. Because it is feasible to organise the delivery of IPT in general practice, 
and because the effectiveness of depression management programmes has 
been proved, there are grounds to support the implementation of IPT as part of 
depression management programmes for patients who prefer psychotherapy 
(Van Schaik et al., 2004) or who do not benefit from antidepressant drug treat-
ment (as a monotherapy). Future research should focus on the fine-tuning of the 
intervention (e.g. optimal number of sessions, comparing IPT with PST) and on 
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Objective  Interpersonal psychotherapy (IPT) is recommended in most depres-
sion treatment guidelines, but little is known about its effectiveness in real-life 
practice. This study investigates whether IPT, delivered by mental health work-
ers to elderly patients with major depressive disorder, is more effective than 
usual general practitioners’ care (CAU). 
Methods  A pragmatic randomised controlled trial was conducted in which 143 
patients were allocated to IPT (10 sessions) or to CAU. PRIMary care Evaluation 
of Mental Disorders (PRIME-MD) and Montgomery Åsberg Depression Rating 
Scale (MADRS) assessments were used as primary outcomes. 
Results  IPT was significantly more effective in reducing the percentage of pa-
tients with a diagnosis of depression (PRIME-MD), but not in inducing remis-
sion (MADRS <10). Among treatment completers, IPT was superior in improving 
social and overall mental functioning. A post hoc analysis revealed that IPT 
was superior to CAU in moderately to severely depressed patients, but not sig-
nificantly so in mildly depressed patients. 
Conclusions  IPT was more effective than CAU for elderly patients with mod-
erate to severe major depressive disorder in general practice. Future research 




Depression among elderly primary care patients is common. Of the older pa-
tients who visit a primary care clinic 5-10% has a depressive disorder (Lyness 
et al., 1999; Schulberg et al., 1998). If depression in the elderly remains untreat-
ed, it increases mortality from co-morbid medical conditions or suicide, and 
increases service utilization and demands on caregivers (Charney et al., 2003; 
Penninx et al., 2000 ). Delivering efficacious treatments is of major importance 
for this group of patients.
There is evidence of sub-optimal treatment for elderly patients with major 
depression in primary care, despite the existence of several effective treatment 
options (Baldwin et al., 2003). Antidepressant drugs are mostly the treatment of 
first-choice when a specific depression treatment is indicated. Patients who do 
not benefit from this medication may switch to psychotherapy, as can patients 
who prefer psychotherapy (Van Schaik et al., 2004). However, psychotherapy 
is mostly not available in general practice, and older patients often resist to 
referral to specialized mental health facilities (Bartels et al., 2004). Therefore, 
providing easily accessible psychotherapy within primary care may contribute 
to the improvement of depression care for the elderly. 
Both the format and the content of Interpersonal Psychotherapy (IPT) are 
especially suitable for elderly patients (Miller et al., 1997). However, dissemi-
nation of IPT is limited, and little is known about its effectiveness for older 
patients in real-life general practice. Before implementation can be further 
promoted, the effectiveness of this intervention should be studied more exten-
sively.
This article examines the effectiveness of IPT, delivered by mental health 
workers within general practice to elderly patients with major depressive 
disorder. The research question is whether IPT is more effective than usual GP 




This randomised controlled trial was based on a protocol approved by the Med-
ical Ethics Review Committee of the VU University Medical Centre in Amster-
dam. It was conducted in 12 general practices in Amsterdam and surroundings. 
Six other practices were approached, but refused participation, mostly because 
they had no office facilities for the therapists in the practices.
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6.2.1  Sample and interventions
Participants were recruited from February 2002 to July 2003 by means of a 
two-stage screening procedure. We sent a depression screening questionnaire, 
the 15-item Geriatric Depression Scale, to individuals of 55 years or older, who 
had recently visited the GP (GDS-15, range 0-15, higher scores indicate more 
depressive symptoms (Sheikh & Yesavage, 1986). A research assistant contacted 
respondents, who scored 5 or more on the GDS-15, and invited them for further 
diagnostic examination. If they consented, the research assistant administered 
the mood module of the PRIMary care Evaluation of Mental Disorders (PRIME-
MD) to asses a diagnosis of depressive disorder (Spitzer et al., 1994). Excluded 
were respondents who had: (i) treatment for depression at the time of screen-
ing, (ii) insufficient understanding of the Dutch language or (iii) severe cognitive 
impairment (Mini-Mental State Examination score of <18). Eligible patients 
were informed about the study, and received written explanation. Those who 
signed informed consent were randomly allocated to either IPT or CAU. An inde-
pendent research assistant performed randomisation per practice at the patient 
level by using a table of random numbers (Pocock, 2002). Blocking by practice 
(blocks of four) was used to ensure that comparison groups were of approxi-
mately the same size per practice.
Interpersonal psychotherapy. Six psychologists and nine psychiatric nurses 
provided IPT. All therapists had worked for more than five years in mental 
health care, and 13 had two or more years of experience in working with elderly 
patients. None of them were IPT therapists. Training in standardized IPT was 
given in a 2-day course, followed by group supervision sessions every two weeks 
during a period of one year, after which the frequency of the supervision ses-
sions was reduced to once a month. All therapy sessions were audiotaped, and 
the tapes were used for individual feedback and for review purposes in the group 
supervision sessions. IPT is a structured, time-limited therapy, specifically devel-
oped for the treatment of depressive disorder; its efficacy has been demonstrated, 
also in the elderly (Reynolds et al., 1999; Thase et al., 1997). The treatment pro-
tocol is described in a manual, and therapists with different therapeutic back-
grounds can learn this therapy relatively easily. In the initial phase, the depres-
sive symptoms are explored and psycho-education about depression is given. The 
interpersonal context of the patient is explored and depressive symptoms are 
linked to recent interpersonal events. There are four possible treatment focuses: 
complicated grief, interpersonal conflict, role-transition and interpersonal deficit. 
One of these focuses is chosen. The nature of this specific interpersonal event 
is explored and accompanying emotions are elicited. The patient is supported 
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in considering and working out possible solutions. In closing, the therapy is 
evaluated, and attention is paid to the prevention of relapses. For use in general 
practice we reduced the number of IPT sessions from 14 to 10, which had to be 
completed within five months. We assumed that with this number of sessions, 
drop-out would be less likely (Browne et al., 2002) and that a less intensive type 
of treatment would be sufficient, since major depressive disorders are in general 
less severe in primary care (Schwenk et al., 1998). When a patient was allocated to 
the IPT intervention, the GP was informed and asked not to prescribe any antide-
pressants or to refer for psychotherapy or counselling. 
Care as usual. GPs were not informed about patients who were included in 
the care as usual arm of the study, except when they were suicidal. 
6.2.2 Outcome 
Follow-up assessments were carried out at two and six months after the 
baseline interview. The primary endpoint with respect to effectiveness was the 
proportion of patients achieving remission of depression at six months follow-
up. Remission was defined as having a score of less than 10 on the Montgomery 
Åsberg Depression Rating Scale (MADRS, range 0-60, higher scores indicate 
higher severity of depression (Montgomery & Asberg, 1979; Hawley et al., 2002). 
Furthermore, analyses were done on the proportion of patients who had a 
diagnosis of depression (PRIME-MD mood module) and on changes in the mean 
MADRS and GDS-15 (self-report) scores. The secondary outcome, general func-
tioning, was measured using the Medical Outcome Study 36-item Short Form 
Health Survey (SF-36, range 0-100, higher scores indicate better functioning; 
Ware & Gandek, 1998). The independent interviewers were trained in a 1½-day 
course. Halfway through the project an additional training day was organised, 
and during the whole study, feedback was given based upon recorded audio-
tapes of interviews. Usual GP care was monitored using diaries about health 
service use, recorded by the patients. 
6.2.3  Analysis
We expected 50% remission in the intervention group versus 25% in the refer-
ence group. This expectation was based on findings of other psychotherapy 
intervention studies on the treatment of major depression in adults in primary 
care (Mynors-Wallis et al., 1995; Schulberg et al., 1996). To detect this risk dif-
ference (RD) of 25% (with alpha=.05 and beta=0.80) 60 patients per arm were 
needed (Pocock, 2002). When accounting for a drop-out percentage of 10 %, a 
total of 140 patients should be selected. 
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Data-analysis consisted of descriptive statistics, including percentages for 
binary outcomes and means and SDs for continuous outcomes. Between group 
differences in binary outcome measures were analysed using chi-square tests 
at different time-points. These analyses were based on available data. When a 
significant difference was found, we performed sensitivity analyses, assuming 
that all patients of whom the data were missing had not improved. For these 
analyses, SPSS for Windows, version 11.0 was used. Effect sizes (defined as the 
difference between the mean end scores of the intervention and control groups, 
divided by the pooled standard deviation of the end scores (standardised mean 
differences) were calculated using Revman (version 1.0.2. The Cochrane Col-
laboration). Random coefficient analysis was performed on the continuous 
outcome data to achieve more efficient statistical inference and enhance power 
of the analyses. We used intention to treat analysis, by including all patients 
who were randomly assigned in these analyses. Per protocol analyses were 
also performed. Patients who completed six or more sessions of IPT, and all 
patients in the usual GP care condition were considered treatment completers. 
These analyses were carried out using MLwiN (version 1.1) statistical software 
(Rasbash et al., 2000). 
Since it has been found that specific interventions, such as short-term 
psychotherapy, may be more effective than control conditions in patients with 
moderate to severe depression (Angst et al., 1993; Elkin et al., 1995), post hoc 
analyses were performed, taking account of the baseline MADRS score dichot-
omised around a score of 21 (Mottram et al., 2000). 
6.3  Results
Figure 6.1 shows that 6719 persons were approached to identify 293 patients 
with major depressive disorder. Of these, 88 (30%) were ineligible, mainly 
because of ongoing treatment for depression at the time of screening. Of the 
eligible patients, 143 (70%) agreed to participate. Participants were on average 
2.9 years (t
 [202] 
= -2.03; p=0.04) younger than non-participants. There were no 
significant differences in gender and severity of depression between participat-
ing and non-participating patients. The intervention and control group did not 
differ on demographic and clinical characteristics (Table 6.1). In the IPT group 
11 patients (16%) and in the CAU group 12 patients (16%) dropped out before six 
months follow-up.
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Figure 6.1.  Flow diagram
6719 Patients received GDS-15 
4301 Patients completed GDS-15 
834 Patients had GDS-15 ≥ 5
667 Patients Assessed for Enrollment
69 Patients allocated to IPT  
55 completed protocol 
2-month Follow-up 
69 included in analysis
   58 Respondents
 11 Non-respondents
6-month Follow-up
69 included in analysis
 58 Respondents 
 11 Non-respondents
74 Patients allocated to Usual GP Care 
2-month Follow-up 




74 included in analysis
 62 Respondents
 12 Non-respondents
Note: PRIME-MDD = PRIME-MD mood module
293 Patients PRIME-MDD positive
143  Patients randomly allocated to 
treatment
2418 Patients did not complete GDS-15 
3467 Patients had GDS-15 < 5
167 Patients Excluded
 30 Ineligible
 46 No contact
 3 Died
 88 Refused
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Patients in the intervention group (N=69) received on average eight (out of 10) 
sessions of IPT. A total of 55 (80%) patients completed six or more sessions of 
IPT, and were therefore included in the completer analysis. A total of 80 pa-
tients, 39 (56%) from the IPT group and 41 (55%) from the care as usual group, 
completed the medical consumption diaries over the first six months after 
inclusion. According to these diaries four patients in the care as usual group 
received counselling, and one used antidepressant drugs. In the IPT group,  
no antidepressant drug use was recorded. The mean number of contacts with 
the GP was 3.9 (SD 3.5) in the IPT group and 5.0 (SD 6.5) in the CAU group  
(t 
[78]
 = -.92; p=0.36). 
From Table 6.2 it can be seen that there was a significant difference in the 
proportion of patients with no diagnosis of major depression at six months fol-
low-up. Assuming that all missings were PRIME-MD positive (a very conserva-
tive assumption), the difference was 17% (50.7% versus 33.8%) and still signifi-
cant. This implies a number needed to treat of six. No difference was found in 
the percentage of patients with response (50% reduction in MADRS score) or 
complete remission (MADRS score < 10). 
Table 6.2. Diagnosis of Depression and Remission 
IPT Usual GP care X2 
[df]
       p
No Diagnosis of Depression 
(PRIME-MD mood negative)






     0.83
0.08
[1]
     0.78






     0.03
4.21
[1]
     0.04
Response (50% reduction MADRS)
         2 months  7 (11.3%)  6 (9.2%) 0.15
[1]
     0.70
         6 months 16 (27.6%) 18 (29.0%) 0.03
[1]
     0.86
Remission (MADRS < 10)
         2 months  8 (12.9%)  7 (10.8%) 0.14
[1]
     0.71
         6 months 19 (32.8%) 20 (32.3%) 0.00
[1]
     0.95
Note: Data are presented as N (%). a: assuming all missings had diagnosis.
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Table 6.3 presents the results of the continuous MADRS and GDS-15 scores. A 
positive value of the b, the regression coefficient of the time versus treatment 
interaction, indicates superiority of the intervention over the control condition. 
No significant differences were seen on either measure. The effect size, calcu-
lated on available cases (n= 58 in IPT group, n=62 in CAU group) was, based on 
the MADRS data:  –0.11 (95% CI: -0.47 to 0.24), and on the GDS data: –0.03 (95% 
CI: -0.39 to 0.33).
Table 6.3.  Depression severity over time








Baseline    
2 months  
6 months   
19.4 (7.9)   
17.1 (7.5)    
13.9 (7.9)    
19.3 (8.6)   
19.4 (8.7)    
14.9 (9.6)    
2.97   

















Baseline    
2 months   
6 months   
8.5 (2.5)      
7.4 (2.9)      
5.8 (3.5)      
8.6 (2.5)    
7.6 (3.0)      
5.9 (3.5)      
0.19 















Note: SD: standard deviation; b: regression coefficient of the time x treatment interaction, computed in 
random coefficient analysis.
Table 6.4 presents the results of the secondary outcome measure, the SF-36. 
In addition to the main physical and mental component summary scores, we 
present the social functioning subscale separately, because IPT focuses on 
improving social functioning. A negative b indicates that the intervention was 
more effective than CAU. A superior effect of the IPT intervention could not 
be demonstrated in the intention to treat analysis. However, in the completer 
analysis, IPT proved to be more effective than usual GP care on the mental com-
ponent summary score and on the social functioning subscale. 
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Table 6.4.  SF-36 results











39.7 (13.2)      
41.2 (11.0)







   Baseline











   Baseline










Note: SD: standard deviation; b: regression coefficient of the time x treatment interaction, computed in 
random coefficient analysis. 
In post hoc analyses, the differential effect of the categorical MADRS baseline 
score (<21, yes/no) was explored. Table 6.5 shows that in the subgroup of pa-
tients with a baseline MADRS score of 21 or more, significantly more patients 
had no diagnosis of depression anymore in the IPT group than in the CAU 
group (RD = 27.1%), whereas in patients with a low initial MADRS score, the 
difference was smaller (RD = 8.8%) and not significant. 
This differential effect could also be demonstrated by the GDS data: In the 
subgroup of patients with an initial MADRS score of ≥21, the IPT group im-
proved more on the GDS-15 than the usual care group, while in patients with 
an initial MADRS score of <21, the care as usual group did better. To test the 
significance of this differential effect, we included the baseline MADRS score 
as a binary variable into the GDS-15 regression equation, and found that the b 
of the interaction term of the categorical MADRS versus time (6 months) and 
treatment was positive and significant. 
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Table 6.5.  Differential effect of initial depression severity on treatment 
outcome (at 6 months)
IPT CAU X2 
[df]
      p
No diagnosis of depression, N (%)
Baseline MADRS ≥ 21 
      











    
4.75
[1]










IPT CAU b t
[df]
p
GDS, mean (SD) 










Note: a: assuming all missings had diagnosis. SD: standard deviation; b: regression coefficient of the 
time x treatment x binary variable MADRS < 21 (yes/no) interaction, computed in random coefficient 
analysis.
6.4  Discussion
The aim of this randomised controlled trial was to explore the effectiveness of 
IPT for depressed elderly patients in general practice. We expected that treat-
ment effects in our pragmatic trial would be demonstrable, but smaller than 
effects in a comparable efficacy trial. We found that IPT was indeed more ef-
fective than usual GP care in reducing the number of patients with a diagnosis 
of major depressive disorder post treatment (RD 17%). However, many patients 
reported residual symptoms. Remission rates were relatively low (32-33%) and 
did not differ between the groups. There were also no significant differences in 
mean scores on the MADRS, GDS-15 and SF-36 scales. Among treatment compl-
eters, IPT was superior in improving social and overall mental functioning. A 
post hoc analysis revealed that severity of the index depression had a differ-
ential effect on treatment outcome: the effect of IPT was more pronounced in 
those with moderate to severe depression (MADRS ≥21) at baseline. 
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6.4.1 Comparison with other studies
Two recent primary care studies on depression care enhancing interventions 
for elderly patients, reported comparable low percentages of remission (Bruce 
et al., 2004; Unützer et al., 2002). Remission percentages in adult primary care 
patients were found to be higher, ranging from 50-67% (Dawson et al., 2004). 
In both younger and older adults, the effect sizes of depression management 
programs in general practice are relatively low. In a recent review of 24 primary 
care studies the pooled effect-size was 0.33 (95% CI: 0.16 to 0.49; Badamgarav 
et al., 2003). Especially for the heterogeneous primary care population, there is 
a need to identify subgroups of patients who do, or do not, benefit from specific 
forms of treatment. 
6.4.2  Methodological considerations
By using a screening procedure we avoided the biased selection that might have 
occurred when participants were recruited by GPs. Additional positive aspects 
of this study are that we used concealed allocation and had independent evalu-
ators. As we wanted to perform a pragmatic trial, we limited the exclusion 
criteria as much as possible. Because it has been demonstrated that also mild 
forms of depression are consequential for well-being and disability (Beek-
man et al., 1997), we included these patients in our trial, to find out whether 
they would benefit from IPT. As was discussed by Posternak (2002), data on the 
efficacy of antidepressant treatments for mild depression are conflicting. In 
recent years, several primary care studies have found that in patients with mild 
depression hardly any treatment effect could be demonstrated, because the per-
centages of spontaneous remissions came close to that of an optimal treatment 
effect (Bruce et al, 2004; Barrett et al., 2001; Williams et al., 2000). Our data con-
firmed these findings. Because the percentage of patients with mild depression 
was high, the power to demonstrate a significant treatment effect in patients 
with moderate to severe depression was negatively influenced. 
We focused on IPT as a mono therapy. Depression treatment as a whole will 
most probably be more effective when patients can choose or switch between 
antidepressants and IPT, or can get combination therapies. This approach takes 
implicitly account of the heterogeneity of the population. Interestingly, it was 
recently demonstrated that a switch from an antidepressant medication to psy-
chotherapy or vice versa was useful for non responders to the initial treatment 
(Schatzberg et al., 2005).
Consonant with real-life circumstances, no experienced IPT therapists were 
available in primary care. Therefore, we had to train therapists in the initial 
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phase of the study. We did not use specific selection criteria other than being 
motivated to participate. This approach may have affected treatment integrity, 
and have decreased effectiveness. Furthermore, the relatively low “dose” of 
IPT (10 instead of 14 sessions) was probably not enough for the patients with 
moderate to severe depression as Shapiro et al. (1994) have found that patients 
presenting with relatively severe depression improved substantially more after 
16 than after 8 sessions of IPT.  
In research comparing psychotherapy with usual care or medication, it is 
not possible to blind patients and therapists to the intervention. Patients in 
the IPT group may therefore have been more positive about treatment outcome. 
However, patients in the usual care group may have informed their GPs about 
their participation in the study and have asked for treatment of the depression. 
Therefore, the effect of a lack of blinding may be both an over- and an underes-
timation of the effect of IPT.  
The care as usual condition in our study was probably of higher quality 
than the ‘real’ usual care in the Netherlands. We randomised at the patient 
level, not at the practice level, to reduce possible bias by different patient 
samples per practice. Consequently, GPs may have treated their study patients 
more actively than they were used to, because the project was being carried 
out in their practice. Additionally, the participating GPs may represent a group 
with above average affinity with the care for depressed elderly patients. These 
factors may have resulted in a less pronounced IPT/CAU difference in our study 
than is to be expected in general. 
6.4.3  Conclusions
This is the first study supporting that IPT is effective in real-life general prac-
tice for elderly patients with moderate to severe major depressive disorder. This 
finding is especially noteworthy, as the therapy dose was relatively low and the 
therapists were not very experienced in delivering IPT. 
The fact that in the present and in other studies only one third of the pa-
tients reached full remission needs further study. Diagnostic or intervention 
strategies should probably be adapted to elderly depressed patients. It can be 
concluded that there are grounds to support the delivery of IPT to moderately 
or severely depressed elderly patients in real-life general practice, but evidence 
is still limited. It should be stated that there is also hardly any evidence for 
the effectiveness of antidepressant drug treatment in comparison to CAU or to 
some form of short term psychotherapy in this group of patients (Freudenstein 
et al., 2001). What we do know is that more extensive depression care enhancing 
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projects, including antidepressant drugs and/or psychotherapy, were effective 
(Bruce et al., 2004; Unützer et al., 2002). Given the large and growing number of 
older primary care patients that may benefit from effective treatment, it is very 
important to further uncover which types of interventions may be of benefit to 
which types of older patients. This requires studies adopting various treat-
ment strategies and studies large enough to discern patient and doctor related 
factors that may modify the effects of treatment. In the mean time, especially 
among (older) patients with more severe depression, offering both IPT and 
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Abstract
Objective  To identify patient characteristics that predict (treatment) outcome 
in elderly patients with major depressive disorder in primary care. 
Methods  Predictors of outcome were explored in two separate, identically 
designed randomised controlled trials: the IPT study that compared the ef-
fectiveness of Interpersonal Psychotherapy (IPT) with usual GP care (CAU), and 
the West Friesland study that compared guideline driven drug treatment by the 
GP with CAU. The primary depression outcomes were diagnosis of depression, 
measured with the PRIMary care Evaluation of Mental Disorders (PRIME-MD) 
and remission, defined as a score of < 10 on the Montgomery Åsberg Depres-
sion Rating Scale (MADRS). The predictive value of 13 candidate predictors was 
studied using backward logistic regression.  
Results  Overall, the predictors of poor outcome were a higher age, a lower 
educational level, recent life events, a lower level of social functioning, higher 
initial depression severity, a lower level of physical functioning, and panic 
symptoms. IPT was more effective in patients with recent life events than in 
patients without such events. IPT was also more effective in women than in 
men. There were no other interactions with treatment. 
Conclusions  Patients who have characteristics that predict poor outcome 
should be treated and monitored more intensively and should probably be re-
ferred earlier to secondary care. IPT may be especially indicated for depressed 
patients with recent life events, as life events predicted a favourable outcome 





In recent years much attention has been paid to the detection and treatment of 
depressed elderly patients in primary care. It has been found that antidepres-
sant drug treatment and psychotherapy as monotherapies and as part of more 
comprehensive depression care enhancing programmes, are more effective than 
care as usual (Bruce et al., 2004; Freudenstein et al., 2001; Unützer et al., 2002; 
Van Schaik et al., 2006). However, treatment effects varied across studies, and 
overall effects were modest. 
Different factors determine this variance in treatment outcome. To further 
improve depression care it is important to explicitly address these factors. 
First, there are differences in the organisation of primary health care that may 
influence treatment outcome. For example, European primary care settings 
are different from the managed care settings in the United States in terms of 
continuity of care and open access. Therefore, there may be considerable differ-
ences in the (usual) care conditions among studies. Second, studies differ in the 
extent to which they succeed in delivering optimal care. Physician factors and 
therapist factors are important in this regard. Third, and this will be the topic 
of the current paper, patient characteristics determine outcome in general, and 
in relation to specific treatment options. When these patient characteristics are 
known, treatment strategies can be applied more selectively, resulting in a more 
effective and more efficient depression care overall.
Several researchers have explored predictors of outcome for depression in 
younger adults in primary care (e.g. Brown et al., 2000; Corey-Lisle et al., 2004; 
Limosin et al., 2004; Mynors-Wallis & Gath, 1997a; Sherbourne et al., 2004; 
Walker et al., 2000). The predictors that were identified in these studies are 
summarized in Table 7.1. None of these studies have focussed on determinants 
of (treatment) outcome in elderly depressed patients in primary care, while it is 
likely that there are relevant differences between elderly patients and younger 
adults. For example, older attendees of general practice often have physical 
health problems, and work-issues are not relevant for most patients of this age 
group. Therefore, we studied determinants of outcome in two highly compara-
ble intervention studies on elderly patients with major depression in general 
practice. In the first study, Interpersonal Psychotherapy (IPT) was compared 
with usual GP care (IPT study), and in the second study, guideline driven anti-
depressant drug treatment by the GP was compared with usual GP care (The 
West Friesland study (WF study)). The treatment effects of these studies were 
modest, but there was much variation in outcome, which supports the impor-
tance of revealing predictors of outcome. 
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Our research questions were:
1)  What are the most important patient characteristics predicting outcome 
among elderly patients with major depression in general practice?
2)  Are these characteristics similar for antidepressant drug treatment and 
for psychotherapy (IPT) i.e. do these predictors interact with the treatment 
conditions?
Table 7.1   Patient factors predicting poor outcome in depressed younger 
adults in primary care 
Sociodemographic Older age 
Unemployment
Race (African American in US)




External health locus of control
Depression  High initial depression severity
Suicidal ideation
Low energy level
Long duration of illness
Recurrent depression
Physical functioning Medical co morbidity
Low physical functioning
Psychiatric co morbidity Panic disorder
Other Non adherence to medication
7.2  Methods
7.2.1  Design and setting
This study explores the predictors of outcome in two randomised controlled 
trials that were designed in order to allow for the analyses that are the sub-
ject of this paper.  The methods of both studies have been reported elsewhere 
(Bijl et al., 2003; van Schaik et al., 2006), but will be briefly summarized here. 
The IPT study and the WF study were performed in separate groups of general 
practices, all in and around the Amsterdam area. The design of the studies was 
identical except for the randomisation procedures. In the WF study, randomisa-
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tion was performed at the practice level as the GPs delivered the intervention, 
and contamination between treatment conditions was therefore probable. In 
the IPT study randomisation was carried out at the patient level, per practice, 
as a mental health worker gave the IPT, and contamination of the care as usual 
(CAU) was not very likely. 
Samples. In both studies patients were recruited in exactly the same way 
by means of a two-stage screening procedure in which all individuals of 55 
years or older who had recently visited the GP, were sent a depression screen-
ing questionnaire: the 15-item Geriatric Depression Scale (GDS-15, range 0-15, 
higher scores indicate more depressive symptoms; Sheikh & Yesavage, 1986). 
Respondents, who scored 5 or more on the GDS-15, were contacted by telephone 
by one of the research assistants and were invited for further diagnostic exami-
nation. If they consented, a diagnosis of depressive disorder was assessed by 
the research assistant who administered the mood module of the PRIMary care 
Evaluation of Mental Disorders (PRIME-MD; Spitzer et al., 1994). Excluded were 
respondents who had: (i) treatment for depression at the time of screening, (ii) 
insufficient understanding of the Dutch language or (iii) severe cognitive im-
pairment (Mini-Mental State Examination score of <18).  All participants gave 
written informed consent after the study procedures were fully explained.
Interventions. In the IPT Study, mental health workers delivered 10 sessions 
of IPT in the general practices within five months. In the WF study GPs were 
trained in using the diagnostic and treatment guidelines for depression of the 
Dutch College of General Practitioners (NHG). Treatment consisted of psy-
cho-education about depression and drug treatment (paroxetine 20 mg daily) 
accompanied by clinical management (monitoring of symptoms and supportive 
counselling by the GP). 
7.2.2  Outcome
We explored the predictors of two outcomes: a) diagnosis of major depres-
sion (yes/no) and b) ‘remission’ (yes/no) at six months. Major depression was 
assessed by means of the PRIME-MD mood module. Remission was defined 
as having a score of < 10 on the MontgomeryÅsberg Depression Rating Scale. 
(MADRS, range 0-60, higher scores indicate higher severity of depression; Mont-
gomery & Asberg 1979; Hawley et al., 2002). Trained, independent interviewers 
carried out the assessments. 
Predictors. We measured 13 candidate predictors of outcome. Nine of these 
determinants were already identified as predictors of outcome in younger 
depressed adults in primary care: age, current stress (life-events schedule, 
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developed for the Longitudinal Aging Study Amsterdam, Beekman et al., 1995), 
social functioning (social functioning subscale of the Medical Outcome Study 
36-item Short Form Health Survey (SF-36), range 0-100, higher score indicates 
better functioning; Ware, 1992) , neuroticism (NEO-FFI, range 0-60; higher score 
indicates more neuroticism;  Costa & McCrae, 1992), locus of control (range 
0-20, higher score indicates more internal locus of control; Pearlin & Schooler, 
1978), baseline depression severity (MADRS), physical functioning (SF-36, 
physical component summary score), anxiety (PRIME-MD anxiety module), and 
treatment. We added two variables because of their possible predictive value in 
elderly patients: age of onset of the first depression and functional dependency, 
ADL (range 0-12; higher score means more functional dependency; Brorsson 
and Asberg, 1984). Furthermore, we added gender and level of education as can-
didate predictors because therapists of the IPT research project suggested at 
the end of the project that IPT was less effective in elderly men, and in patients 
with a lower educational level. 
7.2.3  Analysis
For both the IPT and the WF study, a comparison of the baseline sociodemo-
graphic and clinical characteristics of the intervention and control group was 
already made; it was concluded that randomisation within these studies had 
succeeded. (Bijl et al., 2006; van Schaik et al., 2006). In order to compare the 
determinants of outcome in both studies, we explored possible differences 
between the patient samples by combining the data of both studies resulting 
in four groups: the IPT intervention group (IPT
int





 group, and the WF
CAU
 group. We carried out ANOVA for the 
continuous variables and X2 for categorical variables. 
With regard to missing data: we did not impute missing values, but per-
formed the analyses on available data. To explore potential differential attrition 
we compared the demographic and clinical characteristics of the participating 
patients in the intervention and control groups at six months. We knew that 
there were no differences at baseline, and if there were still no differences at 
six months, it could be concluded that the attrition had not been selective, oth-
erwise we would have to correct for these differences. 
We analysed the determinants of outcome for each study separately. We per-
formed backward logistic regression to identify the most important predictors 
of not having a diagnosis of depression anymore post treatment (at six months). 
In contrast to etiological research, it is common in prediction research to use 





















































































   





















































































   




   







   















































































































































































































































































































































































































































et al., 1996). We used a p-value of 0.10. Finally, we entered the interaction terms 
of every candidate predictor with treatment in the regression equation and 
performed backward regression again. The same procedure was carried out 
with regard to the other outcome measure, remission after six months. For 
these analyses, SPSS for Windows, version 11.0 was used. In these analyses, the 
extent to which a variable predicts outcome is expressed in (Exp(b))= eb.  As this 
value is equal to the odds ratio, we present the odds ratios. 
7.3  Results
Table 7.2 compares the demographic and clinical characteristics of the patients 
from the IPT and WF studies. Patients in the WF study had on average a lower 
level of education; none of the other variables differed significantly between 
the four groups. In the IPT study, 11 patients (16%) from the intervention group 
and 12 patients (16%) from the control group dropped out before six months. 
In the WF study, these numbers were 10 (14%) and 9 (12%) respectively. As there 
were no differences between the baseline characteristics of the participating 
patients in the intervention and control groups of both studies at 6 months, we 
concluded that there was no selective dropout of participants. 
In the IPT study, the predictors of a favourable outcome (no diagnosis of 
major depression anymore) at six months were: a) a higher level of education, b) 
better social functioning at baseline, c) absence of co morbid panic symptoms, 
and d) receiving IPT treatment instead of CAU. Furthermore, two patient char-
acteristics interacted with treatment: i) IPT was more effective in women than 
in men, and i) IPT was more effective for patients who had experienced a recent 
life event than for patients without such events. In Table 7.3, the last step of the 
backward regression model is described; the b represents the regression coeffi-
cient of the variable in the logistic regression equation. The significance of this 
value is tested by the Wald test, and its p-value. The extent to which a variable 
predicts treatment outcome is expressed in the odds ratio. For categorical data 
such as a higher educational level, an OR of 3.55 means that patients with the 
highest level of education have 3.55 times more chance to have no diagnosis of 
depression anymore at six months, than patients with the lower level of educa-
tion. For continuous variables the OR is based on one unit of the measure that 
was used. To interpret the relevance of this result, the OR for a clinical relevant 
difference should be calculated. For example, the OR based on one unit of the 
SF-36 social functioning score was 1.03 (Table 7.3). A clinically relevant differ-
ence on this measure is 26 units (one standard deviation, see Table 7.2). The OR 
for 26 units is 26 x 0.03= 0.78. Exp(0.78)= 2.18. This means that patients, who 
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score one standard deviation higher on the social functioning scale at baseline, 
have 2.18 times more chance to have no diagnosis of depression anymore at six 
months than patients with the lower score.  
Table 7. 3   Predictors of having no diagnosis of depression anymore in the IPT 










0.93 1.07 0.25 4.59
Level of education
              Low 4.30
[2]
0.12
              Intermediate 0.70 1.86
[1]
0.17 2.02 0.74 5.51
               High 1.27 3.94
[1]
0.05 3.55 1.02 12.38
Psychosocial vulnerabilities
SF-36, Social functioning 0.03 9.15
[1]
<0.01 1.03 1.01 1.05
Psychiatric comorbidity
Panic symptoms -0.87 2.87
[1]




0.11 2.80 0.79 9.93
Treatment x gender interaction -2.07 3.97
[1]
0.05 0.13 0.02 0.97
Treatment x life events interaction 1.38 4.51
[1]
0.03 3.97 1.11 14.17
Note: b: regression coefficient ; OR: odds ratio
Three variables predicted remission in the IPT study: a) younger age, b) 
less initial depression severity, and c) better physical functioning (Table 7.3a). 
Treatment condition was not significantly associated with remission in the 
IPT study, because in both conditions, only one third of the patients achieved 
remission. 
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Table 7.3a.  Predictors of remission in the IPT study at 6 months.













0.01 0.93 0.87 0.98
Physical functioning
Sf-36, Physical component 0.04 3.65
[1]
0.06 1.04 1.00 1.08
Note: b: regression coefficient ; OR: odds ratio
In the WF study, the predictors of having no diagnosis of major depression 
anymore at six months were: a) younger age, b) less initial depression severity, 
and c) absence of co morbid panic symptoms (Table 7.4). Treatment condition 
was not a significant predictor in this model, as in both treatment conditions 
patients improved equally well (62% had no diagnosis of depression anymore at 
six months). In the WF study no data were available on neuroticism and locus 
of control; therefore, the predictive value of these determinants could not be 
explored.
Predictors of remission in the WF study were: a) lower level of social func-
tioning, b) no recent life events, c) less initial depression severity, d) higher level 
of physical functioning, and e) being treated in the WF
int
 condition (Table 7.4a). 
There were no significant interactions of the predictors of remission with treat-
ment. 
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Table 7. 4  Predictors of having no diagnosis of depression anymore in the WF 
study at 6 months.  













0.02 0.94 0.89 0.99
Psychiatric comorbidity
Panic symptoms -0.81 3.46
[1]
0.06 0.44 0.19 1.04
Note: b: regression coefficient ; OR: odds ratio 
Table 7.4a. Predictors of remission in the WF study at 6 months.
Variable b Wald 
[df]
p- value     OR 95,0% CI for OR
Lower Upper
Psychosocial vulnerabilities
Recent life event(s) -0.73 3.08
[1]
0.08 0.48 0.21 1.09
Social functioning -0.02 3.12
[1]




<0.01 0.89 0.83 0.95
Physical functioning 
Sf-36, physical component 0.03 3.28
[1]




< 0.01 3.84 1.62     9.13




In this study we explored the predictive value of 13 candidate predictors in 
two intervention studies for elderly patients with major depression in primary 
care in the Netherlands. Our aim was 1) to identify determinants of outcome, 
and compare them with the determinants found in younger depressed adults, 
and 2) to explore possible differences in determinants of outcome for antide-
pressant drug treatment and for IPT. 1) Nine of the 13 candidate predictors 
had a predictive value in our studies on elderly patients, although the relative 
importance of these variables differed depending on outcome measure and 
study. Of the variables that were identified as predictors in younger adults, 
age, recent life events, social functioning, initial depression severity, physical 
functioning, panic symptoms and treatment, predicted outcome in both of our 
studies; neuroticism and locus of control did not. Of the four candidate predic-
tors we added, age of onset of the first depression and functional dependency 
had no predictive value. In the IPT study, level of education and gender did 
affect outcome. 2) In the IPT study, there was a significant interaction between 
the IPT intervention and one or more recent life event(s), and between the IPT 
intervention and gender. In the WF study, no interaction terms of the candidate 
predictors with treatment were significant. 
7.4.2  Methodological considerations
We had the opportunity to analyse and compare possible predictors of outcome 
in two randomised controlled trials that have recently been carried out at our 
research institute and that were similar in their design. Although the baseline 
characteristics did not differ between the studies, except for the level of educa-
tion, other factors may have contributed to differences between the studies in 
the predictive power of the determinants. However, the fact that age, recent life 
events, initial depression severity, physical functioning, panic symptoms and 
treatment were predictive in both studies, and were identified by others (Table 
7.1) supports the predictive value of these characteristics. A high level of educa-
tion predicted a favourable outcome in the IPT study, not only in the interven-
tion group, as we hypothesized, but also in the care as usual group. Probably, 
patients who are highly educated are more effective in their asking for help 
and in making use of the treatment offered. In the WF study only few patients 
were highly educated, consequently the predictive role of education could not 
be sufficiently explored in this study. The IPT intervention proved to be more 
effective in women than in men. As far as we know female gender as a predictor 
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of a positive treatment outcome in IPT has not been identified before. However, 
gender as a predictor of outcome in psychotherapy and in depression treatment 
was detected by others (Goode, 2004; Pyne et al., 2003). Recent life events pre-
dicted a favourable outcome in patients receiving the IPT intervention, while in 
the WF study and in other studies life events/current stress predicted poor out-
come. In IPT recent life events and their influence on interpersonal functioning 
are explicitly the focus of the therapy. It is assumed that disturbed interper-
sonal functioning strongly interacts with the depression, and that depressive 
symptoms decrease when the interpersonal functioning has improved. Our data 
seem to support the importance of focussing on recent life events in IPT. ADL 
turned out not to be a predictor of poor outcome in our studies. This may be 
explained by the fact that there was hardly any variance in ADL scores in our 
samples, as the vast majority of our participants was functionally independent. 
 
7.4.3.  Conclusions
We identified several patient characteristics with a predictive value for the 
outcome of major depression in elderly primary care patients. Overall, a higher 
age, a lower educational level, recent life events, a lower level of social func-
tioning, higher initial depression severity, a lower level of physical functioning, 
and panic symptoms predicted poor outcome. Patients who have these charac-
teristics should be treated and monitored more actively, for example by offer-
ing a combination treatment or by earlier referral to secondary care for further 
diagnostic examination and other forms of treatment. The finding that recent 
life events predicted a favourable outcome in the IPT intervention group, while 
in the IPT control group and in the WF study they predicted poor outcome, 
may have implications for clinical practice. IPT may be especially indicated for 
patients who experienced recent life events. This interesting issue needs further 
study. The same holds for the finding that IPT was more effective for elderly 
women than for elderly men. 
This study adds to the knowledge of predictors of outcome in depressed 
elderly patients in primary care. It is important to continue research on predic-
tors of (treatment) outcome in this patient group. In primary care, the patients 
who present with depressive symptoms are very heterogeneous and if we know 
which patients benefit from what depression treatment, a specific algorithm 
may be developed to help the GP and the individual patient to decide which 










The aim of this thesis was to study the feasibility and effectiveness of Interper-
sonal Psychotherapy (IPT) for late life depression in general practice. Previous 
research had shown that: 
•  Depressive disorder is common among elderly patients in the community and 
in primary care.
•  The prognosis of depression in elderly patients is poor.
•  Depression leads to serious disability and reduced general functioning
•  Depression is associated with increased use of medical services.
•  Antidepressant drug treatment and some forms of psychotherapy have been 
proven to be effective in older depressed patients in secondary care; little is 
known about their effectiveness for elderly depressed patients in normal life 
general practice.
•  In primary care, a minority of older depressed patients is given a specific 
depression treatment. 
We hypothesized that the prognosis of major depressive disorder in older 
primary care patients could be improved by treating them with one of the 
evidence based therapies. We chose to deliver a psychological intervention 
(IPT) because older patients are more sensitive to side effects of antidepressant 
drugs and often use other medication, which increases the risk of unwanted 
drug interactions. Because older patients are often reluctant to be referred, the 
IPT was delivered within general practice, thereby making it more easily acces-
sible. 
To assess the feasibility and effectiveness of the IPT intervention we con-
ducted a randomised clinical trial comparing IPT with care as usual by the GP. 
Before the start of this trial we had to train the therapists in IPT. We developed 
training materials and wrote a Dutch manual for IPT in older patients. We 
carried out three reviews of the literature. Finally, we performed a study on pre-
dictors of treatment outcome in the IPT study and in a parallel antidepressant 
drug intervention study. 
8.1.2. Effectiveness of psychotherapy for depression in general practice.  
A review of the literature (Chapter 2)
As we wanted to know what treatment effect we could expect in our ran-
domised controlled trial, we performed a systematic review of the literature  
on the effectiveness of psychotherapy for depressive disorder in primary care. 
Because there were no studies focussing on elderly patients with major depres-
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sive disorder, we had to rely on data in younger adults (nine studies) and in eld-
erly patients with minor depression or dysthymia (one study). The pooled effect 
size of psychotherapy compared with usual GP care was 0.3 (95% CI: 0.1-0.5), 
representing a small treatment effect. There was no difference in treatment ef-
fect of antidepressant drug treatment and psychotherapy, effect size –0.08 (95% 
CI: -0.21-0.05). In elderly patients with minor depression or dysthymia short 
term psychotherapy (problem solving therapy) was not superior to pill placebo. 
We concluded from this review that the treatment effect we could expect in 
our study comparing psychotherapy (IPT) with usual GP care for major depres-
sion in older patients, was most probably small (effect size < 0.5). Furthermore, 
this review made us aware of a possible interaction between initial depression 
severity and treatment effect: we found some indications that patients with 
initial moderate to severe depression who received psychotherapy, improved 
more compared with usual GP care or placebo, than patients having a minor or 
mild depression at baseline  (Friedli et al., 1997; Barrett et al., 2001; Williams et 
al., 2000; Elkin et al., 1995). 
8.1.3  Cost-effectiveness of psychological treatments for depression in primary 
care. A systematic review (Chapter 3)
When studying the implementation potential of IPT in general practice, the 
cost-effectiveness of this and other comparable interventions is important. A 
systematic search of the literature revealed five cost-effectiveness analyses that 
were performed alongside randomised controlled trials described in Chapter 2, 
and one additional study. 
Four economic studies compared psychotherapy and/or counselling with 
CAU, three studies compared psychotherapy with antidepressant drug treat-
ment. At the one-year follow-up, none of the studies could demonstrate that the 
psychological intervention resulted in a reduced use of other health care serv-
ices, but studies lacked power to detect these possible cost differences. In one 
study, IPT was significantly more effective than CAU, but at higher costs. 
We concluded from this review that there is not enough evidence for the 
cost-effectiveness of psychological interventions in primary care, and that no 
firm conclusions can be drawn. Cost-effectiveness may be increased by improv-
ing the psychotherapy interventions, or by delivering them more selectively. 
This might lead to a cost offset in the use of other health services, but probably 
not. However, if the costs are calculated optimally, decision makers in health 
care can decide at what costs they are willing to improve depression care i.e. 
whether the estimates of the cost for psychotherapy per quality of life year 
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gained are comparable to those found for other treatments provided in routine 
practice.
8.1.4  Patients’ preferences in the treatment of depression in general practice. 
A review of the literature (Chapter 4). 
Because we realised that patients’ preference should be taken into account 
when introducing a treatment option that is not usually available in general 
practice, we performed a systematic review on patients’ preferences in the 
treatment of depressive disorder in general practice. We selected studies that 
presented data about attitudes or preferences towards psychotherapy and anti-
depressant medication, because these are the main treatment options recom-
mended in depression treatment guidelines. In all studies, psychotherapy or 
counselling were more often preferred than antidepressants. Among depressed 
populations 51–69 % of patients preferred psychotherapy or counselling, 
compared with 20-38% who preferred antidepressants. Among non-depressed 
respondents 32-98% had a positive attitude towards psychotherapy or counsel-
ling, compared with 15- 35% towards antidepressant drug treatment. Few stud-
ies paid attention to the underlying assumptions of these preferences. It was 
found that preferences are sometimes based on false assumptions. In the clini-
cal trials in which sufficient information was provided, the majority of patients 
still preferred psychotherapy or counselling. We concluded from this review, 
that there is no doubt that making psychotherapy more easily accessible as a 
treatment option for depression in general practice, is in concordance with the 
preferences of at least 50% of the patients. 
8.1.5  Feasibility and barriers to providing Interpersonal Psychotherapy for late 
life depression in general practice (Chapter 5). 
Feasibilty aspects and barriers to organising IPT in general practice were 
recorded during our randomised controlled trial comparing IPT with usual GP 
care. Motivation and evaluation of all participants (patients, general practi-
tioners, specialist mental health centres and therapists) were assessed. Of the 
205 eligible patients with current major depression, 143 (70%) gave informed 
consent and therefore had a positive or neutral attitude towards the psycho-
therapy intervention. Of the patients who started the psychotherapy at least 
77% were compliant. We approached 18 general (mostly group) practices, and 12 
participated. Lack of office space for the additional therapists was mentioned 
as the main barrier to participation. The two psychologists’ private practices 
that were interested in IPT, could not join the project, because of financial and 
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organisational reasons. All four specialist mental health centres that were ap-
proached were motivated, as long as the extra workload of the therapists would 
be limited. The geriatric teams of these organisations received training in IPT, 
and it turned out that the majority of therapists were interested in joining the 
research project.
After treatment had finished the intervention was evaluated by all partici-
pants. Patients evaluated the IPT intervention positively. GPs (N=22) positively 
evaluated the time-limited, practical and structured nature of IPT. All but one 
GP stated that they were motivated to implement this intervention. The partici-
pating therapists (N=15) also positively evaluated the structure and strategies 
provided by the IPT protocol. They liked to work within the general practice, 
although they occasionally needed extra time and flexibility to find an office 
space, one found this a very unpleasant complication. 
We concluded that it is feasible to make IPT available in general practice for 
elderly patients with major depression as long as the practices have space for 
the therapists and financial barriers can be overcome.
8.1.6  Interpersonal Psychotherapy (IPT) for elderly depressed patients in pri-
mary care. (Chapter 6).
A total of 143 patients were randomly assigned to IPT (N=69) or usual GP care 
(N=74). Patients in the IPT group were offered 10 sessions of IPT. Assessments 
were carried out at baseline and after two and six months. Primary outcome 
measures were: remission of depression (defined as a score of less than 10 
on the Montgomery Åsberg Depression Rating Scale , MADRS), Diagnosis of 
depression (DSM-IV criteria assessed by the mood module of the PRIMary care 
Evaluation of Mental Disorders, PRIME-MD), and Depression severity (continu-
ous MADRS and GDS-15 scores). The secondary outcome measure was general 
functioning measured with the Medical Outcome Study 36-item Short Form 
Health Survey (SF-36).
We found that IPT was more effective than usual GP care in reducing the 
number of patients with a diagnosis of major depressive disorder post treat-
ment.  When using a conservative estimate, 17% more patients in the IPT group 
had no diagnosis anymore post treatment. Remission rates were relatively low 
(32-33%) and did not differ between the groups. Among treatment completers, 
IPT was superior in improving social and overall mental functioning. A post 
hoc analysis revealed that severity of the index depression had a differential 
effect on treatment outcome: the superior effect of IPT over usual GP care was 
more pronounced in those with moderate to severe depression (MADRS>20) at 
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baseline.Thus, our findings were in line with the conclusion of the systematic 
review, described in Chapter 2, that overall treatment effects are relatively 
small in primary care studies concerning interventions for depressive disorder. 
In addition, remission percentages are lower in elderly patients than in younger 
adults. 
8.1.7  Predictors of outcome in participants of two intervention studies for 
elderly depressed patients in primary care (Chapter 7).
Predictors of outcome were explored in the IPT study described in this thesis, 
and the parallel West Friesland study that compared guideline driven drug 
treatment by the GP with CAU. These studies were identically designed. The 
primary depression outcomes were diagnosis of depression, measured with 
the PRIMary care Evaluation of Mental Disorders (PRIME-MD) and remis-
sion, defined as a score of < 10 on the Montgomery Å sberg Depression Rating 
Scale (MADRS). The predictive value of 13 candidate predictors was studied 
using backward logistic regression. We found that a higher age, a lower educa-
tional level, recent life events, a lower level of social functioning, higher initial 
depression severity, a lower level of physical functioning, and panic symptoms 
predicted poor outcome. IPT was more effective in patients with recent life 
events than in patients without such events. IPT was also more effective in 
women than in men. There were no other interactions with treatment. 
In conclusion, we found some predictors of poor outcome in elderly primary 
care patients, which were identified before in younger patients. Patients with 
these characteristics should be treated and monitored more intensively and 
should probably be referred earlier to secondary care. Further study should be 
made of the interesting finding that IPT was more effective in elderly women 
than in elderly men, and in patients who experienced a recent life event. 
8.2  Discussion
As was pointed out in Chapter 1, we focussed on two barriers to optimal de-
pression treatment: the insufficient detection and acknowledgment of major 
depression, and the absence of evidence based psychotherapy in most general 
practices. We used a screening procedure to improve detection and introduced 
IPT in general practice. Now, we can discuss our findings. 
8.2.1  Screening for depression 
Screening for depression was feasible in our research project as long as the 
GPs did not have to carry out the screening themselves. GPs were not moti-
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vated to perform the screening themselves, because of time restraints. By using 
the screening procedure, described in Chapter 6, we were able to include the 
planned number of patients within the reasonable time period of one and a 
half year, and we avoided the biased selection that might have occurred when 
participants were recruited by the GPs themselves. However, the screening pro-
cedure, in which we used a “symptom count” approach by means of the PRIME-
MD mood module, had an important limitation: probably too many patients 
were identified as having a depressive disorder. Many of them had only mild 
symptoms of depression, and we found that for these patients, specific depres-
sion treatment did not add much to usual care. In the combined populations 
of our study and the West Friesland study, the prevalence of major depression 
according to the PRIME-MD was 13.7% (95% CI 7.7% - 19.8%; Licht-Strunk et al., 
2005). In our sample, 57% of the patients had only mild depressive symptoms 
(baseline MADRS score < 21). Of these identified patients, 72% were not being 
treated. Thus, the prevalence of depression in our sample was high, but in line 
with that found by others (Lyness et al., 1999; Schulberg et al., 1998). Our find-
ing that only a minority of the identified patients was being treated for depres-
sion was also in concordance with the literature. We assumed that treating all 
of these patients would improve their prognosis, especially because depression 
in elderly patients often has a chronic recurrent course, and the burden is high 
(Beekman et al., 1997). However, it can be argued that the concept of depres-
sion is extended too much by using only DSM-IV criteria. Mild symptoms of 
depression are harder to classify meaningfully. The symptoms can represent 
early stages of more severe depression, as well as reactions to upsetting life 
events or the response to adverse social circumstances or physical disease ( 
P. Eikelenboom, personal communication; Freudenstein et al., 2001). Probably, 
GPs are right in their restraint to treat all of these patients for depression, as 
they already know, based on clinical experience, that for many of these patients 
specific depression treatment has no additive value. 
In conclusion, our strategy to use the computerized databases of the general 
practices to select patients for screening was feasible and useful, but for future 
intervention studies in primary care an additional depression severity meas-
ure is necessary to select more severely depressed patients for whom specific 
depression treatment is indicated. 
8.2.2. Transmural IPT for depression in elderly primary care patients
At the start of our project, we stated (see Chapter 1) that “If it could be dem-
onstrated that it is feasible and effective to deliver evidence based psycho-
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therapy transmurally, this would prove that ‘expertise transfer’ and collabora-
tion between primary and secondary care settings is an effective approach in 
daily practice, and that organisational changes, necessary to implement this 
intervention, should be supported”. We can conclude that we succeeded in the 
‘expertise transfer’ from secondary to primary care: we delivered IPT, a psycho-
therapy that was developed for secondary care patients with major depression, 
to elderly patients in primary care, and afterwards patients, therapists, and 
general practitioners evaluated the intervention positively. However, there were 
some restrictions to the use of IPT. One aspect of the IPT protocol did not fit 
many of the patients in our study, illustrating that ‘expertise transfer’ as such 
may not be adequate for all patients: According to the standard IPT protocol 
the depression should be discussed explicitly as an illness that can be treated. 
In an early stage of the project, it became clear that this approach was not 
workable for the patients who had more diffuse, mild depressive symptoms. 
The therapists were convinced that speaking about a depressive illness was 
inappropriate for these patients, and the patients did not recognise themselves 
in a depressive illness either. Therefore, the therapists linked the interpersonal 
problems to the complaints of the patients instead of to a depressive disorder. 
Again, this illustrates that the group of patients with mild depression should 
be approached differently. 
Of course, the implementation of an intervention can only be supported if it 
is (cost) effective. In our study, treatment effects were modest. This result was 
in line with the results of our review on the effectiveness of psychotherapy as a 
monotherapy in primary care (Chapter 2). We mentioned that the effectiveness 
might be increased, not only by delivering the evidence based psychotherapies 
optimally and more selectively, but also by delivering them as part of more 
comprehensive collaborative care projects, in which the GP is supported by a 
depression manager (nurse or psychologist) in delivering guideline driven care, 
and in which treatments are tailored to individual patient needs. The results of 
these projects in the elderly were promising (Unützer et al., 2002; Bruce et al., 
2004). Recently, an economic evaluation of the IMPACT study, in which IPT was 
optional, was published (Katon et al., 2005). The authors concluded that the IM-
PACT intervention was a high-value investment for older adults; and that it was 
associated with high clinical benefits at a low increment in health care costs.
In the Netherlands, we do not yet have ‘depression managers’ in primary 
care. However, while our research project was being carried out, organisational 
changes in primary care have been continued: developments are leading to an 
important role of nurses in supporting doctors in specific tasks. Many general 
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practices are already supported in mental health care by a psychiatric nurse, 
and we think that evidence based psychotherapies such as IPT or Problem Solv-
ing Therapy (PST) fit well in the ‘tool kit‘ of these nurses. 
8.2.3   Future research
In future research on the improvement of depression care for elderly primary 
care patients in the Netherlands, attention should be paid to the cost-effective-
ness of a collaborative care model. In addition, to make depression treatment 
more effective, some aspects should have ongoing attention: e.g. the unravelling 
of the heterogeneous group of elderly primary care patients who all present 
with depressive symptomatology (for example by studying symptom profiles); 
further identification of determinants of outcome in general, and in relation to 
specific treatment options; the comparison of IPT with PST or other short term 
psychotherapies; and the possible development of other or modified treatment 
options. Hopefully, this will lead to further improvement of depression care for 
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Hoofdstuk 1. Inleiding. 
In dit proefschrift staat de vraag centraal of Interpersoonlijke Psychotherapie 
(IPT), een geprotocolleerde vorm van psychotherapie, een haalbare en effectieve 
aanvulling kan zijn op het behandelaanbod voor depressieve ouderen in de  
huisartsenpraktijk. Uit eerder onderzoek was bekend dat:
•  Depressies vaak voorkomen bij ouderen die de huisarts consulteren, 10% van 
hen voldoet aan de criteria voor een depressieve stoornis. 
•  De prognose van depressie bij ouderen niet gunstig is, na een jaar heeft de 
meerderheid nog steeds klachten.
•  Depressie de kwaliteit van leven aanzienlijk vermindert.
•  Patienten die een depressie hebben, verhoogd gebruik maken van 
(para)medische voorzieningen.
•  Depressies in de huisartsenpraktijk vaak niet als zodanig benoemd en behan-
deld worden.
Uit deze onderzoeksbevindingen kan geconcludeerd worden dat depressie 
onder ouderen een serieus gezondheidszorgprobleem is, zeker ook gezien het 
toenemende aantal ouderen in de bevolking. Daarom is het van groot belang 
hiervoor een optimale detectie- en behandelstrategie te ontwikkelen. 
Als een depressie gediagnosticeerd is, volgt een stapsgewijze aanpak: de huis-
arts legt aan de patiënt uit dat de klachten binnen een depressieve stoornis 
passen en geeft voorlichting over de depressie. Eventuele lichamelijke ziektes 
die de depressie kunnen veroorzaken of onderhouden worden uitgesloten of 
behandeld. Ook gaat de huisarts na of de patiënt medicatie gebruikt die van 
invloed is op de depressie. Verder zijn leefstijladviezen van belang, zoals het 
aanmoedigen tot lichamelijke activiteiten, het houden van een structuur in 
de dag en het afzien van het gebruik van alcohol en andere middelen die het 
psychisch functioneren beïnvloeden. Als de depressie aanhoudt zal de huisarts 
veelal voorstellen antidepressieve medicatie te gaan gebruiken. Soms ook wor-
den patiënten verwezen voor een gesprekstherapie naar maatschappelijk werk, 
vrijgevestigd psycholoog of een instelling voor geestelijke gezondheidszorg. De 
meeste depressieve patiënten blijven echter bij de huisarts in behandeling. De 
werkzaamheid van antidepressieve medicatie en sommige vormen van geproto-
colleerde psychotherapie is voornamelijk aangetoond bij depressieve patiënten 
die in de psychiatrische praktijk gezien worden. Er is weinig bekend over de 
effectiviteit van deze therapiëen voor depressieve ouderen in de huisartsen-
praktijk. Bovendien zijn de “evidence based” psychotherapievormen vaak niet 
beschikbaar in de eerste lijn. 
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Het doel van het onderzoeksproject was om een bijdrage te leveren aan het opti-
maliseren van de depressiezorg voor ouderen in de huisartsenpraktijk. Het idee 
daarbij was om expertise in specifieke behandeltechnieken vanuit de tweede 
lijn over te dragen naar de eerste lijn. We hebben ons gericht op twee aspecten: 
•  Het verhogen van de detectie van depressie door een screeningsprocedure toe 
te passen onder alle ouderen die zich meldden in de deelnemende huisartsen-
praktijken.
•  Het laagdrempelig beschikbaar maken van een evidence based vorm van 
psychotherapie, Interpersoonlijke Psychotherapie (het behandelprotocol staat 
beschreven in de Appendix van dit proefschrift). We kozen voor een psycho-
logische interventie, omdat juist ouderen gevoelig zijn voor bijwerkingen van 
antidepressieve medicatie en omdat zij vaak ook nog andere medicatie ge-
bruiken, waardoor er een risico is op interacties tussen de diverse middelen. 
Aangezien ouderen verwijzing naar een GGZ instelling vaak een te grote stap 
vinden, werd de psychotherapie aangeboden ìn de huisartsenpraktijk, uitge-
voerd door een GGZ medewerker. 
Om de haalbaarheid en effectiviteit van IPT te bestuderen hebben we een ge-
randomiseerd gecontroleerd onderzoek uitgevoerd, waarin we de effectiviteit 
van IPT vergeleken met die van de gebruikelijke zorg door de huisarts. Dit pro-
ject werd gefinancierd door Zorg Onderzoek Nederland (ZONmw). Aan het begin 
van het project hebben we therapeuten en huisartsen geworven voor deelname. 
We hebben trainingsmateriaal ontwikkeld, waaronder een handleiding voor 
therapeuten in het Nederlands, en therapeuten getraind in IPT. Daarnaast heb-
ben we drie literatuurstudies verricht om het onderzoeksproject in een breder 
perspectief te kunnen plaatsen. Verder hebben we geanalyseerd welke factoren 
een (on)gunstig beloop voorspelden onder patienten uit deze studie en die uit 
een parallel studie naar het effect van antidepressiva.  
Hoofdstuk 2. De effectiviteit van psychotherapie in de eerste lijn bij patiën-
ten met een depressieve stoornis: een systematisch overzicht.  
Om een indruk te krijgen hoe groot het te verwachten effect zou zijn in onze 
interventiestudie hebben wij een systematische literatuurstudie verricht naar 
de effectiviteit van psychotherapie bij depressies in de huisartsenpraktijk. We 
vonden 10 studies bij volwassenen die zich op dit onderwerp richtten, er waren 
geen studies over ouderen. Het bleek dat gemiddeld gesproken psychotherapie 
vergeleken met de gebruikelijke zorg door de huisarts effectiever was, maar dat 
dit effectverschil relatief klein was (effect size 0.3 (95% betrouwbaarheidsin-
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terval: 0.1-0.5)). Psychotherapie was in alle studies even effectief als medicatie 
en Problem Solving Therapie was effectiever dan placebo. We concludeerden 
dat we waarschijnlijk ook in onze studie een bescheiden therapie-effect zouden 
kunnen verwachten in vergelijking met de gebruikelijke zorg door de huisarts. 
Verder vonden we in de literatuur aanwijzingen dat het verschil tussen psycho-
therapie en de gebruikelijke zorg mogelijk groter is bij patiënten met ernstiger 
vormen van depressie, dan bij patiënten met lichte depressies.  
Hoofdstuk 3. De kosteneffectiviteit van psychologische behandelingen voor 
depressie in de eerste lijn: een systematische review. 
Aangezien wij wilden bestuderen of het haalbaar is om IPT in de eerste lijn 
te implementeren was de vraag naar de kosten-effectiviteit van een dergelijke 
interventie bijzonder relevant. We vonden in totaal zes studies, waarvan vijf 
parallel waren uitgevoerd aan studies beschreven in hoofdstuk 2. Voor kosten-
effectiviteits studies wordt veelal een evaluatieperiode van één jaar of meer 
genomen. Het bleek dat de verschillen in kosten-effectiviteit tussen cognitieve 
gedragstherapie of counselling met de gebruikelijke zorg door de huisarts niet 
aantoonbaar waren. In één studie was IPT effectiever dan de gebruikelijke 
huisartsenzorg, maar ook duurder. Er werden geen significante verschillen in 
kosten-effectiviteit aangetoond tussen psychotherapie of counselling en an-
tidepressieve medicatie. Bij deze bevindingen moet de kanttekening geplaatst 
worden dat kosten-effectiviteitsanalyses een specifieke methodologie vragen, 
waaraan de meeste van deze studies niet voldeden. Zo waren deze studies niet 
opgezet om een verschil in kosten te kunnen aantonen en waren bijvoorbeeld 
de patiënten aantallen te klein om significante verschillen te demonstreren. We 
concludeerden dat er wat betreft de kosten-effectiveit van de psychologische 
interventies nog geen duidelijke conclusies getrokken kunnen worden.
Hoofdstuk 4. Patiënt voorkeuren bij de behandeling van depressie in de eer-
ste lijn: een literatuur overzicht. 
De mening van de patiënt is van groot belang als het gaat om het implemente-
ren van een bepaalde behandeloptie. Daarom hebben we gezocht naar studies 
waarin de voorkeuren van patiënten werden onderzocht wat betreft de twee 
voornaamste behandelopties voor depressie namelijk antidepressieve medicatie 
en gesprekstherapie. Ook op dit gebied was er weinig over ouderen te vinden, 
de bevindingen gaan dus voornamelijk over jonger volwassenen of gemengde 
groepen. In groepen van depressieve patienten gaf 51-69% van de respondenten 
aan een voorkeur te hebben voor gesprekstherapie, 20-38% had een voorkeur 
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voor antidepressieve medicatie. In groepen van niet-depressieve respondenten 
had 32-98% een voorkeur voor gesprekstherapie en 15-35% voor antidepressieve 
medicatie. Als doorgevraagd werd naar de overwegingen bij deze voorkeuren, 
bleek dat respondenten vaak onvoldoende geïnformeerd waren over één of beide 
behandelopties. Hun keuzes waren dus in feite gebaseerd op foutieve aanna-
mes. Als patiënten goed voorgelicht waren zoals in sommige interventiestudies, 
waren de verschillen minder groot, maar nog steeds gaven meer patiënten 
de voorkeur aan gesprekstherapie. Wij concludeerden uit deze studie dat het 
aanbieden van psychotherapie in de huisartsenpraktijk aansluit bij de voorkeur 
van veel patiënten. 
Hoofdstuk 5. Is Interpersoonlijke Psychotherapie een haalbare behandeloptie 
voor depressieve ouderen in de huisartsenpraktijk? 
Om te kunnen onderbouwen of het haalbaar is IPT in te voeren, uitgevoerd door 
GGZ medewerkers in de huisartsenpraktijk, hebben wij de motivatie tot deelname 
van alle participanten beschreven. Na het afronden van de interventie hebben we 
alle participanten gevraagd het project te evalueren. Van de 205 patiënten die aan 
het eind van de screeningsprocedure in aanmerking kwamen voor deelname aan 
de interventiestudie, was een relatief hoog percentage gemotiveerd: 70%. Van de 
69 patiënten die de IPT kregen aangeboden rondde 77% een volledige therapie af. 
Achteraf beoordeelden de patiënten de behandeling positief. Tweederde van de 
huisartsen die wij benaderden wilde deelnemen aan het project. Bij de anderen 
was de voornaamste reden om niet mee te doen een gebrek aan ruimte voor de 
GGZ therapeut. Achteraf gaven alle huisartsen aan een positieve indruk te heb-
ben van de IPT interventie, 21 van de 22 huisartsen zeiden dat zij gebruik zouden 
willen maken van de interventie als die ook na het project beschikbaar zou zijn. 
Voor twee psychologenpraktijken was het niet haalbaar om aan het project deel te 
nemen, voornamelijk om financiële redenen. De vier benaderde GGZ instellingen 
wilden allen meedoen als het aantal therapiëen dat de therapeuten geacht werden 
te doen beperkt bleef, omdat er geen extra financiering voor dit werk beschikbaar 
was. Na training in IPT van de ouderenteams van deze instellingen bleek de meer-
derheid van de therapeuten interesse te hebben in IPT en in deelname aan de stu-
die. Achteraf gaven de therapeuten aan dat zij het werk in de huisartsenpraktijk 
waardeerden, evenals het werken volgens het IPT protocol. In sommige praktijken 
was het herhaaldelijk moeten zoeken naar een therapieruimte wel interferend. 
We concludeerden dat het haalbaar is IPT beschikbaar te maken in de huisart-
senpraktijk, zeker ook als IPT kan worden gegeven door sociaal psychiatrisch 
verpleegkundigen of psychologen die al werkzaam zijn in de huisartsenpraktijken 
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in het kader van één van de vele eerstelijns consultatieprojecten die in Nederland 
zijn opgestart. 
Hoofdstuk 6. De effectiviteit van Interpersoonlijke Psychotherapie voor de-
pressieve ouderen in de eerste lijn. 
Om de effectiviteit van IPT te meten, werden 143 patiënten via loting toe-
gewezen aan òf IPT (N=69) òf de gebruikelijke zorg door de huisarts (N=74). 
Patienten in de IPT groep kregen 10 sessies IPT aangeboden. Vóór het begin, 
na twee maanden en na zes maanden werden alle deelnemers geïnterviewd. De 
belangrijkste uitkomstmaten met betrekking tot het verloop van de depressieve 
klachten waren: remissie (een score van < 10 op de Montgomery Åsberg Depres-
sion Rating Scale, MADRS), diagnose depressie (DSM-IV criteria, gemeten met 
de PRIMary care Evaluation of Mental Disorders, PRIME-MD) en ernst van de 
depressie (gemiddelde score op de MADRS of GDS-15). Daarnaast werd ook het 
algemeen functioneren gevolgd met de Medical Outcome Study 36-item Short 
Form Health Survey (SF-36). 
We vonden dat IPT effectiever was dan de huisartsenzorg in het reduceren 
van het aantal patiënten met een diagnose depressie (verschil van 17%). De 
remissie percentages waren in beide condities even laag (32-33%), en ook op 
de gemiddelde ernstscores werden geen significante verschillen gevonden. De 
groep completers, patiënten die een IPT behandeling van minimaal 6 sessies 
kregen, bleken significant meer te verbeteren dan de patiënten uit de controle-
groep wat betreft het algeheel psychisch functioneren en wat betreft het sociaal 
functioneren in het bijzonder. Uit een post hoc analyse bleek dat het effectver-
schil tussen IPT en de gebruikelijke huisartsenzorg meer uitgesproken was in 
de groep patiënten die bij aanvang van de studie een matig tot ernstige depres-
sie had (MADRS>20); we concludeerden dat een intensieve interventie als IPT 
voornamelijk geïndiceerd is voor patiënten met een matige tot ernstige depres-
sie. 
Hoofdstuk 7. Predictoren van het beloop van depressie bij ouderen in twee 
interventie studies in de eerste lijn. 
Omdat er veel variatie in uitkomst gevonden wordt in interventiestudies, is 
een volgende stap in het onderzoek om na te gaan welke variabelen die variatie 
bepalen. Wij hadden de mogeiljkheid om deze analyses uit te voeren in twee stu-
dies die qua opzet identiek waren: de IPT Studie beschreven in dit proefschrift 
en de West Friesland Studie, waarin een behandeling met antidepressiva (uit-
gevoerd conform de richtlijn van het Nederlands Huisarts Genootschap) werd 
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vergeleken met de gangbare huisartsenzorg. Als maten voor de uitkomst van de 
depressie werden genomen: diagnose depressie (PRIME-MD) en remissie (MA-
DRS <10). We onderzochten de voorspellende waarde van 13 mogelijke predicto-
ren door middel van ‘backward logistisic regression’. We vonden dat een hogere 
leeftijd, een lager educatie niveau, recente ingrijpende levensgebeurtenissen, 
een lager niveau van sociaal functioneren, een hogere ernst van de depres-
sie, een lager niveau van fysiek functioneren en paniekklachten, een slechtere 
uitkomst voorspelden. Opvallend was dat IPT effectiever was bij patiënten die 
recent een ingrijpende levensgebeurtenis hadden meegemaakt, ook was IPT ef-
fectiever bij vrouwen dan bij mannen. We concludeerden dat de predictoren die 
wij bij ouderen vonden overeen kwamen met die in studies bij jongere volwas-
senen. Patiënten met karakteristieken die een slecht beloop voorspellen moeten 
zorgvuldig gevolgd en mogelijk eerder verwezen worden.
Hoofdstuk 8. Discussie. 
We richtten ons in dit onderzoek dus op twee aangrijpingspunten ter verbete-
ring van de depressie zorg voor ouderen in de huisartenpraktijk, we screenden 
voor depressie en introduceerden IPT.
Wat betreft de screening: Screening bleek haalbaar als het uitgevoerd werd 
door onze onderzoeksassistenten. De huisartsen zelf hadden te weinig tijd om 
dit te doen. Door onze screeningsprocedure, beschreven in hoofdstuk 6, waren 
we in staat voldoende deelnemers voor ons project te recruteren binnen ander-
half jaar.Ook voorkwamen we door onze werkwijze dat huisartsen selectief zou-
den verwijzen. Echter, de selectieprocedure gebaseerd op het DSM-IV systeem 
had een beperking: mogelijk werden hierdoor te veel patiënten geïdentificeerd 
als lijdend aan een depressieve stoornis, terwijl gemeten met de MADRS, meer 
dan de helft van deze patiënten slechts een lichte depressie had, beneden de 
drempel voor ‘caseness’ (MADRS ≥21). Juist voor deze groep patiënten met licht 
depressieve klachten bleek IPT weinig toegevoegde waarde te hebben. Deze 
bevinding raakt aan een knelpunt in de huidige depressie diagnostiek: door al-
leen symptomen te tellen is de diagnose van depressie mogelijk te veel opgerekt. 
Weliswaar is aangetoond dat licht depressieve klachten samen gaan met veel 
beperkingen en een toename in het gebruik van (para)medische voorzienin-
gen, maar in feite zijn deze klachten moeilijker te classificeren. De symptomen 
kunnen vroege stadia van een ernstiger depressie representeren, maar kun-
nen ook een reactie zijn op vervelende levensgebeurtenissen of op lichamelijke 
ziekten. Op basis van prevalentiestudies, die vergelijkbare DSM-IV diagnostiek 
gebruiken, wordt vaak gesteld dat huisartsen onderdiagnosticeren en onderbe-
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handelen, maar het is de vraag of die ‘kritiek’ terecht is. De tweedelijnsvisie op 
depressie geldt waarschijnlijk niet voor deze groep patiënten, waarbij de toege-
voegde waarde van specifieke depressiebehandelingen beperkt is. 
We concluderen dat de door ons gebruikte screeningsprocedure haalbaar en 
succesvol was voor het recruteren van patiënten voor de interventiestudie. In 
toekomstig onderzoek naar specifieke depressiebehandelingen in de eerste lijn, 
is het echter raadzaam om aan de selectieprocedure een maat voor de ernst van 
de depressie toe te voegen, zodat patiënten met ernstiger vormen van depres-
sie geselecteerd kunnen worden, bij wie specifieke depressiebehandelingen een 
grotere additieve waarde hebben.
Wat betreft het transmuraal toepassen van IPT: Het uitgangspunt was dat 
we de expertise in het behandelen van depressie wilden overdragen van de 
tweede lijn naar de eerstelijns gezondheidszorg door een intensieve samen-
werking te realiseren. We concludeerden dat het inderdaad mogelijk is IPT, een 
therapie ontwikkeld in de tweede lijn, toe te passen in de eerste lijn door GGZ 
medewerkers te ‘detacheren’ in de huisartsenpraktijk. Echter, de therapie kon 
niet zonder meer worden toegepast bij alle eerstelijns patiënten. In het IPT pro-
tocol ligt een sterke nadruk op de depressie als ziekte. In de eerste sessie wordt 
de ziekte depressie centraal gesteld en wordt voorlichting over deze ziekte 
gegeven. Dit aspect gaf problemen bij de groep patiënten met lichte klachten. Zij 
herkenden zich niet in het hebben van een ziekte. Ook de therapeuten vonden 
dat er bij deze mensen niet over een ziekelijke depressie, zoals zij die kenden 
uit de tweede lijn, gesproken kon worden. Daarom werd al vroeg in het project 
de strategie bij deze patiënten gewijzigd. Er werd bij hen alleen maar over de 
klachten gesproken en hoe die in verband stonden met het interpersoonlijk 
functioneren. Vervolgens kon dan het reguliere IPT protocol gevolgd worden 
met betrekking tot het zoeken naar het voornaamste probleemgebied en het 
uitwerken hiervan. Het feit dat deze aanpassing noodzakelijk was illustreert 
opnieuw dat de groep patiënten met licht depressieve klachten een andere be-
nadering vraagt. 
Het implementeren van IPT kan alleen op grotere schaal worden onder-
steund als de interventie (kosten)effectief is. In onze studie kon een bescheiden 
behandeleffect worden aangetoond. Dit resultaat sloot aan op de bevindingen 
van andere studies naar de effectiviteit van psychotherapie als monotherapie 
in de eerste lijn (Hoofdstuk 2). We bespraken in Hoofdstuk 6 dat de effectiviteit 
waarschijnlijk kan worden verhoogd als IPT of een andere vorm van evidence 
based  psychotherapie optimaal wordt uitgevoerd door goed getrainde thera-
peuten en selectief wordt toegepast. Daarnaast kan de depressiezorg als geheel 
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verbeteren door de psychotherapie op te nemen in een meer uitgebreid depres-
siebehandelpakket ter ondersteuning van de huisarts. In een tweetal Ameri-
kaanse projecten, waarin in de eerstelijns praktijk een depressiemanager (spv of 
psycholoog) actief was, waren de behandeleffecten meer uitgesproken positief 
(Unützer et al., 2002; Bruce et al., 2004). In dergelijke projecten kunnen patiën-
ten kiezen tussen psychotherapie en medicatie, kunnen zij switchen als de be-
handeling niet aanslaat of kan er overgegaan worden op een combinatiebehan-
deling. Op basis van een economische evaluatie van een dergelijke interventie 
concludeerde men dat deze aanpak een zeer waardevolle investering was voor 
depressieve ouderen en dat de interventie geassocieerd was met aanzienlijke 
klinische verbeteringen, terwijl de gezondheidszorgkosten relatief laag waren 
(Katon et al., 2005).
In Nederland zijn er nog geen depressiemanagers in de huisartsenprak-
tijken, maar er zijn veel eerstelijns consultatieprojecten opgestart, waarbij 
psychiatrisch verpleegkundigen of psychologen de huisartsen ondersteunen in 
GGZ taken. Het is een kleine stap om deze hulpverleners te trainen tot depressie 
managers die huisartsen bijvoorbeeld ondersteunen in het voorlichting geven 
over depressie, het monitoren van antidepressiva gebruik en die zo nodig ook 
IPT kunnen toepassen. Als onderdeel van een dergelijke ‘stepped care’ strategie 











Deze handleiding voor therapeuten is ontwikkeld ten bate van een door ZONmw 
gesubsidieerd onderzoek naar de haalbaarheid van het transmuraal toepassen 
van Interpersoonlijke Psychotherapie (IPT) bij depressieve ouderen. De eerste 
versie van deze handleiding, gemaakt in 2001, is aangepast op basis van de 
ervaringen opgedaan tijdens het onderzoek (jan 2004). 
Praktisch gezien hield dit onderzoek in dat depressieve patiënten in de 
praktijk van hun huisarts IPT aangeboden kregen, uitgevoerd door therapeuten 
van de regionale instelling voor Geestelijke Gezondheidszorg. Het project werd 
uitgevoerd in de periode van December 2000 tot april 2004, in huisartsenprak-
tijken in Amsterdam en omstreken. De uitvoering was in handen van de Afdelin-
gen Huisartsgeneeskunde en Psychiatrie van het EMGO/ VU medisch centrum te 
Amsterdam. 
Achtergrond van het onderzoek was dat depressies bij ouderen veel voor-
komen in de huisartsenpraktijk. De diagnostiek en behandeling, zo blijkt uit 
epidemiologische onderzoek, kan echter nog aanzienlijk verbeterd, maar de 
huisartsen zijn al zwaar belast. Het is gewenst dat huisartsen ondersteuning 
krijgen op GGZ gebied. In de tweede lijn is veel onderzoek gedaan naar ef-
fectieve behandelmethodes (psychotherapie en/of medicatie) voor depressies. 
Psychotherapie en psychofarmaca blijken even effectief te zijn bij niet-psycho-
tische depressies (Schulberg et al., 1998). De effectiviteit van cognitieve thera-
pie (Koder et al., 1996) en interpersoonlijke psychotherapie bij ouderen (Frank 
et al., 1993) is aangetoond. Er is nog geen vergelijkend onderzoek tussen deze 
twee vormen van psychotherapie met ouderen beschikbaar. De IPT methodiek 
is relatief makkelijk aan te leren voor therapeuten met diverse achtergronden 
en disciplines. De IPT werkwijze sluit ook goed aan bij de problematiek van 
ouderen. Op interpersoonlijk gebied treden er bij ouderen veel veranderingen 
op (bijvoorbeeld overlijden van partner, pensionering, gevolgen van lichamelijke 
ziekte). Deze veranderingen bieden een goed aanknopingspunt voor een gepro-
tocolleerde gesprekstherapie als IPT. Voor een meer uitgebreide toelichting op 
het project verwijzen wij naar ons artikel in Directieve Therapie (Van Schaik et 
al., 2003). Daarin wordt ook een overzicht gegeven van het bestaande onderzoek 
naar de effectiviteit van IPT bij ouderen. 
In de eerste Standaard Depressie van het Nederlands Huisartsen Genoot-
schap waren de uitgangspunten voor het beleid dat bij een milde depressie 
eventueel vervolgcontacten werden afgesproken en bij een ernstige depressie in 
ieder geval vervolgcontacten en eventueel medicatie (Van Marwijk et al., 1994). 
Sommige van de ouderen met een depressie willen of verdragen echter geen me-
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dicatie en willen ook niet naar de tweede lijn verwezen worden. De kans bestaat 
dat de behandeling hierdoor in een impasse raakt. Voor deze groep patiënten 
kan een psychotherapie zoals IPT een adequate oplossing zijn, waarmee het 
herstel versneld wordt en mogelijke chroniciteit voorkomen kan worden. In de 
herziene versie van de Standaard Depressieve stoornis is de plaats van psycho-
therapie meer expliciet aangegeven (Van Marwijk et al., 2003). 
Uit het Amsterdamse onderzoek bleek dat patiënten voornamelijk positief 
waren over de IPT werkwijze. Ook de therapeuten (psychologen en sociaal psy-
chiatrisch verpleegkundigen) die voor het onderzoek in IPT getraind werden en 
die verschillende therapeutische achtergronden hadden, waren positief over het 
IPT protocol als middel om een acute depressie te behandelen. Huisartsen heb-
ben zelf beperkte tijd voor gesprekscontacten en velen van hen vinden het pret-
tig dat hun patiënten op deze manier een gerichte behandeling krijgen als de 
medicamenteuze behandeling niet (voldoende) effect heeft. Training en super-
visie in IPT zullen in de toekomst beter toegankelijk worden nu het “Centrum 
voor Interpersoonlijk Psychotherapie” (Blom en Jonker, Parnassia, Den Haag) is 
opgericht met onder andere als doel het stroomlijnen van de opleiding tot IPT 
therapeut en het opleiden van meer supervisoren en trainers in Nederland 
2. Wat is Interpersoonlijke Psychotherapie (IPT)?
IPT is een gestructureerde vorm van psychotherapie die, toegepast in de tweede 
lijn, uit 12-16 sessies bestaat. De therapie is ontwikkeld voor depressieve 
patiënten. Er wordt uitgegaan van het ziektemodel voor depressie dat wil zeg-
gen dat de depressie expliciet als ziekte benoemd wordt en dat er voorlichting 
over deze ziekte gegeven wordt. Daarnaast is het uitgangspunt dat depres-
sieve symptomen vaak in verband staan met interpersoonlijke problemen. Aan 
het begin van de therapie wordt een “interpersoonlijke anamnese” afgenomen 
waarin wordt nagegaan welke personen belangrijk zijn voor de patiënt en of er 
spanningen of grote veranderingen in de relaties met belangrijke anderen zijn. 
Deze inventarisatie leidt tot een behandelfocus. 
Het doel is symptoomvermindering en een betere aanpassing aan de 
huidige levensfase. De benadering is sterk op het hier-en-nu gericht. De 
(overdrachts)relatie naar de therapeut wordt in principe buiten beschouwing 
gelaten. Er worden technieken uit verschillende psychotherapeutische stromin-
gen gebruikt. 
Voor toepassing in het Amsterdamse eerste lijnsproject is het aantal sessies 
teruggebracht tot 10. Voor ongeveer 65% van de patiënten in het onderzoeks-
project was dit aantal goed volgens de inschatting van de therapeuten. In 
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ongeveer 20% van de gevallen leken minder sessies noodzakelijk en in 10% zou 
er voorkeur zijn geweest voor meer sessies. In de praktijk kan een flexibele aan-
pak gevolgd worden d.w.z. dat met de patiënt besproken wordt dat het aantal 
therapiesessies afgebakend is, tussen acht en 14 sessies, en dat na vijf sessies 
afgesproken zal worden welk aantal uiteindelijk gekozen zal worden. Er wordt 
vastgehouden aan de structuur van IPT wat betreft de opbouw in drie fasen, de 
variatie wordt vooral bepaald door de duur van de behandelfase: 
Fase 1.  Diagnostiek en uitleg (sessies 1-3). De therapeut maakt een inven-
tarisatie van de depressieve symptomen en geeft voorlichting over de ziekte 
depressie en de behandeling. Vervolgens wordt de interpersoonlijke anamnese 
afgenomen en wordt er een behandelfocus vastgesteld.
Fase 2.  Behandeling (sessies 4-8). Eén van de volgende vier interpersoonlijke 
focussen wordt uitgewerkt: 
•  Rouw
•  Interpersoonlijk conflict
•  Rolverandering
•  Interpersoonlijk tekort, ook wel interpersoonlijke sensitiviteit genoemd.
Fase 3.  Afsluiten van de behandeling (sessies 9 en 10). Het afronden van de 
therapie wordt besproken, er wordt geanticipeerd op eventuele problemen in 
de toekomst en op vroege herkenning van eventuele depressieve klachten. De 
behandeling wordt geëvalueerd. 
Alhoewel IPT ontwikkeld is voor de behandeling van een depressieve stoor-
nis bij volwassenen, is er inmiddels met meerdere aangepaste versies onderzoek 
gedaan. Naast onderzoek bij ouderen met een depressie is IPT ook onderzocht 
bij adolescenten (Mufson et al., 1993), bij patiënten met een dysthyme stoor-
nis (Markowitz, 1997) en bij patiënten met recidiverende depressies (Reynolds, 
et al., 1999), als onderhoudsbehandeling. Verder is IPT effectief gebleken bij 
patiënten met  boulimia nervosa (Fairburn et al.,1993). 
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3. Het behandelprotocol
In de studies waarin de werkzaamheid van IPT werd aangetoond vonden de 
sessies wekelijks plaats. Het is de vraag of dit in de gewone praktijk haalbaar 
en wenselijk is. Het lijkt van belang om intensief te starten zodat een goede 
werkrelatie kan ontstaan. In het Amsterdamse onderzoek werd de volgende 
sequentie nagestreefd: vier maal één keer per week, vier maal één keer per twee 
weken en twee maal één keer per maand. Voor de duur van de sessies wordt 35-
45 min gerekend. 
Voor de navolgende uitwerking van de behandelrichtlijnen is gebruik 
gemaakt van het protocol “Interpersoonlijke psychotherapie” (Blom & Jonker, 
1999) en van “IPT in the Treatment of late life Depression” (Frank et al., 1993). 
3.1 Diagnostiek en uitleg
Doelen van deze fase:
•  de depressie bespreken
•  de interpersoonlijke anamnese afnemen en de depressie relateren aan de in-
terpersoonlijke context
•  de grootste probleemgebieden identificeren
•  de IPT concepten en het contract uitleggen
Sessie 1. In de eerste sessie wordt ingegaan op hoe de verwijzing tot stand 
is gekomen en wordt besproken of het doel hiervan voor de patiënt duidelijk is. 
Als de patiënt vooraf informatie over de therapie heeft gehad is het zinnig na te 
gaan of hij/zij deze informatie gelezen heeft en of er nog vragen zijn. Als er dui-
delijke weerstand van de patiënt is dient hierop te worden ingegaan. Meestal 
lukt het wel om misverstanden of vooroordelen (“ik wil niet alles van vroeger 
oprakelen”) te bespreken zodat deze geen interfererende rol meer spelen. 
Over de depressie: de patiënt wordt gevraagd zijn/haar klachten te beschrij-
ven en specifieke kenmerken van de depressie worden gericht uitgevraagd. 
De therapeut vat de klachten samen en plaatst deze binnen het kader van de 
depressieve stoornis. Het beloop van de depressieve klachten bij deze patiënt, 
inclusief eerdere episodes, en beïnvloedende biologische factoren (familieanam-
nese, medicatie, alcohol, somatische aandoeningen) wordt verder uitgevraagd. 
Ook over de depressie heeft de patiënt mogelijk voorlichtingsmateriaal ontvan-
gen (bijvoorbeeld de NHG folder) ontvangen. Naar aanleiding hiervan kan na-
gegaan worden wat de patiënt van de ziekte depressie weet en kan er zo nodig 
aanvullende informatie gegeven worden. Het is belangrijk zelfbeschuldigende 
reacties die vaak bij een depressie voorkomen, vanaf het begin te neutraliseren.
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In het Amsterdamse project bleek dat veel therapeuten gewend zijn meteen in te 
gaan op de levensproblemen die de patiënt inbrengt. Het is voor de IPT stra-
tegie echter van belang dat de therapeut steunend is, maar ook sturend in de 
gesprekken. Met interventies als “Het is duidelijk dat de ruzies met uw man u 
erg in beslag nemen. We zullen daar ook nog uitgebreid op terugkomen, maar in 
dit eerste gesprek wil ik vooral aandacht besteden aan uw depressieve klach-
ten” moet getracht worden in de eerste fase díe onderwerpen aan bod te laten 
komen die op dat moment belangrijk zijn binnen de IPT strategie. Ook bleek dat 
een aantal patiënten moeite had met de term depressie. Voor sommigen is dit 
een zeer beladen term. Het is van belang die lading te exploreren. Als de patiënt 
zich hoe dan ook van de term blijft distantiëren, of als er in feite sprake is van 
een zeer lichte depressie, kan men het beste aansluiten bij de terminologie van 
de patiënt. 
Eventueel kan in de eerste sessie al gestart worden met de interpersoonlijke 
anamnese. Aan het eind van het eerste gesprek worden bij voorkeur een serie 
vervolgafspraken gepland, zo mogelijk op een vaste therapietijd in de week.
Sessie 2-3. Na de eerste sessie start de therapeut alle volgende sessies met: 
“Hoe is het deze week gegaan?” Daarmee wordt de aandacht van de patiënt 
direct gericht op de wereld buiten de therapie. In het begin van de behandeling 
zal de patiënt vaak zijn of haar klachten naar voren brengen. De therapeut heeft 
een empathische houding en benoemt de klachten als (nog) duidelijk aanwezig 
zijnde symptomen van de depressie. Aangezien er in het eerste gesprek uitvoe-
rig aandacht is besteed aan de depressieve klachten, hoeven deze niet iedere 
keer opnieuw uitvoerig besproken te worden. Het is wel van belang steeds de 
relatie tussen het beloop van de klachten en interpersoonlijke voorvallen te ex-
ploreren en te verduidelijken. Op die manier leert de patiënt het verband te zien 
tussen gebeurtenissen in de relatie met belangrijke anderen en de stemming. 
Het kan soms moeite kosten de beschrijving van de ervaringen in de afgelo-
pen week af te bakenen. Dit geldt zeker bij ouderen die regelmatig ingrijpende 
voorvallen, met name rondom ziekte van henzelf of naasten meemaken. Van de 
therapeut wordt een steunende, maar ook actief structurerende houding ver-
wacht, die waarborgt dat de IPT strategie wat betreft de inhoud en opbouw van 
de gesprekken gevolgd wordt. Dus als de patiënt bijvoorbeeld vertelt over een 
spannend bezoek aan een arts wordt daar op steunende wijze op ingegaan. In 
principe wordt altijd nagegaan hoe een dergelijke gebeurtenis van invloed was 
op de depressieve klachten. Ook wordt besproken bij wie de patiënt steun heeft 
gezocht. Vervolgens wordt het gesprek weer teruggebracht naar de IPT benade-
ring. Dus bijvoorbeeld “Het is wel duidelijk dat het nu extra moeilijk is met dit 
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soort spanningen om te gaan, omdat uw psychische weerstand verminderd is 
door de depressie. Het doel van onze gesprekken hier is aan die depressie iets te 
verbeteren. Vorige keer bespraken we... en nu wil ik verder met u gaan over…”. 
Het is de bedoeling dat in het tweede en derde gesprek een nauwkeurige 
inventarisatie van het sociale netwerk van de patiënt plaatsvindt. Wie zijn be-
langrijke personen in het leven van de patiënt, wat is de aard van de relatie, wat 
zijn wederzijdse verwachtingen en mogelijk recente veranderingen in de relatie? 
Als het sociale netwerk erg uitgebreid is, bijvoorbeeld bij ouderen met veel 
kinderen en kleinkinderen, kan alleen ingegaan worden op de meest belangrijke 
contacten (in positieve of negatieve zin). Samenvattend is de interpersoonlijke 
anamnese er op gericht díe interpersoonlijke gebeurtenis(sen), of díe specifieke 
relatie(s) te vinden die het meest van invloed zijn op de klachten.
Bij ouderen kunnen er twee kanttekeningen gemaakt worden bij de interper-
soonlijke inventarisatie: 
•  Ouderen kunnen een vrij geïsoleerd bestaan leiden. Alhoewel IPT in principe 
op het hier en nu gericht is kan dit een reden zijn om toch vooral op interper-
soonlijke gebeurtenissen uit het verleden in te gaan. Dit is noodzakelijk om 
een indruk te krijgen van hoe de patiënt met anderen omgegaan is. Het is ver-
der belangrijk om na te gaan of het gebrek aan contacten veroorzaakt is door 
reële verliezen in de laatste jaren of dat er sprake is van persoonlijkheidspro-
blematiek en dus, in IPT termen, van interpersoonlijke tekortkomingen.
•  Als de ouderen een uitgebreid (familie)netnetwerk hebben kan een geno- of 
sociogram nuttig zijn. 
Aan het eind van het derde gesprek vat de therapeut de bevindingen uit de 
interpersoonlijke anamnese samen en legt voor aan de patiënt wat hij/zij als 
belangrijkste luxerende of onderhoudende factor van de depressieve klachten 
ziet. Als de patiënt zich in deze samenvatting kan vinden wordt afgesproken dat 
dit het behandelfocus wordt. Het is vaak niet noodzakelijk de IPT termen voor 
het focus (bijvoorbeeld “interpersoonlijk conflict” of “rolverandering”) te gebrui-
ken. Men kan meestal volstaan met de termen die de patiënt zelf gebruikte. Het 
kiezen van het focus gaat dus wel in overleg, maar de therapeut neemt het ini-
tiatief. Meestal is de patiënt het met het voorstel van de therapeut eens. Soms 
zijn er meerdere focussen aan te geven. In overleg met de patiënt wordt dan het 
meest geschikte focus gekozen. Een enkele keer komt het voor dat de patiënt 
een ander focus wil bespreken dan de therapeut. Het is weinig therapeutisch 
de patiënt een focus op te dringen, het is beter in een dergelijke situatie aan te 
sluiten bij de keuze van de patiënt met de kanttekening dat er later in de thera-
pie alsnog overgegaan kan worden op het andere focus, als de gekozen aanpak 
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te weinig resultaat geeft. Bij ouderen is het advies dàt focus te nemen waar vrij 
snel verbetering lijkt te kunnen worden  bewerkstelligd, aangezien een gevoel 
van hopeloosheid kan overheersen en snelle verbetering op een bepaald punt 
weer hoop kan geven. 
Overigens werd in het Amsterdamse onderzoek het focus rolverandering 
(vooral de rolverandering van actieve gezonde persoon naar iemand met be-
perkingen door lichamelijke ziekte) het meest gekozen, daarna interpersoonlijk 
conflict en daarna rouw. Deze verdeling sloot aan bij bevindingen in de litera-
tuur over IPT bij ouderen(Miller et al., 2001). Interpersoonlijk tekort wordt 
zelden als focus gekozen. 
Voorbeeld van het kiezen van een focus: 
Therapeut:   U vertelde mij dat u steeds somberder werd nadat u was  
verhuisd, begreep ik dat goed? 
Patiënt:   Ja, dat klopt wel, maar ik begrijp niet waarom. Ik wilde die 
flat juist heel graag. 
Therapeut:   Ja, want uw wilde graag dichter bij uw kinderen wonen. U 
heeft verteld dat uw kinderen het druk hebben en dat u ze 
minder ziet dan u gehoopt had. Na de verhuizing bent u ver 
van uw oude buurt komen te wonen. U had daar veel con-
tacten, een kaartclubje en goede buren. Die contacten bent u 
zo goed als kwijtgeraakt.
Patiënt:  Ja, ik zie sommigen nog wel, maar een stuk minder. 
Therapeut:   Ja, uw leven is er heel anders uit komen te zien, u bent veel 
vaker alleen en dat valt u niet mee. Ik denk dat uw de-
pressieve klachten sterk in verband staan met deze verander-
ingen. Wat denkt u daarvan? 
Patiënt:   Ja, dat heb ik eigenlijk ook al gedacht, maar ja, ik kan niet 
meer terug. 
Therapeut:   Nee, ik denk ook niet dat dat de beste oplossing is maar we 
kunnen de recente veranderingen in uw leven wel bespreken 
en kijken wat voor oplossingen er te bedenken zijn zodat het 
beter met u gaat. Wat denkt u daarvan? 
Patiënt: Ja, dat wil ik wel proberen.




In deze eerste fase van de behandeling wordt door gericht te vragen aan de 
patiënt impliciet duidelijk gemaakt wat de bedoeling is, vooruitlopend op de 
behandelfase. De patiënt wordt verder uitgelegd dat hij/zij in de volgende 
gesprekken de onderwerpen kiest en wordt aangemoedigd te praten over de 
dingen die hij/zij meemaakt (met anderen). 
3.2 De behandelingsfase
In de behandelingsfase (sessies 4-9) wordt het gekozen focus uitgewerkt. Elk ge-
sprek start ook in deze fase met: ‘hoe is het deze week met u gegaan?’ Hieronder 
volgt een bespreking van de focussen. 
3.2.1 Focus Rouw  
In het algemeen wordt binnen IPT alleen het focus rouw gekozen als er een 
directe relatie lijkt te zijn tussen de depressie en het overlijden van een belang-
rijke ander. Bij ouderen wordt het focus rouw ook gekozen als er niemand is 
overleden, maar als er rouw is om een dementerende of ernstig zieke partner 
met wie geen of nauwelijks contact meer te krijgen is. Doel van de behandeling 
is vermindering van de depressieve symptomatologie door het rouwproces te 
faciliteren. Daarnaast wordt het opbouwen van activiteiten en sociale contacten 
die het verlies enigszins kunnen compenseren, aangemoedigd. 
Het kan voorkomen dat de depressieve reactie veroorzaakt lijkt door een 
relatief licht verlies bijvoorbeeld het overlijden van een verre kennis, terwijl 
eerdere grote verliezen goed opgevangen werden. In dat geval is het belangrijk 
ook aandacht aan de eerdere verliezen te besteden.
De therapeut begint naar relatief ‘veilige’ onderwerpen te vragen, bijvoor-
beeld naar de persoon van de zieke/overledene en ervaringen en gebeurtenissen 
verder in het verleden. Geleidelijk worden meer belastende onderwerpen nage-
vraagd totdat uiteindelijk ervaringen en emoties rond het eventuele ziekbed, het 
afscheid en de begrafenis of crematie aan bod komen. Als de patiënt erg geremd 
is in het uiten van emoties kan de therapeut hem of haar vragen foto’s van de 
overledene of zieke mee te nemen naar de therapie. Ook kan getracht worden 
meerdere zintuiglijke ervaringen (horen, zien, voelen, ruiken) bij de beschrijvin-
gen te betrekken zodat een levendige herinnering ontstaat. IPT is geen cathar-
tische therapie in díe zin dat van het uiten van emoties, een heilzame werking 
wordt verwacht. Bij ouderen is in dit opzicht sowieso enige terughoudendheid 
op zijn plaats. Het is in ieder geval belangrijk dat de patiënt verschillende 
gevoelsmodaliteiten (verdriet, woede, schaamte) leert herkennen en ermee leert 
omgaan. Als de emotionele beleving te sterk wordt is het goed om steunend/
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structurerend in te grijpen bijvoorbeeld door de sessie even te onderbreken.
Het is van belang duidelijk te maken dat sterk emotionele reacties bij nor-
male rouw horen. Het gevoel gek te worden of de angst alle controle te verliezen 
moet benoemd worden. Door het geven van voorlichting over emoties kan de pa-
tiënt meer controle gaan ervaren. Als te verwachten is dat in een sessie heftige 
gevoelens aan bod zullen komen kan worden geanticipeerd op hoe de patiënt 
eventuele steun na de sessie kan organiseren bijvoorbeeld door een afspraak bij 
een vriendin te maken.
Voorbeeld van hoe in te gaan op het affect bij een patiënte met rouw-
problematiek: 
Therapeut:  Kunt u mij vertellen wat er gebeurde tijdens de begrafenis 
van uw man?
Patiënte: Het ging eigenlijk best goed.
Therapeut: Wat ging er best goed?
Patiënte:  Ik had me voorgenomen bij het graf een toespraak te houden 
en dat is gelukt. Ik huilde zelfs niet eens en kreeg compli-
mentjes dat ik zo sterk was.
Therapeut: Weet u nog wat er door u heen ging toen u bij het graf stond?
Patiënte:  Nou, eigenlijk weinig, ik wilde perse de toespraak houden. Het 
leek wel of ik verdoofd was, ik voelde niets. Vlak daarna voe-
lde ik me wel heel verlaten van iedereen. Ik heb ook niemand 
echt gesproken. Ik liet alles maar over me heen komen.
Therapeut: U wilde perse sterk zijn en sloot u eigenlijk af van anderen?
Patiënte: ja
Therapeut: maar u voelde u ook erg alleen met uw verdriet?
Patiënte :  Ja, ik heb er eigenlijk sowieso met niemand over gepraat, 
maar als u er zo naar vraagt.. (huilt).
Therapeut  (na korte stilte) Kan u aangeven wat u nu vooral verdrietig 
maakt?
Patiënte:  … alles. Ik denk aan dingen die ik samen met mijn man deed 
en die ik nu zo mis. 
(Deze worden verder uitgewerkt. Daarna:)
Patiënte:  Het is toch niet normaal dat ik toen niet moest huilen en nu 
wel?
Therapeut:  Ik denk dat er verschillende manieren zijn om met verdriet 
om te gaan. Tijdens de begrafenis wilde u sterk zijn en hield u 
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uw gevoel weg. Daardoor kon u de toespraak houden en kreeg 
u zelfs complimenten dat u zo sterk was. Nadeel daarvan was 
dat u zich in uw verdriet alleen voelde. 
Patiënte: Ja. (stilte)
Therapeut: Hoe is het voor u nu hierover met mij te praten?
Patiënte: Het lucht me wel op.
 (de therapeut gaat hierop verder in)
 
De therapeut geeft  dus aan dat er geen ideale manier is van omgaan met emo-
ties is, maar dat er verschillende manieren zijn. Het wisselen tussen “contentaf-
fect” (“Wat deed het u toen en daar”) en procesaffect (“Hoe is het voor u nu u het 
hier vertelt?”) helpt om dit te illustreren. Eén van de meest krachtige inter-
venties in IPT is het geven van hoop. De therapeut moet duidelijk maken dat 
verbetering mogelijk en waarschijnlijk is. Benadrukt wordt daarbij dat rouwen 
een cyclisch proces is. Er blijven momenten terugkomen die herinneringen en 
emoties oproepen, bijvoorbeeld de verjaardag en de sterfdag. Deze verdrietige 
perioden worden afgewisseld met perioden waarin het leven weer wat makkelij-
ker gaat. 
Nadat een nauwkeurige reconstructie is gemaakt van de verloren relatie 
en alles wat daarmee samenhing, komt er meer ruimte in de therapie om het 
toekomstperspectief bij de behandeling te betrekken en de aandacht te richten 
op het vinden van een nieuwe en zinvolle invulling voor datgene wat men is 
kwijtgeraakt. Met het overlijden of een langdurig ziekbed van een belangrijk an-
der vervalt immers niet alleen het contact met die persoon, maar vaak worden 
ook allerlei andere sociale bindingen minder. Als een vrouw vroeger met haar 
man naar een kaartclub ging, maar nu ook daar haar overleden partner mist, is 
de kans groot dat zij niet meer naar die bijeenkomsten zal gaan. De introductie 
van dit deel van de therapie gebeurt met de nodige voorzichtigheid. Men heeft 
immers meestal al te vaak gehoord dat hij of zij het verleden van zich af moet 
zetten en iets nieuws moet gaan doen. Belangrijk is dat de patiënt zich reali-
seert dat het nooit meer zal zijn zoals het was. De daarmee verbonden connota-
tie dat het leven over is en nooit meer zinvol zal worden moet echter bestreden 
worden. Er wordt geëxploreerd wat de behoeftes en wensen van de patiënt zijn 
en hoe die te verwezenlijken zijn. Het weer opzoeken van oude kennissen en 
familie  is meestal (voor een deel) wel haalbaar. Zo mogelijk wordt de patiënt 
ook aangemoedigd nieuwe sociale contacten aan te gaan. De therapeut kan 
suggesties of adviezen geven. Ook het weer opstarten van oude hobby’s is vaak 
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haalbaar. Soms komt de patiënt toe aan interesses of bezigheden die toen de 
partner nog leefde moeilijk waren, bijvoorbeeld reizen als de partner daar een 
hekel aan had. 
Voorbeeld van probleem oplossende strategie 
Therapeut:   Dus, als ik het goed begrijp zit u het grootste deel van de tijd 
alleen thuis?
Patiënt:   Ja, in de jaren dat mijn man ziek was zijn we steeds meer 
contacten kwijtgeraakt.
Therapeut:   Toen uw man nog gezond was, wat deed u dan zoal samen? 
Patiënt:   We tennisten en speelden bridge op de tennisclub 
Therapeut:   Wat denkt u ervan om weer te gaan tennissen of bridgen?
Patiënt:   Tja, ik heb daar wel over gedacht, maar ik zie er erg tegenop 
om daar alleen naar toe te gaan.
Therapeut:   Dat is ook heel moeilijk, maar zijn er misschien mensen van 
de tennis waar u nog contact mee heeft gehouden? 
Patiënt:   Nee, ik had een goede vriendin die hier ook wel thuis kwam, 
maar ze had haar eigen problemen en het contact is verwa-
terd. 
Therapeut:  Zou u weer contact met haar willen zoeken?
Patiënt:   Ja, dat zou ik eigenlijk best kunnen doen. Ik weet niet eens of 
zij nog tennist. .
 
De therapeut stimuleert de patiënt dus weer activiteiten op te starten. Er wordt 
benadrukt dat dit heel belangrijk is voor een goed herstel van de ziekte. Bij 
patiënten bij wie “rouw” het focus van de behandeling is, is er vaak een periode 
geweest waarin zij soms jarenlang overbelast waren ten gevolge van de zorg 
voor de zieke partner (of andere naaste). De therapeut benadrukt dat de patiënt 
nu toe mag komen aan eigen behoeftes en wensen.  IPT richt zich op de behan-
deling van de depressie en beperkt zich tot het op gang brengen van een vastge-
lopen rouwproces. Is dat eenmaal gebeurd dan kunnen normale gevoelens van 
verdriet weer naar boven komen. Het is belangrijk  de patiënt uit te leggen dat 
een normaal rouwproces over het algemeen veel langer duurt dan de maanden 
die de behandeling met IPT duurt en dat het normaal is daarna nog regelmatig 
verdriet te voelen.
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3.2.2 Focus Interpersoonlijk conflict
Meestal gaat het bij dit focus om een conflictueuze relatie met de partner. Het 
belangrijkste conflict waarin iemand verwikkeld is kan echter ook zijn met een 
kind, ouder of werkgever. Het eerste doel is het conflict te identificeren en te 
actualiseren. Het moet duidelijk zijn met wie het conflict zich afspeelt. 
Met de term interpersoonlijk conflict binnen IPT wordt niet zozeer een 
patroon bedoeld waarin de patiënt herhaaldelijk in conflicten raakt met men-
sen om haar of hem heen, maar het gaat om  één conflict met één belangrijke 
persoon. Als een interpersoonlijk conflict een rol speelt bij de actuele depressie, 
is er meestal sprake van een impasse in het conflict. Ofwel er zijn zoveel hoog-
oplopende ruzies dat de spanning haast onverdraaglijk wordt òf er zijn geen 
ruzies meer, maar men leeft in een koude oorlog met elkaar. Eerdere onderhan-
delingen zijn mislukt.
Als er hoogoplopende ruzies zijn moet getracht worden een “staakt-het-vu-
ren” te bewerkstelligen door bijvoorbeeld te adviseren een tijdje zoveel mogelijk 
bij elkaar uit de  buurt te blijven. Als er geen discussies meer zijn worden de 
verschillen door de therapeut aangescherpt. Het doel is in beide situaties het 
conflict weer in de onderhandelingsfase te brengen. Om een indruk te krijgen 
van de aard van het conflict wordt getracht een zo concreet mogelijk beeld te 
krijgen van de communicatiepatronen die in het conflict gebruikt worden. Aan 
de hand van voorbeelden wordt dit goed uitgevraagd bijvoorbeeld wie wat zei 
en wat de ander toen zei (communicatie analyse).
Voorbeeld communicatie analyse 
Therapeut:  U vertelde me dat u gisteren een nare dag had omdat u weer 
ruzie had met uw man. Kunt u aangeven hoe dat precies 
ging? 
Patiënt  Zoals ik al eerder vertelde klaagt mijn man de laatste jaren 
altijd over zijn rug. Hij kan dit niet meer en dat niet meer, ik 
word er gek van! Gisterenochtend was ik gaan winkelen met 
mijn dochter. Mijn man zou het huis een beetje opruimen, 
maar hij bleek dit natuurlijk weer eens niet gedaan te hebben.
Therapeut:  Dus u zag dat toen u thuis kwam en wat gebeurde er toen?
Patiënt  Niets. Hij zat in zijn stoel en deed of er niets aan de hand was. 
Ik ben meteen gaan opruimen, maar ik kreeg zo’n hoofd-
pijn dat ik ‘s middags in bed ben gaan liggen. Toen ik weer 
beneden kwam vroeg hij me of ik even de krant wilde halen. 
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Dat was voor mij de druppel. Ik ben naar de keuken gegaan 
en heb niets meer gezegd.
Therapeut: En wat gebeurde er toen?
Patiënt  Hij kwam na een tijdje achter me aan en vroeg waarom ik in 
de keuken ging zitten. Toen heb ik voor de zoveelste maal te-
gen hem gezegd, dat hij nooit iets doet en dat ik zijn voetveeg 
niet ben. 
Therapeut En wat zei uw man toen?
Patiënt  Dat hij er niets van begreep, dat hij me chagrijnig vindt de 
laatste tijd en dat hij nou eenmaal minder kan door zijn rug. 
Toen hij daar weer over begon heb ik gezegd dat hij altijd 
zeurt over zijn rug, maar dat hij nooit iets gedaan heeft om 
mij te helpen in de huishouding en eigenlijk sowieso niet. Ik 
kan er niet meer tegen, ik heb gedreigd dat ik weg zal gaan.
 
Als duidelijk is hoe de problematische communicatie verloopt, hoe de patiënt 
dit ervaart en wat hij/zij al geprobeerd heeft, wordt vervolgens gestart met het 
zoeken naar nieuwe oplossingen. Verschillende opties om op een andere manier 
met de partner te communiceren worden nagegaan. Bij elke mogelijkheid die 
besproken wordt, wordt zorgvuldig nagegaan of het iets oplevert: ‘als u aan uw 
man vraagt om de afwas op woensdag te doen in plaats van boos op bed te gaan 
liggen, hoe zou dat voor u zijn? Wat zou u dan precies willen zeggen?’ Er kan 
worden geoefend in een rollenspel. Nadat de patiënt oefent: ‘en hoe voelt dat, als 
u het zo zegt?’  Het is belangrijk dat er altijd een concrete situatie wordt bespro-
ken. Rollenspelen zijn niet noodzakelijk, maar kunnen een goede aanvulling zijn. 
De patiënt moet het gevoel krijgen over meerdere mogelijkheden te beschikken 
om met een bepaalde situatie om te gaan. Als in deze fase van de behandeling 
de patiënt gaat experimenteren met gedragsopties zal de therapeut in principe 
elke actie aanmoedigen. “Als het lukt is het mooi, als het niet lukt zullen we de 
volgende keer bekijken wat er precies gebeurde, daar leren we van.”
Het is vaak zinvol de partner bij de behandeling te betrekken. Er kan dan 
uitleg over de depressie worden gegeven en er kan gezamenlijk worden inge-
gaan op de communicatieproblemen. Eventueel kan bepaald gedrag geoefend 
worden. IPT is echter geen relatietherapie in de klassieke zin. De therapeut is 
niet neutraal en neemt nadrukkelijk positie achter de patiënt. Er is overigens 
ook een aanpassing van het IPT protocol gemaakt voor een relatiebehandeling 
(IPT-CM; Conjoint IPT for depressed patients with marital disputes), beschre-
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ven in de Comprehensive Guide to IPT van Weissman et al. Het gaat hierbij om 
een relatietherapie, gebaseerd op de IPT principes. Hiermee is in het Amster-
damse project niet gewerkt.
Bij ouderen kan het moeilijk zijn de communicatiepatronen te veranderen. 
Als dat na enkele pogingen tot verandering het geval blijkt wordt de strategie 
aangepast. Mogelijke andere oplossingen worden besproken zoals de conse-
quenties van een eventuele relatiebreuk. In deze levensfase wordt daarvoor 
vaak niet gekozen, omdat de voordelen van een eventuele scheiding in deze 
levensfase niet opwegen tegen de nadelen. Dit inzicht kan de patiënt helpen 
een meer accepterende houding ten aanzien van de situatie te ontwikkelen. Er  
wordt gekeken naar manieren om afleiding te vinden, of, zo mogelijk worden 
ook de meer positieve kanten van de partner belicht. Kortom het doel wordt hoe 
het mogelijk is binnen de huidige relatie er het beste van te maken. 
3.2.3 Focus interpersoonlijke rolverandering
Bij dit focus is er een belangrijke verandering in het leven van de patiënt 
geweest voorafgaand aan de depressie. Bij ouderen gaat het vaak om pensione-
ring, verhuizing, grootouder worden en omgaan met ziekte of beperkingen.
De therapeut start met het exploreren van de recente veranderingen. Zoals ook 
bij de andere focussen werd genoemd is het van belang zo gedetailleerd moge-
lijk op de verandering in te gaan, zodat er een concrete beschrijving ontstaat, 
meestal van wat men allemaal (vooral op het gebied van sociale contacten) is 
kwijtgeraakt. Zoals steeds bij IPT is het van belang  nadrukkelijk in te gaan op 
de affecten die bij de verschillende situaties een rol speelden of die nu tijdens 
de sessie een rol blijken te spelen. Het is een belangrijk onderdeel van de thera-
pie dat patiënten verschillende soorten gevoelens leren herkennen en ook voor 
zichzelf serieus nemen. Vaak is voor de patiënt het verband tussen de depressie 
en de verandering in hun leven, maar beperkt duidelijk. Het uitwerken van de 
situatie kan het hopeloze, machteloze gevoel van de depressie naar de achter-
grond doen verdwijnen. Er ontstaat dan meer mogelijkheid om aan de hand van 
de concrete situatie naar oplossingen te gaan zoeken.
Voorbeeld rolverandering 
Therapeut:  U zegt dat u eigenlijk niet begrijpt waarom u depressief bent 
geworden. Er zijn geen vervelende gebeurtenissen geweest.
Patiënte: Nee, ik begrijp het niet.
Therapeut:  U heeft verteld dat de klachten in het afgelopen half  jaar 
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ontstaan zijn. Wat heeft u zoal meegemaakt in het afgelopen 
half jaar, zijn er dingen in uw leven veranderd? 
Patiënte:  Ja, dat wel. We hebben vier maanden geleden onze winkel 
verkocht, We hebben er veel geld aan overgehouden, dus dat is 
niet iets om somber over te worden. Ik had me er juist erg op 
verheugd een rustiger leven te hebben, maar nu heb ik er niets 
aan, want ik zit maar voor me uit te staren.
Therapeut:  Ja, de depressieve klachten beperken u erg. Wat u nu vertelt, 
het verkopen van de winkel en de veranderingen die hiermee 
gepaard zijn gegaan kan wel een grote invloed hebben op  
uw klachten. Kunt u iets meer vertellen over hoe uw leven 
veranderd is?
(Patiënte vertelt over de tijd dat ze de winkel nog hadden. Ze wordt levendiger 
en beschrijft hoe de zaak steeds mooier geworden was in de loop der jaren, 
dat ze veel tevreden klanten hadden, dat er zelfs bij waren die 35 jaar klant 
waren geweest. Ze waren eigenlijk altijd met de zaak bezig geweest, omdat er 
ook buiten de openingstijden veel te doen viel. Al vertellend wordt het patiënte 
ook duidelijk dat ze veel uit die tijd mist, vooral het contact met de klanten. 
Dit was iets waar ze eigenlijk niet bij stil had gestaan temeer daar haar man 
alleen maar blij lijkt te zijn dat de zaak is verkocht. Hij heeft een stuk grond 
gekocht en is heel actief met tuinieren. Het blijkt echter dat patiënte zelf nog 
geen andere invulling heeft en nu veel alleen thuis zit. Ze mist activiteiten die 
haar voldoening geven).
 
Nu de probleemsituatie en het bijbehorende gevoel duidelijk is kan verder 
gegaan worden met het zoeken naar oplossingen. Interessegebieden, wensen en 
mogelijkheden van de patiënt worden nagegaan. Vervolgens wordt de patiënt 
aangemoedigd activiteiten en contacten op te bouwen, waardoor hij/zij zich 
beter kan aanpassen aan de verandering in zijn/haar leven. Bij iedere stap die 
de patiënt zet wordt geëvalueerd hoe dat gegaan is. Eventueel wordt gewerkt 
met opdrachten. 
Vervolg voorbeeld rolverandering 
De depressieve klachten van patiënte nemen af nu zij meer verband ziet tus-
sen haar klachten en de huidige levensfase; ze ervaart de depressie niet meer 
als iets wat haar zo maar overkomen is. Zij is het er mee eens dat zij eigenlijk 
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meer activiteiten zou moeten hebben, want alleen zijn is niets voor haar. Sa-
men met haar wordt gekeken wat zij zou kunnen gaan doen. Ze zou eigenlijk 
best vaker op de kleinkinderen willen passen, maar dat kon voordien nooit 
en nu hebben de kinderen andere oplossingen gezocht. Ze wordt aangemoed-
igd dit eens met haar kinderen te bespreken. Aangezien ze creatief is  wordt 
ze aangemoedigd in een buurtcentrum te informeren wat de mogelijkheden 
zijn. Verder heeft ze ooit in een koor gezongen, maar is daarmee gestopt toen 
ze zwanger was van haar eerste kind. Hoe de verschillende stappen verlopen 
wordt nabesproken en eventueel aangevuld met andere suggesties of op-
drachtjes “zullen we afspreken dat u deze week die kennis belt die in dat koor 
zingt, zodat u eens kan horen hoe het gaat in dat koor en wat men verwacht 
van koorleden? U kan dan duidelijker afwegen of het u iets lijkt”.
 
Bij sommige patiënten ontbreken de vaardigheden om uit zichzelf te experimen-
teren in de nieuwe rol. Rollenspelen kunnen dan zinvol zijn. Overigens wordt 
sowieso ook weer ingegaan op hoe de patiënt zich voelt bij de verschillende 
stappen. Onzekerheden of twijfels worden besproken. De rol van de therapeut is 
in feite die van een coach, die aanmoedigt en adviezen geeft.
3.2.4 Focus Interpersoonlijke tekorten
Van een interpersoonlijk tekort is sprake als de patiënt duurzaam moeite heeft 
met het aangaan of onderhouden van betekenisvolle relaties. De behandeling 
is gericht op het vergroten of verbeteren van het sociaal netwerk. Vaak kiest 
men dit focus als men niet kan uitkomen met één van de drie andere focussen. 
Volgens Markowitz (1997) zijn er aanwijzingen dat patiënten die met dit focus 
behandeld worden minder goed reageren op IPT. Dat heeft wellicht te maken 
met het feit dat IPT beter werkt als er sprake is van een redelijk intact sociaal 
netwerk. Bij patiënten waar dat netwerk niet of nauwelijks aanwezig is, zal IPT 
een minder grote kans van slagen hebben. Er is bij dit focus per definitie sprake 
van een arm sociaal netwerk zodat de therapeut vaak de therapeutische relatie 
zelf moet gebruiken als model- en oefensituatie. In die zin wijkt de werkwijze 
dus af van wat bij IPT gebruikelijk is namelijk dat de therapeutische relatie 
nauwelijks in de therapie betrokken wordt en dat de aandacht vooral gericht 
wordt op wat er gebeurt buiten de spreekkamer, in contacten met anderen. 
Na het vaststellen van het focus, gaat de therapeut zorgvuldig na hoe relaties 
in het verleden verlopen zijn. De therapeut gaat na welke sociale contacten er 
geweest zijn, hoe deze begonnen en hoe ze weer afliepen, wat de positieve en 
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wat de negatieve kanten waren. Bij deze inventarisatie wordt nauwkeurig gelet 
op patronen die zich hierbij voordeden: is de patiënt iemand die snel geneigd 
is om zelfs bij  verdenking op krenking, het contact te verbreken? Of is het juist 
iemand die steeds afgewezen wordt en klagend alleen achterblijft? Het is be-
langrijk er op bedacht te zijn dat patronen die zich in veel van de eerdere relaties 
hebben voorgedaan, zich ook in de sessies kunnen manifesteren. Positieve en 
negatieve gevoelens ten opzichte van de therapeut moeten eventueel in een vroeg 
stadium besproken worden en het streven is dat de patiënt oog krijgt voor de 
parallel tussen de gevoelens over de therapeut en die in andere relaties. Op deze 
wijze wordt getracht problemen binnen de werkrelatie hanteerbaar te houden 
en de patiënt zicht te geven op zijn/haar interactiepatronen. De therapeut tracht 
niet-veroordelend maar wel doortastend communicatieproblemen in te brengen. 
‘Eilandjes van gezondheid’ worden gebruikt als aanknopingspunt voor de the-
rapie. Wat maakte dat een bepaalde relatie ook als positief werd ervaren, welke 
aspecten van die relatie waren waardevol? Hoe was de intensiteit van het con-
tact? Hoe kreeg de patiënt wat hij of zij wilde? Vervolgens wordt besproken wat 
de patiënt verwacht en/of hoopt van toekomstige relaties? Uiteindelijk wordt een 
plan opgesteld waarin rekening wordt gehouden met de reële beperkingen. 
Voorbeeld interpersoonlijk tekort 
De patiënt, een 70-jarige man, heeft een sessie voorbij laten gaan en komt 
nu, na een telefonische uitnodiging van de therapeut, weer naar de therapie. 
Hij spreekt weinig spontaan en heeft een ontwijkende houding. In eerdere 
sessies werd duidelijk dat hij zich snel afgewezen voelt en al jarenlang een 
teruggetrokken bestaan leidt. Toen zijn vrouw nog leefde zorgde zij dat er wel 
contacten met anderen bleven, maar zij is inmiddels al tien jaar overleden 
en van hun gezamenlijke contacten is niets meer overgebleven. Patiënt heeft 
aangegeven erg teleurgesteld te zijn in anderen, inclusief zijn kinderen. Zijn 
kleinkinderen ziet hij weinig en hij voelt zich als grootvader falen. Nadat deze 
situatie geëxploreerd werd, werd de vorige sessie gestart met het bespreken 
van mogelijke oplossingen voor dit probleem. 
Therapeut:  U heeft de vorige afspraak voorbij laten gaan. Was daar een 
reden voor?
Patiënt: (ontwijkend). Nee, ik was het gewoon vergeten.
Therapeut:  Is dat zo, of speelde ook mee dat u op zag tegen het therapie 
gesprek? 
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Patiënt:  (na enige aarzeling) Het hoeft voor mij niet meer, ik ben ge-
komen omdat u me belde, maar ik geloof er niet in dat deze 
gesprekken me verder helpen. 
Therapeut:  Na het vorige gesprek had u er dus weinig vertrouwen meer 
in. In ieder geval goed dat u toch gekomen bent zodat wij dit 
kunnen bespreken. Had het te maken met wat er besproken is 
de vorige keer?
Patiënt:  We hadden het over mijn zoon en zijn kinderen. U liet me 
duidelijk merken dat ik niets waard ben als grootvader. Daar-
door ging ik beroerder weg dan toen ik kwam.
Therapeut:  Ik kan me voorstellen dat u er daardoor tegen opzag om een 
volgende keer te komen. 
Ik heb niet willen zeggen dat u geen goede grootvader bent. 
Waaruit leidde u af dat ik u afkeurde?
Patiënt: Ik zag het gewoon aan hoe u keek.
Therapeut:  Tja, wat kan ik daar tegenin brengen? Kan u het nu van mij 
aannemen als ik zeg dat dat niet mijn bedoeling was? 
Patiënt Misschien valt het mee.
Therapeut  Het ging erom dat u momenteel geen kans krijgt om een 
grootvader te zijn en we spraken erover hoe dat kan verander-
en. Kan het zijn dat hier met mij gebeurde waar u eerder over 
vertelde, dat u snel het gevoel heeft dat mensen u afkeuren?
Patiënt:  Ja, maar ik dacht het ook echt. Ik had er geen zin meer in en 
wilde niet meer terugkomen.
Therapeut:  Maar u bent na mijn telefoontje toch weer gekomen. Dat is 
een goede stap, want misschien kunnen we het misverstand, 
door er over te spreken recht zetten. Wat denkt u?
Patiënt: Misschien. 
(De therapeut gaat hierop door tot de weerstand afneemt)
Therapeut: Wat vindt u ervan om dit zo te bespreken?
Patiënt: Ik heb er nu wel weer wat vertrouwen in.
Therapeut  Mooi dat u merkt dat het een gunstig effect kan hebben om 
dergelijke dingen uit te spreken. Nadat u zich door mij niet 
begrepen voelde kreeg uw weer meer depressieve klachten. Dat 
illustreert eigenlijk weer hoe u er letterlijk ziek van wordt als 
uw contacten met anderen niet goed verlopen. 
Patiënt: (knikt)
Therapeut:  Denkt u dat het u nu lukt om verder te gaan en te kijken wat 
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er kan veranderen zodat u zich minder beroerd voelt?
Patiënt: We kunnen zien..
 
Door een relatie te leggen tussen het (slecht lopen of ontbreken van) sociale 
contacten en de ziekte depressie, kan de ziekte als een hefboom worden ge-
bruikt om veranderingen in de gewenste richting te krijgen: ‘hiervan wordt u 
ziek. In het belang van uw gezondheid moeten er een aantal dingen in uw leven 
veranderen. Hoe moeilijk dat ook is.” De patiënt wordt gestimuleerd om, in 
eerste instantie heel bescheiden, veranderingen in zijn leven uit te proberen. 
Vrijwel elke actie van de patiënt wordt aangemoedigd. Wel dient de therapeut 
er voor te waken dat realistische doelen worden nagestreefd. Ook hier geldt dat 
als er iets niet lukt, dit benoemd wordt als iets om van te leren eerder dan een 
signaal van falen. 
Vervolg voorbeeld interpersoonlijk tekort: 
Het lukte om geleidelijk verder naar oplossingen te zoeken. Zo werd ingegaan 
op welke manier een contact met zijn zoon kans van slagen zou kunnen heb-
ben. Al explorerend blijkt dat het meest haalbare een laagfrequent contact 
met de zoon is. Uiteindelijk wordt afgesproken dat patiënt één keer per twee 
weken samen met zijn zoon naar het voetballen van de kleinzoon gaat  kijken.
 
Ook bij deze problematiek kan gebruik gemaakt worden van rollenspelen. Er 
wordt vanuit gegaan dat bepaalde patronen niet te veranderen zijn. Dus als 
iemand erg rigide is wordt dit als gegeven gezien. “U bent erg vasthoudend en 
precies. Dat is een eigenschap die gemaakt heeft dat u in uw werk goed gepres-
teerd heeft. Anderzijds is het tot op heden vaak moeilijk voor u dat andere 
mensen andere maatstaven hebben ”. Een steunende en begrijpende houding 
ten aanzien van dit soort hinderlijke karaktertrekken heeft vaak een positieve 
invloed op het therapieproces. Meer dan bij de andere focussen is een dergelijke 
houding noodzakelijk, omdat de patiënten die met dit focus behandeld worden 
in het algemeen minder frustratietolerantie hebben en weinig zelfvertrouwen. 
3.3 Afsluiten van de behandeling
De laatste sessies zijn voor alle vier de focussen in principe gelijk en worden 
daarom in één keer behandeld. Omdat IPT een kortdurende behandeling is 
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waarbij de nadruk ligt op veranderingen in het dagelijks leven van de patiënt 
en in principe niet op de therapeutische relatie, wordt de beëindiging van de 
therapie als vanzelfsprekend benaderd. De therapeut heeft de patiënt aan het 
begin en tijdens het verloop va de behandeling ook regelmatig geattendeerd op 
het tijdelijke karakter van de therapie. Tijdens deze fase wordt de nadruk gelegd 
op de vorderingen die gemaakt zijn. Er wordt ingegaan op het beëindigen van 
het samenwerkingsverband en wat dit oproept. Voorts wordt benadrukt wat de 
patiënt geleerd heeft en vooral wat hij of zij zelf heeft bijgedragen aan het her-
stel. Als verdere behandeling noodzakelijk is of de kans op terugval groot, wordt 
dat aan de orde gesteld. Er wordt besproken hoe symptomen van een depressie 
in een vroeg stadium gesignaleerd kunnen worden en welke stappen de patiënt 
dan kan ondernemen. Vooral indien er sprake is van recidiverende depressies 
moeten afspraken over een onderhoudsbehandeling gemaakt te worden. Zoals 
bekend is de kans op een recidiefdepressie groot. Na één depressieve episode  
is de kans op een recidief 50%, oplopend tot 90% na drie of meer doorgemaakte 
depressieve episoden. IPT beschermt onvoldoende tegen het optreden van een 
recidief (Reynolds et al., 1999; Shea et al., 1992). Het kan nuttig zijn de onder-
houdsbehandeling IPT, al dan niet in combinatie met medicatie, aan te bie-
den (IPT-maintentance; Spanier & Frank, 1998). Het is belangrijk de eventuele 
noodzaak van een vervolgbehandeling in te schatten. Wanneer een patiënt ook 
tijdens de laatste afspraak onvoldoende verbetering vertoont, moet een andere 
behandeling worden voorgesteld bijvoorbeeld een medicamenteuze behandeling 
of een langerdurende behandeling gericht op persoonlijkheidsproblematiek
Therapeutische houding en technieken:
Bij IPT worden technieken uit verschillende therapierichtingen gebruikt. In de 
onderstaande opsomming is de aanpassing voor ouderen verwerkt. 
•  Van de therapeut wordt een steunende, actieve houding verwacht. Dit is in de 
meeste gevallen waarborg voor het tot stand komen van een positieve werkre-
latie.
•  Non-directieve exploratie is een belangrijke techniek bij IPT. Bij ouderen is 
echter meestal een meer directieve houding, zeker in het begin van de the-
rapie, noodzakelijk. Gericht vragen stellen naar interpersoonlijke contacten 
maakt duidelijk wat de bedoeling is en wat belangrijk is voor de therapie. Het 
gebruik maken van stiltes in het gesprek wordt bij ouderen afgeraden. Het kan 
geïnterpreteerd worden als een gebrek  aan belangstelling of afwijzing. 
•  Directieve technieken zijn belangrijk. Ouderen hebben vaak een beperkt net-
werk en behoefte aan steun bij praktische problemen (vervoer, huisvesting,  
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financiën). De therapeut tracht samen met de patiënt een onderscheid te ma-
ken tussen praktische problemen die de patiënt zelf kan oplossen en proble-
men waarvoor steun van anderen noodzakelijk is. De therapeut legt eventueel 
zelf contact met anderen om het oplossen van een probleem te faciliteren. 
Ook kan een therapeut gerichte adviezen geven over hoe de patiënt zijn/haar 
sociale netwerk kan uitbreiden.
•  De therapeut wordt binnen IPT geacht nadrukkelijk in te gaan op het affect 
(de emotionele reacties). Hierbij gaat het zowel om gevoelens die tijdens de 
sessies naar voren komen, alsook om gevoelens die patiënten in bepaalde si-
tuaties hadden. Bij ouderen moet hiermee mogelijk wat voorzichtiger worden 
omgegaan. Ervaringen van Frank e.a. (1993) waren dat depressieve ouderen 
vaker heftige negatief gekleurde affecten hadden die ze moeilijk onder con-
trole konden houden. Stimuleren van deze affecten werkte contraproductief. 
Bij deze patiënten is het doel om hen op een steunende manier te leren hun 
emoties  te reguleren. Bij geremde patiënten geldt deze restrictie niet en moet 
er, zoals altijd binnen IPT juist gezocht worden naar onderwerpen die gevoel 
oproepen. Deze worden als uitgangspunt genomen voor nadere exploratie. 
•  In de interpersoonlijke context is het analyseren van communicatiepatronen 
een onderdeel van de therapie. Op basis van deze analyses wordt de patiënt 
aangemoedigd met andere manieren van communiceren te oefenen.
•  Door middel van verschillende clarificatietechnieken tracht de therapeut 
het verhaal van de patiënt te verduidelijken. Zo kan de therapeut in andere 
woorden  samenvatten wat de patiënt vertelt. Ook kunnen tegenstrijdigheden 
en bepaalde (extreme) standpunten nog eens expliciet aan de patiënt worden 
voorgelegd. Doel is dat er gedetailleerde, reële beschrijvingen ontstaan van 
concrete situaties met bijpassende emotionele reacties.
•  De therapeutische relatie wordt in principe buiten beschouwing gelaten. 
Positieve overdracht wordt niet geïnterpreteerd. Daarom kunnen bijvoor-
beeld kleine attenties van patiënten geaccepteerd worden. Vooral bij ouderen 
heeft het vermogen iets te kunnen maken of kopen een positief effect op het 
zelfgevoel. Het is contraproductief hen dit te ontnemen door een duiding te 
doen. Soms kunnen overdrachtsfenomenen zodanig interfererend werken op 
de therapie dat hierop ingaan noodzakelijk is. Dit is binnen IPT echter een 
uitzonderlijke situatie.
•  De therapeut moet in staat zijn om te gaan met eigen gevoelens ten aanzien 
van oudere patiënten. Ouderen kunnen specifieke gevoelens oproepen bij  
meestal jongere therapeuten. Deze kunnen een negatieve invloed hebben op 
het therapeutisch proces. Zo kan de therapeut zich geremd voelen, omdat de 
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patiënt van de generatie van de eigen ouders of grootouders is. Ook kan angst 
voor eigen ouderdom of ziekte bepalen dat de therapeut meegaat in de hope-
loosheid van de patiënt. 
•  Confrontatie is ook bij ouderen een goed toepasbare techniek. Het is echter 
niet de bedoeling de therapeutische relatie te veel op de proef te stellen.
Afsluitend
Deze handleiding is bedoeld ter ondersteuning bij een twee-of driedaagse IPT 
cursus. Om zich de IPT werkwijze eigen te maken is het verder van belang over 
een tweetal therapieën supervisie te krijgen. Momenteel is de Comprehensive 
Guide to Interpersonal Psychotherapy (Weissman et al., 2000) het meest geëi-
gende naslagwerk. Daarnaast is er recent een op de klinische praktijk gericht 
boek over IPT verschenen dat voor enigszins gevorderde IPT therapeuten erg 
nuttig is (Stuart & Robertson, 2003). 
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Dat heb ik erg gewaardeerd. Danielle van de Windt, bij jou kon ik terecht voor 
vragen over mijn eerste systematische review. Dank dat je me tussen de bedrij-
ven door hebt bijgeschoold en hebt meegewerkt aan mijn eerste artikel. Koen 
van der Kooij, ons beider onderzoeken hebben wij in een gemeenschappelijk 
project uitgevoerd. Dat vroeg zeker in het begin veel afstemming. Het is goed 
gelukt, dank voor de samenwerking! Hein van Hout, als co-promotor van Koen 
was je nauw bij het project betrokken. Je ondersteunde ons in het begin met het 
toesturen van relevante literatuur en werkte mee aan een aantal artikelen van 
dit proefschrift. Dank voor je nauwgezette inbreng. Judith Bosmans, dankzij 
de samenwerking met jou heb ik veel geleerd over kosteneffectiviteitsanalyses. 
Dank voor je actieve inzet.
Herman Adèr, tot 2005 “huisstatisticus” van de Common Mental Disorders 
onderzoekslijn binnen het EMGO Instituut. Beste Herman, gezamenlijk hebben 
wij vele uren achter de computer doorgebracht. Geleidelijk werd ik steeds meer 
wegwijs in de geheimen van SPSS en MLwin. Dank voor je geduldige inspan-
ning. Chad Gundy, opvolger van Herman. Beste Chad, de predictorenstudie 
bleek een moeilijk project, maar door de opzet te reduceren tot haalbare propor-
ties is er een toegankelijk en interessant artikel tot stand gekomen. Dank voor je 
ondersteuning daarbij.
Marijke van ter Toolen en Anneke Hermans, bibliothecaresses. Beste Marijke 
en Anneke, in de afgelopen jaren heb ik jullie met heel wat mailtjes bestookt. 
Altijd reageerden jullie meteen en vond ik snel de gewenste artikelen in mijn 
postvak. Daarvoor hartelijk dank. 
Elizabeth Gyurgyak. Beste Elizabeth, voor één keer communiceer ik nu met 
je in het Nederlands. Als native speaker en docente Engels corrigeerde je mijn 
teksten en hielp je mijn spreekvaardigheid in de Engelse taal te verbeteren. Ik 
heb de uren bij jou met genoegen doorgebracht! 
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Harm van Marwijk, co-promotor. Beste Harm, mede door jou heb ik met veel 
plezier aan dit onderzoeksproject gewerkt. Door jouw toedoen kreeg ik een plek 
binnen de afdeling Huisartsgeneeskunde. Je altijd bereidwillige en positieve 
inbreng was precies wat ik nodig had. “Het is jouw feestje..” was jouw aanmoe-
digende reactie een aantal keren toen ik kwam voorleggen of ik op de goede weg 
was. Die zin is voor mij een eigen leven gaan leiden. Ik dank je voor de prettige 
samenwerking en heb er vertrouwen in dat we die ook kunnen voortzetten in 
nieuwe projecten. 
Aartjan Beekman, promotor. Beste Aartjan, wij kenden elkaar al langere tijd, 
omdat we gezamenlijk de opleiding tot psychiater in de Valeriuskliniek doorlie-
pen. Jij bent een enorme stimulans voor me geweest in de afgelopen jaren. Niet 
alleen heb je me aangemoedigd dit onderzoeksproject te gaan uitvoeren, ook 
was je gedurende het hele traject “een baken in zee”. Jouw overzicht hielp mij de 
grote lijnen te bewaken en je creativiteit stimuleerde me nieuwe invalshoeken te 
kiezen. Gelukkig ziet het er naar uit dat we de inspirerende samenwerking ook 
de komende tijd kunnen voortzetten. 
Richard van Dyck, promotor. Beste Richard, je relativerende humor gecombi-
neerd met een gedreven scherpzinnigheid was een niet meteen te doorgronden, 
maar zeer gewaardeerde inbreng. Het was en is een genoegen terug te kunnen 
vallen op jouw ervaring en inzicht. 
Marten de Haan, promotor. Beste Marten, je was een enthousiasmerende 
promotor, die altijd razendsnel op toegezonden stukken reageerde. Herhaalde-
lijk nuanceerde je mijn formuleringen of vroeg je om verheldering als ik te veel 
vanuit tweedelijnsperspectief redeneerde. Mede hierdoor heb ik een bredere 
visie op de depressiezorg ontwikkeld.  
Brenda Penninx, jij hebt het onderzoeksvoorstel voor dit project geschreven 
en bent co-auteur geweest bij het artikel over de effectiviteitsstudie. Dank voor 
je waardevolle aanvullingen. 
Ingrid de Voogd, paranymf. Lieve Ingrid, wij kennen elkaar via de genees-
kundestudie die we samen in Utrecht doorliepen. We hebben veel lief en leed ge-
deeld. Jij bent huisarts geworden, ik psychiater. In dit proefschrift komen onze 
gedeelde werkinteresses mooi tot zijn recht. Ik ben erg blij dat onze vriend-
schap al zoveel jaar bestaat en dat jij me nu terzijde staat. 
Abdoeline Soleman, paranymf. Lieve Abdoeline, jou leerde ik kennen in de 
opleiding tot psychiater in de Valeriuskliniek. Tijdens een etentje met de arts-
assistenten van toen, zei je vertwijfeld dat je òf bij mij uit de buurt moest blij-
ven (in verband met met mijn soms wat onverwacht rake opmerkingen) of vrien-
din moest worden. Het is gelukkig het laatste geworden, 15 jaar vriendschap 
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overziend kunnen we stellen dat het een veelzijdige vriendschap is geworden. 
Dank dat je aan mijn zijde staat.
Jet en Benyamin, geliefde schoonouders. Iedere donderdag halen jullie onze 
kinderen op van school en crèche en verwennen ons gezamenlijk met een heer-
lijke maaltijd. Daarnaast zijn jullie altijd bereid bij te springen als dat nodig is. 
Zonder jullie was het veel moeilijker geweest het promoveren te combineren met 
een druk gezinsleven. Jullie zijn fantastisch!  
Lieve pa en ma, drie kinderen en nu ook de derde Doctor. Dat kan geen toeval 
zijn! Het zullen voor een deel degelijke Zeeuwse genen zijn, maar nog belangrij-
ker: jullie hebben ons een gezond leven vol interesses en werklust voorgedaan. 
Goed voorbeeld doet goed volgen. Heel veel dank voor alle steun en toewijding!
Lieve Benyamin, je was nog een baby toen ik aan dit onderzoek begon. In de 
tussentijd ben je uitgegroeid tot een grote jongen van 7, die dit stukje al zelf 
kan lezen. Je mopperde wel eens, dat ik weer aan het werken was en toen je op 
een gegeven moment tegen ons buurjongetje zei: “ Sorry, ik heb nu echt geen tijd 
om te spelen, want ik heb nog zóveel te doen”, begon ik me te realiseren dat het 
tijd werd dat het einde van het proefschrift in zicht kwam. Het is nu zover en ik 
hoop nog veel tijd met jou door te brengen!
Lieve Hannah. Jij bent nu bijna 4, een leeftijd die je erg graag wilt berei-
ken, want je wilt naar school. Naarmate je groter werd nam je er steeds minder 
genoegen mee dat ik me terugtrok om te werken. “Ik wil ook werken!” was je 
reactie de laatste tijd. Hoe dan ook, werk of geen werk, jouw aanwezigheid is 
een feest voor mij!
Lieve Vita, aan jou is dit alles nog voorbij gegaan. Jij bent nu bijna een half 
jaar. Jouw lieve lach doet alles relativeren!
Lieve Hansje, vriendin en grote liefde. Wat hebben wij in de afgelopen tien 
jaar fantastische dingen meegemaakt! Jij hebt me geholpen grenzen te verleg-
gen: we hebben gereisd, kinderen gekregen en een heerlijk familieleven ge-
crëeerd. Jij moedigde me aan onderzoek te gaan doen, waar ik nu ook de rust 
voor had. Het was wel eens schipperen tussen strijdige belangen, maar in tijden 
van hoge werkdruk gaf je me de ruimte. Heel veel dank daarvoor. Ik ga niet zeg-
gen dat het nu rustiger wordt, want als dat op het ene gebied al zo zou zijn dan 
zoeken we wel weer iets op het andere. Dat geldt gelukkig zowel voor jou als 
voor mij. Daar varen wij nu eenmaal wel bij. Ik vertrouw erop dat we de wind in 
de zeilen blijven houden!


